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Stimulus-responsive polymer microgels swell and shrink reversibly upon exposure to 
various environmental stimuli such as change in pH, temperature, ionic strength or magnetic 
fields. Therefore, they become ideal candidates for biomaterial applications. For this work, we 
focus on the several intelligent microgels and their application on two areas: the cell scaffold and 
the drug delivery system.  
As for the cell scaffold, it can be realized by colloidal supra-structure microgels, which 
constructed by the thermo-driven gelation of the colloidal dispersion of poly(N-
isopropylacrylamide-co-acrylamide) poly(NIPAM-co-AAm) microgels (Chapter 3). Such 
microgels exhibit a reversible and continuous volume transition in water with volume phase 
transition temperature (VPTT) ≈ 35 oC and remain partially swollen and soft under physiological 
conditions. More importantly, the size of the microgel particles can affect the sol-to-gel phase 
transition of the microgel dispersions, alter the syneresis degree of the constructed colloidal 
supra-structures, and tailor the cytocompatibility. The constructed colloidal supra-structure can 
be regarded as a model system for a new class of cell scaffolds. 
As for drug delivery system, Chapter 4 and Chapter 5 focus on the development of 
biocompatible microgels–based systems for delivering a traditional anti cancer drug−curcumin. 
iv 
 
These thermo-responsive core-shell structure microgels are constructed from oligo(ethylene 
glycol) as a hydrophilic shell and hydrophobic biocompatible materials as core, such as poly(2-
vinylanisole) and poly(4-allylanisole). The rationally designed core chain networks can 
effectively store the hydrophobic curcumin drug molecules via hydrophobic interactions, thus 
provide high drug loading capacity; while thermo-sensitive nonlinear poly(ethylene glycol) (PEG) 
gel shell can trigger the drug release by local temperature change, offering sustained drug release 
profiles. In Chapter 5, additionally embedded of magnetic Fe3O4 nanoparticles enable such 
hybrid nanogels to delivery pharmaceuticals to a specific site of the body by applying a gradient 
magnetic field. 
Chapter 6 investigated a class of well-defined glucose-sensitive microgels as an insulin 
drug release carrier, obtained via polymerization of 4-vinylphenylboronic acid (VPBA), 2-
(dimethylamino) ethyl acrylate (DMAEA), and andoligo(ethylene glycol)methyl ether 
methacrylate (MEO5MA). The presence of MEO5MA monomer could retard the glucose-
sensitive network from swelling because the rapid hydrogen bonding between the glucose 
molecules and the ether oxygens of the MEO5MA is prior to the glucose binding to the PBA 
groups.  Therefore, the set point of glucose sensitivity of microgels could be adjusted possibly 
and result in potential biomedical applications. Compared to the non-imprinted copolymer 
microgels, the glucose imprinting of the microgels can create and rigidly retain more binding 
sites complementary to the shape of the target glucose molecule in the crosslinked polymer 
network, thus improve the sensitivity and selectivity of the microgels in response to the glucose 
level change. Additionally, the introduction of fluorescent Ag nanoparticles (NPs) to the 
microgels can realize the integration of optical glucose detection and self-regulated insulin 




I first wish to express my deepest appreciation to my supervisor, Professor Shuiqin Zhou, 
who not only served as my supervisor but also encouraged and challenged me throughout my 
academic program. Without her help, this dissertation would not have been written.  
I am most grateful for having had the opportunity to work with wonderful people in our 
group. Thanks to Dr. Weitai Wu, who used to be Post-doctoral fellow in our group and gave me 
a lot of great suggestions on my research projects. Thanks to Ting Zhou, Yingyu Li, Dr. Hui 
Wang. They helped me a lot to develop my work. 
I am also grateful to Professor Michal Kruk and Professor Yujia Xu for being on my 
supervisory committee, and for their valuable insights and helpful discussion. 
I wish to thank my family and friends who have been supportive and kind throughout all 
my years as a graduate student. Special thanks to my parents and my husband. 
We gratefully acknowledge the financial support from American Diabetes Association, 












Table of Contents 
Chapter 1 Introduction of Microgels. ...….........…...…...…...… ………………...…….……....1 
1. 1            Definition of Microgels ……………………………….………………………...…….1 
1. 2            Microgel Synthesis ……...…….……………………………………….………...……3 
      1. 2. 1  Synthetic Routes …………………………………………………………….………..3  
      1. 2. 2  Precipitation Polymerization ……………………………….....……………..…...…...5 
1. 3            Microgel Properties …….. ……………………………………………………………7 
      1. 3. 1  Microgel Structure.………………………………… …..…………………………….7 
      1. 3. 2  Microgel Swelling Theory ……………………………..………………………….….8 
      1. 3. 3  Stimuli-Responsive Behavior…………………………..………..…………………..10 
          1. 3. 3. 1 Temperature…………………………………..……………...………………….10 
          1. 3. 3. 2 pH…………………………………………….……………..……….……….….11 
           1. 3. 3. 3 Ionic ……………………………………………………...……………..……….12 
          1. 3. 3. 4  Other Influences …………………………………..…..…………………….….13 
1. 4            Characterization ..........................................................................................................14 
1. 5            Applications of Microgels ………………………………..……..…………………...14 
      1. 5. 1  Biomaterials/Biomedical Applications............................….................................…...14 
      1. 5. 2  Optical Sensor …………………………...……….……………………....…...……..17 
      1. 5. 3  Intelligent Drug Delivery Systems ……...…………...….……………………...……21 
1. 6            Conclusion ..........................................................................................................…....24 
1. 7            References ……………………………………………………………………..…….25 
 
Chapter 2 Materials and Methods..........................................................................................…29 
vii 
 
2. 1            Preparation of Microgels …………………………………………………….…........29 
      2. 1. 1  Reagents……….………………………………………………………………….….29 
      2. 1. 2  Synthesis of Microgels ………………………………………………………....……32 
      2. 1. 3  Purification of Microgels ……………….…………………………...……................32 
2. 2            Characterization of microgels ……………….………………………………………33 
      2. 2. 1  Transmission electron microscopy …………………...………..…………….………33 
      2. 2. 2  Size and Size Distribution …………………………….………..……………………35 
      2. 2. 3  Confocal Microscopes ……………………………………………….....…...............36 
      2. 2. 4  Cell toxicity…………………………………………….……………….…………....37 
2. 3            Synthesis of inorganic nanoparticles (NPs) in the microgels.……..… …...………...38 
      2. 3. 1  Synthesis of Ag NPs …………………………...…………………….....…………...38 
      2. 3. 2  Synthesis of Fe3O4 NPs …………………………...…………..……….....………….38 
      2. 3. 3  Characterizations of NPs……………………………..………………...…………….39 
2. 4            References ..……………………………………………….…………..………….….40 
 
Chapter 3 A Colloidal Supra-structure of Responsive Microgels  
                  as a Potential Cell Scaffold…………………………………………….……..….....41 
3. 1            Introduction…………………………………………………………….……….…....41 
3. 2            Experimental ………………………………………………………….………..…....44 
      3. 2. 1  Materials………………………………………………………………………..……44 
      3. 2. 2  Synthesis of poly(NIPAM-co-AAm) microgels ………...………………………..…45 
      3. 2 .3  TEM characterization …………………………………..………………………..….45 
      3. 2. 4  Dynamic light scattering (DLS) characterization ……………….………………..…45 
viii 
 
      3. 2. 5  ζ-Potential characterization……………………………………………………………………..…. 46 
      3. 2. 6  Rheological characterization ……………………………………………………..….46 
      3. 2. 7   Syneresis…………………………………………………………...……………..….47 
      3. 2. 8  Cell culture………………………………………………………………………..….47 
      3. 2. 9  Cell viability……………………………………………………………..………..….48 
      3. 2. 10   Quantification of cell viability by using MTT assay……………………………….48 
3. 3            Results and Discussion……………………………………………………………....49 
      3. 3. 1  Synthesis of poly(NIPAM-co-AAm) microgels …………………………...……..…49 
      3. 3. 2  Temperature-responsive volume phase transition  
                  and surface charge of poly(NIPAM-co-AAm) microgels …………………..……….51 
      3. 3. 3  Formation of a colloidal supra-structure  
                  of poly(NIPAM-co-AAm) microgels ……………………………………..……….54 
      3. 3. 4  Syneresis of the collodial supra-structure ……………………………………...……60 
      3. 3. 5  Cytocompatibility of the collodial supra-structure……………………..……...…….63 
3. 4            Conclusion………………………………………………………………………..….66 
3. 5            References…………….…………………………………………………………..….68 
 
Chapter 4 Tailored Core-Shell Microgels for Highly Efficient  
                  Curcumin Delivery Carrier……………………………………………………......71 
4. 1            Introduction....……………………………………………………….…………..…...71 
4. 2             Experimental……………………………....……….……………………………......75 
      4. 2. 1  Materials…………………………………………………………………………..…75 
      4. 2. 2  Synthesis of poly(2-vinylanisole) core microgels ………….….........................…….75 
ix 
 
      4. 2. 3  Synthesis of PVAS@PEG core-shell microgels…………….……...…………….….76 
      4. 2. 4  Drug loading and release …………………………………………......…………..…77 
      4. 2. 5  Incorporation of microgels into mouse melanoma cells B16F10………….………...78 
      4. 2. 6  In vitro cytotoxicity ………………………………………………………......…..….78 
      4. 2. 7  Characterization ………………………………………………………….............….79 
4. 3            Results and Discussion ………………………………………………................…...80 
      4. 3. 1  Synthesis and structure of PVAS@PEG core-shell microgels.…...……........…….…80 
      4. 3. 2  Temperature-responsive volume phase transitions of the core-shell microgel. . . .….83 
      4. 3. 3  Drug loading capacity of the PVAS@PEG core-shell microgels..… . ..…………….85 
      4. 3. 4  In vitro release studies...………………………………………………...……………88 
      4. 3. 5  Hydrolytic Degradation of Curcumin …………………........…………….……..…..91 
      4. 3. 6  Tumor cell imaging...………………………………… . . ……………..……………93 
      4. 3. 7   In vitro cytotoxicity...…………………………………. ..……………..……………95 
4. 4            Conclusion………………………………………………….…..…..…...…..…....….97 
4. 5            References…………………………………………….……………..…....……...…..99 
 
Chapter 5 Magnetic Core-Shell Hybrid Nanogels for  
                  Antitumor Drug Delivery…………………………………………….…………..……104 
5. 1            Introduction ..…………………………………………………………………..…...104 
5. 2            Experimental……………………………………………………………………..…109 
      5. 2. 1  Materials....………………………………………………………… .……………..109  
      5. 2. 2  Synthesis of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels ……...…...……...110 
          5. 2. 2. 1 Synthesis of Fe3O4 nanoparticles……...…………….……………...……….…110 
x 
 
          5. 2. 2. 2 Synthesis of Fe3O4@poly(4-allylanisole) nanogels……...………….…....……110 
          5. 2. 2. 3 Synthesis of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels…….....…..…112 
      5. 2. 3  In vitro magnetic manipulation ……...…………….………………………....….…113 
      5. 2. 4  Curcumin loading and release ………………………………………….….….……113 
      5. 2. 5  In vitro cytotoxicity ……………………………………………………..….....……114 
      5. 2. 6  Characterization ………………………………………………………………...….115 
5. 3            Results and Discussion………………………………….………………………….116 
      5. 3. 1  Synthesis of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels ……….………....116 
      5. 3. 2  Temperature induced volume phase transition ………………………………...…..120 
      5. 3. 3  Magnetic properties of the synthetic Fe3O4@poly(4-allylanisole) nanogels and 
                  Fe3O4@poly(4-allylanisole)-PEG hybrid nanogel…………………………....…….123 
      5. 3. 4  Drug loading capacity of the  
                  Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels ……………………..................126 
      5. 3. 5  In vitro release studies …………………………………………………..…………129 
      5. 3. 6  In vitro cytotoxicity ……………………………………………………..…….……131 
5. 4            Conclusion…………………………….……………………………………………132 
5. 5            References………………………………………………………….……………….134 
 
Chapter 6 A Microgel of On-Site Tunable Glucose-Response for  
                  Efficient Insulin Delivery…..……..…………………………………….…….......138 
6. 1            Introduction…………………………………………………….…………………...138 
6. 2            Experimental……………………………………………………………….……….143 
      6. 2. 1  Materials…………………………………………………………………………....143 
xi 
 
      6. 2. 2  Synthesis of glucose responsive  
                  poly(VPBA-DMAEA-MEO5MA) microgel….……………………………..…………..143 
      6. 2. 3  Synthesis of imprinted glucose responsive  
                  poly(VPBA-DMAEA-MEO5MA) microgels…………………………….………...…144 
      6. 2. 4  Insulin loading and release ...…………………………………… …...……….……145 
      6. 2. 5  In vitro cytotoxicity...………………………………………… ……….……….……146 
      6. 2. 6  Synthesis of hybrid microgels with Ag NP as core and the glucose-imprinted 
                  poly(VPBA-DMAEA-MEO5MA) gel as shell...………… …………… …….……147 
          6. 2. 6. 1  Synthesis of Ag NPs...…………………………………………… .… ….……147 
          6. 2. 6. 2  Synthesis of Ag @ glucose-imprint  
                          poly(VPBA-DMAEA-MEO5MA) hybrid microgels.……………….. ….……147 
       6. 2. 7  Characterization...……………………………………………….………...…………148 
6. 3            Results and discussion………………………………………………………….…..149 
      6. 3. 1  Synthesis of glucose responsive  
                  poly(VPBA-DMAEA-MEO5MA) microgels ………………………………….…...149 
      6. 3. 2  Glucose-induced volume phase transition ……………………..……………….…..152 
      6. 3. 3  Insulin loading and in vitro  
                  glucose-regulated drug release from the microgels……........……………….….…154 
      6. 3. 4  In vitro cytotoxicity …………….………………………...…………………….…..158 
      6. 3. 5   Glucose-induced volume phase transition of imprinted microgels……….…….…..159 
      6. 3. 6   FITC-insulin loading and in vitro glucose regulated  
                   insulin release from the imprinted microgels ……………..…………………….…..161 
      6. 3. 7   Optical glucose detection of the core-shell hybrid microgels with Ag NP as core and 
xii 
 
                  glucose-imprinted poly(VPBA-DMAEA-MEO5MA) gel layer as shell….….……..164 
6. 4            Conclusion……………………………………………………………………….....169 
6. 5            Reference…………………………………………………………………………...171 
 
Chapter 7  Summary………….…………………………………………………………...….174 
 
Bibliography 
Chapter 1 …………………………………………………………………………………..…….25 
Chapter 2 …………………………………………………………………………………..…….40 
Chapter 3 …………………………………………………………………………………..…….68 
Chapter 4 …………………………………………………………………..………..………..….99 
Chapter 5 ………………………………………………………………………………….……134 













List of Figures 
Chapter 1 
Figure 1−1 Schematic of change in microgel size in response to environmental stimuli  
…………………………………………………………………………………………….……….2 
Figure 1−2 Mechanism of emulsion polymerization 
……………………………………………………………………………………………………..4 
Figure 1−3 Mechanism of precipitation polymerizations.  
………………………………………………………………………………………………….….6 
Figure 1−4 a Illustration of typical thermoresponsive behavior of poly(NIPAM) microgel 
particles; b associated change in hydrodynamic diameter of poly(NIPAM) microgel particles as a 
function of temperature 
……………………………………………………………………………………...............…….10 
Figure 1−5 Conformational changes of a polyelectrolyte microgel as a function of pH 
……………………………………………………………………………………………...…….11 
Figure 1−6 Hydrodynamic diameter of poly(NIPAM-co-AA) (95:5%) microgel particles as a 
function of ionic strength of NaCl at pH 6 and 25 °C at a microgel concentration of 0.07% (w/w). 
………………………………………………………………………………...………………….12 
Figure 1−7 Change in the de-swelling ratio of poly(NIPAM) (9% MBA) microgel particles as a 
function of increasing volume fraction of three alcohols. The alcohols investigated are MeOH 
(filled diamond), EtOH (empty square) and 2-PrOH (filled circle). 
…………………………………………………………………………………...............……….13 
Figure 1−8 The size of soft microgels can affect the thermo-driven sol-to-gel transition, the 
xiv 
 
syneresis degree, and the cell proliferation rate of the constructed colloidal supra-structures for 
cell scaffolds. 
…………………………………………………………………………………...............……….16 
Figure 1−9 Schematic diagrams showing three types of hybrid micro-/nanogel-based optical 
probes: (A) Type 1 where the antibody or specific targeting ligand acts as a 
chemical/biochemical signal receiver; (B) Type 2 where an optical moiety acts directly as the 
chemical / biochemical signal receiver; and (C) Type 3 where a responsive polymer gel network 
chain acts as the chemical/biochemical signal receiver, which will undergo a volume phase 
transition, change the physicochemical environment of the optical moieties, and convert the 
received signal into an optical signal. 
…………………………………………………………………………………...............……….18 
Figure 1−10 Schematic illustration of multifunctional core-shell hybrid nanogels. 
…………………………………………………………………………………...............……….19 
Figure 1−11 Reversible fluorescence quenching and antiquenching of CdS QDs embedded in the 
interior of p(NIPAM-AAm-PBA) microgels in response to the change in glucose concentration. 
…………………………………………………………………………………...............……….21 
Figure 1−12 Model of triggerable drug release from the responsive microgels or shell-responsive 
core-shell structure microgels with drug in the core. 
…………………………………………………………………………………...............……….22 
Chapter 2 
Figure 2−1 Schematic illustration of Transmission Electron Microscope. 
……………………………………………………………………………………………..…….34 




Figure 2−3 Schematic of confocal microscope.  
……………………………………………………………………………………..………….….36 
Chapter 3 
Figure 3−1 Typical TEM image of the poly(NIPAM-co-AAm) microgels. 
…………………………………………………………………….………………………..…….49 
Figure 3−2 Size distribution of poly(NIPAM-co-AAm) microgels. All measurements were made 
at 37 °C and a scattering angle θ = 45o. 
………………………………………………………………………………………………..….50 
Figure 3−3 (A) Temperature-dependent average Rh value of poly(NIPAM-co-AAm) microgels. 
(B) Size distributions of NM5 at different temperatures All measurements were made at pH = 7.4 
and a scattering angle θ = 45o. 
……………………………………………………………………………………………..…….51 
Figure 3−4 ζ-potential of poly(NIPAM-co-AAm) microgels All measurements were made at pH 
= 7.4. 
……………………………………………………………………………………………..…….53 
Figure 3−5 Stress dependence of dynamic modulus of a 4 wt% poly(NIPAM-co-AAm) microgel 
dispersion in the presence and absence of NaCl, respectively. All measurements were made at 
37.0 oC and an oscillation frequency of 0.1 Hz. 
……………………………………………………………………………………………..…….55 
Figure 3−6 Temperature dependence of dynamic modulus of 4 wt% poly(NIPAM-co-AAm) 
microgel dispersions (pH = 7.4, and ion strength = 0.154 M): (A) NM1, (B) NM2, (C) NM3, (D) 
xvi 
 
NM4, and (E) NM5. All measurements were made at a stress of 0.05 Pa and an oscillation 
frequency of 0.1 Hz. 
…………………………………………………………………………………………...……….57 
Figure 3−7. Observed phases of poly(NIPAM-co-AAm) microgel dispersions (pH = 7.4, and ion 
strength = 0.154 M) at 37.0 °C, showing the effect of particle size on the critical ϕeffective for sol-
to-gel transition.  
……………………………………………………………………………………………..……..60 
Figure 3−8 (A) Syneresis kinetics of the colloidal supra-structures as-constructed from 4 wt% 
poly(NIPAM-co-AAm) microgel dispersions of pH 7.4 and ion strength 0.154 MAll 
measurements were made at 37.0 oC. (B) Time dependence of ∆Lt/∆L0 during Syneresis. The 
solid lines are based on the fitting of Tanaka-Fillmore’s model as described in Eq. (3−4). 
……………………………………………………………………………………………..…….61 
Figure 3−9 Live/Dead assay of the colloidal supra-structures constructed from the poly(NIPAM-
co-AAm) microgels of (A) NM1, (B) NM2, (C) NM3, (D) NM4, and (E) NM5, respectively, 
after 1, 4, 7, 14, and 21 days’ of cell seeding. 
……………………………………………………………………………………………..…….63 
Figure 3−10 Results of MTT assay, showing the cell viability with the colloidal supra-structures 
acting as cell scaffolds, which were constructed from 4 wt% of poly(NIPAM-co-AAm) 




Figure 4−1 Typical Schematic illustration of curcumin-loaded core-shell microgels with PVAS 
xvii 
 
gel as a core and the nonlinear PEG gel as a shell. The hydrophobic curcumin drug is 
encapsulated within the inner PVAS core, which is coated by an outer PEG-based shell to offer 
both stability in aqueous media and temperature sensitivity. Such designed core-shell microgels-
based drug delivery system has the potential to render the hydrophobic curcumin dispersible in 
aqueous media, thus overcome the barriers of poor solubility of curcumin in water. 
…………………………………………………………………………………………..……….74 
Figure 4−2 Hydrodynamic radius distribution of PVAS@PEG core-shell microgels measured at 
22 °C and a scattering angle of θ = 45°. 
……………………………………………………………………………………………..…….81 
Figure 4−3 Typical TEM images of PVAS@PEG core-shell microgels VEM2 (A) and VEM3 
(B). 
………………………………………………………………………………………………..….82 
Figure 4−4 Temperature dependence of the average Rh values of PVAA@PEG core-shell 
microgels measured at a scattering angle θ = 45°. 
…………………………………………………………………………………..………….…….83 
Figure 4−5 Curcumin loading capacity of the PVAS@PEG core-shell microgels as a function of 
shell thickness, measured at 22 °C. 
…………………………………………………………………………………..……………….85 
Figure 4−6 Releasing profiles of curcumin from the core-shell microgels VEM1 (A), VEM2 (B), 
VEM3 (C), and VEM4 (D) at different temperatures. Curcumin has been pre-loaded into core-
shell microgel at 22°C. In the blank, 1 mL diluted solution of free curcumin (containing 5% 
ethanol) with an equivalent amount of drug to the trapped in VEM1 was performed at 41°C. All 




Figure 4−7 Releasing profiles of curcumin from the core-shell microgels VEM2 (A) and VEM3 
(B) at different temperatures. Curcumin has been pre-loaded into core-shell microgel at 37 °C. 
All releasing experiments were carried out in 50 mL PBS (0.005M) of pH = 6.15. 
………………………………………………………………………………………….……….90 
Figure 4−8 Fluorescence spectra of curcumin in pH = 7.4 PBS buffer (A) and curcumin-loaded 
VEM3 (B) over a course of 180 min. The decays of the curcumin at the absorption maxima are 
shown in C All experiments were carried out at 37 °C. 
………………………………………………………………………………………….……….92 
Figure 4−9 Scanning confocal fluorescence images of mouse melanoma B16F10 cells upon 
staining with curcumin loaded core-shell microgels VEM1 (A), VEM2 (B), VEM3(C), and 
VEM4 (D), respectively. Excitation wavelength is 496 nm. 
………………………………………………………………………………………….……….93 
Figure 4−10 Z-Scanning confocal fluorescence transmission images of mouse melanoma cells 
B16F10 incubated with curcumin loaded core-shell microgels VEM3. 
………………………………………………………………………………………….……….95 
Figure 4−11 Comparison of B16F10 cell survivability following treatments with core-shell 
microgels VEM1 and VEM4 as drug carriers, respectively; B16F10 cell survivability after 
treated with free and free curcumin solutions  
………………………………………………………………………………………….……….97 
Chapter 5 
Figure 5−1 Typical TEM images of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels FAE−1. 
……………………………………………………………………………….……………..….118 
Figure 5−2 Hydrodynamic radius distribution of Fe3O4@poly(4-allylanisole)-PEG hybrid 
xix 
 
nanogels measured at 24 °C and a scattering angle of θ = 30°. 
……………………………………………………………………….…..…..………………….120 
Figure 5−3 Temperature dependence of the average Rh values of Fe3O4@poly(4-allylanisole)-
PEG hybrid nanogels measured at a scattering angle θ = 30°. 
………………………………………………………………………………………………….120 
Figure 5−4 Size distribution of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels FAE−1 at 
different temperatures All measurements were made at pH = 7.4 and a scattering angle of θ = 30°. 
………………………………………………………………………………………………….122 
Figure 5−5 Typical digital photographs, showing, Fe3O4@poly(4-allylanisole) nanogels (FA−1, 
A), and Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels (FAE−1, B) before (left) and after 
(right) placing a permanent magnet next to it. 
……………………………………………………………………………………………….….123 
Figure 5−6 Typical hysteresis loop at 300 K showing typical ferromagnetic behavior of Fe3O4 
nanoparticles, Fe3O4@poly(4-allylanisole) nanogels (FA−1), and Fe3O4@poly(4-allylanisole)-
PEG hybrid nanogels (FAE−1). 
……………………………………………………………………………………………….….124 
Figure 5−7 Zero-field-cooling (ZFC) and field-cooling (FC) curves of Fe3O4 nanoparticles, 
Fe3O4@poly(4-allylanisole) nanogels (FA−1), and Fe3O4@poly(4-allylanisole)-PEG hybrid 
nanogels (FAE−1), respectively,  measured in an applied field of 50 Oe. 
……………………………………………………………………………………………….….125 
Figure 5−8 Releasing profiles of curcumin from the Fe3O4@poly(4-allylanisole)-PEG hybrid 
nanogels FAE−1 (A), FAE−2 (B), FAE−3 (C), and FAE−4 (D) at different temperatures. 
xx 
 
Curcumin has been pre-loaded into core-shell microgel at 22 °C.  
……………………………………………………………………………………………….….129 
Figure 5−9 Comparison of B16F10 cell survivability following treatments with Fe3O4@poly(4-
allylanisole)-PEG hybrid nanogels FAE−1 and FAE−4 as drug carriers, respectively; B16F10 cell 
survivability after treated with free microgels and free curcumin solutions. 
……………………………………………………………………………………………….….131 
Chapter 6 
Figure 6−1 Typical TEM image of the poly(VPBA-DMAEA-MEO5MA) microgels (VDM-3). 
…………………………………………………………………………………………….…….150 
Figure 6−2 pH-dependent average Rh values of the microgels All measurement were made at 37 
°C and a scattering angle θ = 45°. 
…………………………………………………………………………………………….…….151 
Figure 6−3 Swelling ratio of the microgels as a function of glucose concentration in PBS of pH 
= 7.4. All measurements were made at 37 °C and a scattering angle θ = 45°. 
…………………………………………………………………………………………….…….154 
Figure 6−4 Releasing profiles of FITC-insulin from VDM-1 (A), VDM-3 (B), and VDM-4 (C), 
in the presence of 0, 3, 6, 8, and 15 mM glucose in PBS of 7.4. In the blank release, the release 
experiment of the FITC-insulin solution with an equivalent amount of drug to that trapped in 
VDM-1 was performed in PBS of 7.4. All experiments were carried out at 37 °C. 
…………………………………………………………………………………………….….…157 
Figure 6−5 In vitro cytotoxicity of the microgels against B16F10 cells.  
…………………………………………………………………………………………….…….158 
Figure 6−6 Glucose-dependent average Rh values of the microgels of VDM-3, IVD-1, and IVD-
xxi 
 
2, in PBS of pH = 7.4. All measurements were made at 37 °C and a scattering angle θ = 45°. 
…………………………………………………………………………………………….…….161 
Figure 6−7 Releasing profiles of FITC-insulin from IVD-1 (A) and IVD-2 (B), in the presence 
of 0, 3, 6, 8, and 15 mM glucose in PBS of 7.4. All experiments were carried out at 37 °C. 
…………………………………………………………………………………………….…….163 
Figure 6−8 Typical UV−vis absorption spectra of the Ag@IVD-2 hybrid microgels. As a 
comparison, the absorption spectrum of the free Ag NPs is also presented. 
…………………………………………………………………………………………….…….164 
Figure 6−9 TEM image of the core-shell hybrid microgels Ag@IVD-2 hybrid microgels with Ag 
NP as core and glucose-imprinted poly(VPBA-DMAEA-MEO5MA) gel layer as shell. 
…………………………………………………………………………………………….…….165 
Figure 6−10 PL spectra of the Ag NPs, Ag@IVD-2 hybrid microgels, and IVD−2 microgels, 
respectively. 
…………………………………………………………………………………………….…….167 
Figure 6−11 Typical evolution of the PL spectra of the Ag@IVD-2 hybrid microgels in response 
to the increase in glucose concentration change. All measurements were made in PBS of pH = 
7.4 and 37 °C. Excitation wavelength = 492 nm. 
…………………………………………………………………………………………….…….167 
Figure 6−12 Glucose-responsive PL decay (I0−I)/I0 of the imprinted and non-imprinted hybrid 
microgels, respectively. I0 and I are the PL intensity at 588 nm in the absence and presence of 
glucose at different level. All measurements were made in PBS of pH = 7.4 and 37 °C. Excitation 




List of Tables and Schemes 
Chapter 2 
Table 2−1 Structures and function of reactants used in free radical precipitation polymerization 
for the synthesis of microgels in this work. 
…………………………………………………………………………………….…………..….31 
Chapter 3 
Scheme 3−1 The size of soft microgels can affect the thermo-driven sol-to-gel transition, the 
syneresis degree, and the cell proliferation rate of the constructed colloidal supra-structures for 
cell scaffolds. 
……………………………………………………………………………………..………….….44 
Table 3−1 Dependence of microgel particle size (Rh) on feeding ratios of NIPAM/BIS/SDS. All 
measurements were made at 37.0 °C. 
……………………………………………………………………………………..………….….50 
Chapter 4 




Scheme 5−1 Schematic illustration of curcumin-loaded Fe3O4@poly(4-allylanisole)-PEG hybrid 
nanogels with small Fe3O4 NPs core embedded in the poly(4-allylanisole)-PEG double-layer gel 
shell. The hydrophobic curcumin drug is encapsulated within the inner poly(4-allylanisole), 
which is coated by an outer PEG-based shell to offer both stability in aqueous media and 
xxiii 
 
temperature sensitivity. When temperature increases, the hybrid nanogels shrink and release 
curcumin molecules out. 
………………………………………………………………………………………...………...106 
Table 5−1 Structures and function of all the monomers, crosslinkers, and curcumin molecules 
using in this work. 
………………………………………………………………………………………………..…109 
Table 5−2 Feeding compositions and hydrodynamic radius (Rh) for synthesis of the 
Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels. 
…………………………………………………………………………………………..……....112 
Table 5−3 Curcumin loading capacity of the Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels. 
………………………………………………………………………………………………..…126 
Chapter 6 
Scheme 6−1 Complexation equilibrium between the PBA and glucose in aqueous solution.  
……………………………………………………………………………………………….….140 
Scheme 6−2 Schematic illustration of poly(VPBA-DMAEA-MEO5MA) microgels that can tune 
the onset for glucose-induced volume phase transition only after the glucose concentration 
beyond a certain level. 
…………………………………………………………………………………………….…….142 
Table 6−1 
Feeding compositions for synthesis of the poly(VPBA-DMAEA-MEO5MA) microgels. 
…………………………………………………………………………………………….…….144 
Scheme 6−3 Schematic illustration of the approach to the molecularly imprinted poly(VPBA-
DMAEA-MEO5MA) microgels with specific glucose-binding sites for highly sensitive and 
xxiv 
 

























List of Abbreviations 
AAm                           Acryamide 
AAPH                        2,2′-azobis(2-methylpropionamidine) dihydrochloride 
AO                                 Acridine Orange 
EB                              Ethidium Bromide 
APS                            Ammonium Persulfate  
BIS                              N,N'-methylenebisacrylamide  
Con A                          Concanavalin A 
CSM                           Core-shell Microgels  
DLS                            Dynamic Laser Scattering  
DMEM                       Dulbecco’s Modified Eagle Medium 
DMSO                           Dimethyl Sulfoxide 
DVB                           Divinylbenzene 
EDC                            N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide Hydrochloride 
EGDM                        Ethylene Glycol Dimethacrylate  
FBS                             Foetal Bovine Serum 
FITC-insulin               Fluorescein Isothiocyanate-Labeled Insulin 
GOx                            Glucose Oxidase 
LCST                          Lower Critical Solution Temperature 
MBAAm                     N,N'-methylenebisacrylamide  
MEO2MA                   2-(2-methoxyethoxy)ethyl methacrylate 
MEO5MA                   Oligo(ethylene glycol)methyl ether methacrylate (Mn = 300 g/mol) 
MTT                           3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium Bromide 
xxvi 
 
NaOH                         Sodium Hydroxide 
NPs                             Nanoparticles 
PANI                          Polyaniline 
PBA                            Phenylboronic Acid 
PEG                            Poly(ethylene glycol)  
PEGDMA                   Poly(ethylene glycol) Dimethacrylate 
PL                                   Photoluminescence 
PMAA                           Polymethylmethacrylate 
PNIPAM                     Poly(N-isopropylacrylamide)  
PRINT                           Particle Replication Inn Non-wetting Templates 
PS                               Polystyrene 
PSD                                Particle Size Distribution 
PVAS                          Poly(2-vinylanisole) 
QDs                            Quantum Dots 
SDS                            Sodium Dodecyl Sulfate      
SFEP                           Surfactant-Free Emulsion Polymerization          
TEM                           Transmission Electron Microscopy 
VPBA                         4-Vinylphenylboronic acid  





Chapter 1  
Introduction of Responsive Polymer Microgels 
 
1. 1 Introduction of Microgels 
            Aqueous microgels are an important part of water-borne polymer colloids and have been 
widely employed in coating industry, agriculture, food processing, and medicine formulation to 
modify rheological properties, to retain water, and for many other purposes1. There is no 
universal definition of microgels; however, some special properties can be described.  Aqueous 
microgels are mostly spherical particles with average diameter between 50 nm and 5 µm. They 
are stabilized in continuous medium and form stable dispersions. Microgels are characterized by 
a degree of swelling, an average cross-linking density, and characteristic time constants for 
swelling and shrinking1. The swelling degree depends upon the interplay between polymer-
polymer and polymer-water interactions and the crosslinking degree. Swelling occurs when ionic 
repulsion and osmotic forces exceed attractive forces, such as hydrogen bonding, van der Waals 
interactions, hydrophobic and specific interactions among the polymer chains2, 3. Numerous 
factors can influence the behavior of polymer chains inside the microgel, such as temperature, 
pH4, ionic strength, electric field5, and etc.. By taking into account these features, aqueous 




adjust their dimensions, densities, and related properties according to the surrounding conditions6. 
(Figure 1−1) 
 
Figure 1−1 Schematic of change in microgel size in response to environmental stimuli2. 
 
            In the last decade, numerous stimuli-sensitive polymers have been applied in the design 
of microgel systems. One of the widely studied stimuli-sensitive polymers is poly(N-
isopropylacrylamide) (PNIPAM)7. The PNIPAM microgel has been first reported by Philip 
Chibante, a high school summer student, under Dr. Pelton’s supervision in 19788. This microgel 
exhibits endothermic entropy-driven phase transition in water9. The amide side chains of 
PNIPAM form hydrogen bonds to water, while the isopropyl group induces hydrophobic 
structure and this leads to entropy-controlled polymer-polymer interactions. The PNIPAM chains 
exhibit a random-coil structure if the solvent-polymer interactions are stronger than the polymer-
polymer interactions. If the hydrogen bonds between water and the PNIPAM chains break 
because of the increased temperature, polymer-polymer interactions become dominant, leading 
to a coil-globule transition. The temperature at which this phase separation occurs is called the 
lower critical solution temperature (LCST) of a polymer10. The microgels of crosslinked 
PNIPAM chains exhibit a thermoresponsive volume phase transition temperature (VPTT) close 
to the LCST of non-crosslinked PNIPAM chains11.  PNIPAM-based microgels will shrink if the 




            Compared to bulk gels, microgels have several advantages. First, they can respond very 
quickly to the environmental change. Second, the mono-dispersed microgel particles, as building 
blocks, can be readily assembled to meet various application requirements5. Third, they can 
provide potential biocompatibility and their surface can be conjugated to receptor-specific 
molecules to achieve targeting ability12. Therefore, microgels have attracted much attention for 
applications in materials and biomedical fields during the past several decades.       
 
1. 2 Microgel Synthesis 
1. 2. 1  Synthetic Routes 
            Aqueous microgels can be prepared by three synthetic strategies: (1) physical self-
assembly or chemical crosslinking of prepolymers in homogeneous phase or in microdroplets; (2) 
polymerization of monomers in homogeneous phase or in microdroplets; (3) photolithographic 
techniques6.  
            Physical or chemical crosslinking of polymers can be realized in water or in a water-in-
oil (W/O) emulsion system. The former strategy is usually used to prepare chitosan-based 
microgels. Reversible physical crosslinking of chitosan and polyethyleneimine13 or 
tripolyphosphate14−16 based on electrostatic interactions leads to formation of pH-sensitive 
microgels. In later case, aqueous droplets of prepolymers are stabilized by oil-soluble surfactants 
in a continuous oil phase. For example, hyaluronan-based microgels were synthesized by 
crosslinking of carboxylic units of hyaluronan with adipic dihydrazide in aqueous droplets17. 
            The polymerization (free radical or controlled radical) of monomers in the presence of a 
crosslinking agent in aqueous phase is most popular these days, which can be divided into two 




            For precipitation polymerization, all ingredients are dissolved in a solvent (water) to form 
a homogeneous mixture, then initiation of polymerization takes place. The formed polymers are 
transformed into a collapsed state because the reaction temperature is far above its VPTT and 
become crosslinked by crosslinker agent, forming colloidal polymer network microgels. We will 
describe the detail of this technique later. 
            The term emulsion polymerization encompasses several related processes: (1) 
conventional emulsion polymerization, (2) inverse emulsion polymerization, (3) miniemulsion 
polymerization, (4) dispersion polymerization, and (5) microemulsion polymerization18. 
Conventional emulsion polymerization accounts for the majority of the world’s production of 
commercial polymers, such as polystyrene (PS). The conventional emulsion polymerization is 
carried out in an oil-in-water emulsion (Figure 1−2), in which surfactant is dissolved in water 
until micelle has been formed, droplets of monomer (the oil) are emulsified by surfactant in a 
continuous phase of water. The polymerization will take place in the micelle when free radicals 
migrate into the micelle and react with monomers. Monomer migrates in the large monomer 
droplets of the micellar core to sustain polymerization until all the monomer is consumed. 
 





          The photolithographic technique has been recently used on solid substrates for preparation 
of hydrogel layers with variable thickness19. The PRINT (particle replication inn non-wetting 
templates) technique utilizes elastometic molds from a low surface energy perfluoropolyether 
network20, 21. The molds prevent the formation of an interconnecting film between molded 
objects and allow production of monodisperse microgel particles of different sizes, shapes, 
compositions, and surface functionalities. 
 
1. 2. 2  Precipitation Polymerization 
            Precipitation polymerization is probably the most frequently used technique for microgel 
synthesis. We used this technique to synthesize the micro-/nanogels used in our projects. The 
mechanism of free radical precipitation polymerization has been demonstrated in Figure 1−3. In 
such system, all ingredients, including the monomer(s), crosslinker, and initiator, are dissolved in 
water. A homogeneous nucleation mechanism leads the formation of microgel particles. One 
initiator molecule (peroxide- or azo- based compound) decomposes into two free radicals under 
reaction temperature (50−70 °C), which can initiate polymerization in the homogenous solution 
phase; therefore, the water-soluble oligomers start to grow. As oligomers reach a critical chain 
length, the growing chain condenses to form precursor particles because the phase separation 
occurs at the polymerization temperature higher than the LCST of the polymer. The precursors 
can grow by different mechanisms. Precursor particles can (1) aggregate with other precursor 
particles to form a larger colloidally stable polymer particles; (2) deposit onto an existing, 
colloidally stable microgel particle; or (3) grow by addition of monomers or macroradicals. 
Surfactant is used to prevent precursors from aggregating; thus the precursors formed in the early 




particles will be formed. The growing chains prefer to deposit onto these existing precursor 
particles. Hence, the higher the concentration of surfactant, the smaller the resulting gel particle 
size is. Besides surfactants, the growing polymer particles can also achieve colloidal stability by 
the presence of electrostatic stabilization provided by the ionic groups originating from the 
initiator. At this time, microgel particles are in a collapsed state but still contain a lot of water. 
When the polymerization is completed and the reaction mixture cools down to room temperature 
(below LCST of polymer chains), microgel particles swell and develop a “hairy” morphology. 
Microgels are stabilized by steric mechanisms because of the formation of hydrogen bonds 
between polymer segments and water molecules.  
 
Figure 1−3 Mechanism of precipitation polymerizations.  
 
            The precipitation polymerization is a versatile technique and offers several advantages 
for the preparation of aqueous microgels6. 
1. The polymerization process can be carried out as a batch, semibatch, or continuous 
process.  
2. Microgel size can be controlled over a broad range (from tens of nm to 3 μm) by the 
use of surfactants or co-monomers. 




4. Copolymer-based microgel can be prepared by integrating different co-monomers 
into the microgel network during the polymerization process. 
5. Hybrid colloids can be obtained by encapsulation of nanoparticles (NPs) during 
microgel formation. 
            However, precipitation polymerization has some limitations: 
1. Because of the high polymerization temperature, only thermally stable materials can 
be used, which limits the incorporation of delicate biomacromolecules. 
2. It is difficult to prepare very small microgels (size below 50 nm) without use of 
additional stabilizing agents. 
3. Formation of soluble fraction during the polymerization process.  
 
1. 3 Microgel Properties 
1. 3. 1  Microgel Structure 
            The internal structure of microgels particles influences its swelling properties. The most 
important structural information is the distribution of cross-linked monomers as a function of 
distance from the particle center22. The crosslinking density usually decreases from the center of 
the particles toward the periphery. Nieuwenhius et al. examined polymethylmethacrylate 
(PMMA) microgel particles cross-linked with divinylbenzene (DVB) and ethylene glycol 
dimethacrylate (EGDM) dispersed in benzene. The results from laser light scattering and 
viscometry techniques showed that the microgel particles had different diameters and possessed 
a heterogeneous distribution of cross-links23. Mcphee et al. proposed that a large proportion of 
the cross-links were incorporated during the initial growth of particles by measuring the 




emulsion polymerization (SFEP)24. This is because the solubility of a polymer chain decreases 
with increasing molecular weight and addition of cross-linking monomer facilitates a substantial 
increase in its length. Accordingly, attainment of uniformly swollen microgel particles may be 
more likely using polymerization in a good solvent. 
 
1. 3. 2  Microgel Swelling Theory 
            The swelling of microgel particles in organic solvents has been described by using 
Flory’s theory of network swelling25. A polymer network immersed in a good solvent imbibes 
solvent in order to balance the chemical potential inside and outside the gel network. At the same 
time, the presence of cross-links restricts the extent of swelling. Therefore, swelling continues 
until the sum of the elastic forces between cross-links in equal to osmotic force. The extent of 
network swelling is usually described by the polymer volume fraction (φ2) obtained at 
equilibrium (φ2 = 1 in the collapsed state). Flory’s theory leads to25: 







                                                          (1−1) 
where Χ is the number of cross-links present within a collapsed network volume Vc. The 
subscripts 1 and 2 refer to the solvent and network polymer, respectively; ν1 is the molar volume 
of the solvent and 𝑥12  is the Flory solvent-polymer interaction parameter. The term (x/Vc) 
represents the average density of cross linked units in the collapsed particle. 
            There is usually a high proportion of non-cross-linking polymer segments (monomer B) 
contained in microgel particles as well as a minor proportion of (normally) difunctional cross-
linking segments (A). The mole fraction of the latter (XA) is typically less than 0.1. If it is 










                                                              (1−2) 
where MB and ρ𝐵  are the molecular weight and density of the B segments, respectively. 
Substitution of Eq. (1−2) into Eq. (1−1) and assuming ρ𝐵= 1 leads to a simple expression 
describing the dependence of the volume fraction of microgel particles on the network 
composition and solvency: 





                                                              (1-3) 
where the excluded volume parameter v12 = (0.5 − x12). The polymer volume fraction increases 
(particles de-swell) if the cross-link density increase of the solvency becomes poorer (v12 
decreases).  
            Flory’s theory of network swelling has been applied to polystyrene microgel particles 
dispersed in ethylbenzene and was extended to consider the effect of added non-adsorbing (free) 
polymer26. The effective concentration of incorporated cross-linking monomer has been found to 
be less than that actually used during the preparation, thus a significant proportion may not have 
reacted. 
          There are two drawbacks to Flory’s theory of gel swelling. First, it assumes a uniform 
cross-link density within the network. The cross-linked density is more likely decreased from the 
center of the particles toward the periphery (as discussed in Section 1.3.1). Second, the 
concentration dependence of χ is not included27. There might be a problem with aqueous gel 
systems related to hydrogen bond and hydrophobic bonding, because the segment/water 




1. 3. 3  Stimuli-Responsive Behavior 
1. 3. 3. 1  Temperature 
 
 
Figure 1−4 a) Illustration of typical thermoresponsive behavior of PNIPAM microgel particles; 
b) associated change in hydrodynamic diameter of PNIPAM microgel particles as a function of 
temperature30. 
 
            In Figure 1−4a, the typical thermoresponsive behavior of PNIPAM has been illustrated. 
At room temperature (∼25 °C), the particle is swollen due to extension of the polymer networks 
toward a soft porous structure31. When microgels are immersed in a good solvent, solvent 
molecules can penetrate into the polymer structure until the chemical potential balance between 
inside and outside. Thus, microgel particles swell until the elastic forces of the cross-links that 




increases, the particle collapses, becoming a tightly packed structure more like a hard particle 
such as a polystyrene latex33. 
          Figure 1−4b shows a typical plot of the change in microgel particle size (hydrodynamic 
diameter) as a function of temperature. The temperature at which the particle switches between 
swollen and collapsed conformations is volume phase transition temperature (VPTT), which is 
usually considered being the midpoint of the transition curve using particle diameter versus 
temperature34.  
 
1. 3. 3. 2  pH 
 
Figure 1−5 Conformational changes of a polyelectrolyte microgel as a function of pH32. 
 
            Microgel particles containing acidic or basic functional groups (e.g. carboxylic acid, 
amines etc.) exhibit a pH-dependent swelling/shrinking behavior. Figure 1−5 shows the 
conformational change of pH sensitive microgel driven by change of pH. The mechanism of 
swelling of pH-responsive particles is explained by the internal osmotic pressure due to the 
mobile counter-ions contained within the particles, which balance the internal electrostatic 




the polymer network chains become ionized and repel each other, resulting in the swelling of the 
particles. At the pH below the pKa, the deionized groups facilitate the adoption of a more 
compact structure of the polymer chains32, 36. Additionally, by combining a pH-sensitive co-
monomer such as acrylic acid (AA) with a temperature-sensitive monomer such as NIPAM, it is 
possible to prepare microgel particles sensitive to both pH and temperature36. 
 
1. 3. 3. 3  Ionic  
 
Figure 1−6 Hydrodynamic diameter of poly(NIPAM-co-AA) (95:5%) microgel particles as a 
function of ionic strength of NaCl at pH 6 and 25 °C at a microgel concentration of 0.07% 
(w/w)36. 
            The size and stability of microgel particles prepared from the copolymerization with 
ionizable monomers can be influenced by the presence of electrolyte. For example, the 
hydrodynamic diameter of poly(NIPAM-co-AA) microgels decreases with the increase in the 
NaCl concentration (Figure 1−6)36. This is attributed to the electrolyte screening on the internal 
charge repulsion, which is reversible by removing the electrolyte. It should be noted that the 
temperature may influence the response to changes in ionic strength when the microgels contain 




concentration of electrolyte (such as NaCl), dilute P(NIPAM-co-AA) microgel dispersions are 
colloidally stable even when the temperature is above the VPTT of the microgels3. However, at 
high ionic strengths, aggregation of microgels may occur, especially when the dispersion 
temperature of microgel particles is above their VPTT. 
 
1. 3. 3. 4  Other Influences  
          Other influences or triggers for inducing the swelling/shrinking transition of microgels 
include alcohol additions37, light, and magnetism38. For example, the swelling degree of 
PNIPAM microgel particles can be controlled by addition of short-chain alcohols such as 
methanol (MeOH), ethanol (EtOH) and 2-propanol (2-PrOH). As shown in Figure 1−7, the 
microgel particles collapse to a minimum size when volume fraction of alcohol increase, but re-
swell in the alcohol-rich region37. 
 
Figure 1−7 Change in the de-swelling ratio of PNIPAM (9% MBA) microgel particles as a 
function of increasing volume fraction of three alcohols. The alcohols investigated are MeOH 





1. 4     Characterization 
Several techniques are used to characterize microgel particles. They include light 
scattering, fluorometry, UV-VIS spectrophotometry, TEM and confocal imaging technique. 
Dynamic light scattering (DLS) has been the most widely used technique to study the size, size 
distribution, and the volume phase transition behavior of microgels. A dilute dispersion of 
microgels appears transparent because the microgels are swollen in water at T < VPTT and the 
contrast in refractive indices of the polymer and the solvent is small. At T > VPTT, the expulsion 
of water from the particles causes an increase in refractive index contrast between the polymer 
and the solvent, and the microgel dispersion may appear turbid, depending on the concentration. 
TEM could show the morphology of dried microgel particles. More details of this experimental 
technique are provided in Chapter 2. 
 
1. 5      Applications of Microgels 
            The reversible shrinking/swelling transition of microgels in response to specific 
environmental conditions enables these “smart nanoparticles” to have great potential for a variety 
of applications. Indeed, they have already been utilized in a wide range of industries, including 
chemical sensing, drug delivery, and biomedical applications.  
 
1. 5. 1  Biomaterials/Biomedical Applications 
            Microgels have been widely utilized in biomaterials area, including implantation, 
incorporation with a living system to supplement, and replace functions of living tissues39. The 




should be able to co-exist with its tissue environment without having any undesirable or 
inappropriate effect on each other40. 
Cell Scaffolds           
            Zhang’s group reported that the in situ gelable dispersions of poly(NIPAM-co-2-
hydroxyethyl methacrylate) and poly(NIPAM-co-AA) microgels in electrolyte solutions of high 
ionic strength can be used as scaffolds for cell culture41−43. Our group demonstrated that the cell 
scaffolds can be also synthesized from a colloidal supra-structures constructed by the thermo-
driven gelation of a colloidal dispersion of poly(NIPAM-co-AAm) microgels (Figure 1−8)44. The 
microgels exhibit a reversible and continuous volume transition in water with VPTT = 35 °C and 
remain partially swollen and soft under physiological conditions (37 °C). More importantly, we 
found that the size of the microgel particles can affect the sol-to-gel phase transition of the 
microgel dispersions, alter the syneresis degree of the constructed colloidal supra-structures, and 
tailor the cytocompatibility when the colloidal supra-structures are used for cell scaffold. We 
believe the relationship between the size of the building microgel particles and the 
cytocompatibility of the constructed colloidal supra-structure could provide fundamental 






Figure 1−8 The size of soft microgels can affect the thermo-driven sol-to-gel transition, the 
syneresis degree, and the cell proliferation rate of the constructed colloidal supra-structures for 
cell scaffolds44. 
 
Detachment and Delivery of Human Cells 
          Hopkins et al. modified poly(NIPAM) microgels with a cell-adhesive peptide (GRGDS), 
which bound to cell surface integrins on dermal fibroblasts and entholial cells45. The microgels 
remove the cells from their normal culture substrate at temperature above LCST, and released 
the viable cells to grow on new substrates on cooling. The authors suggested that such systems 
will have a wide range of applications in cell biology and tissue engineering. 
 
Slimming Aids 
            Microgels have been also applied as slimming aids46. Microgels were embedded with a 
cationic fat-binding agent in an edible matrix, which disintegrates in the digestive tract. The 
microgels swell up to 100 times the dry volume in stomach, creating a feeling of fullness. 





1. 5. 2  Optical Sensor 
Real-time measurements of biological/chemical/physical processes in live cells, with no 
interferences, are an ultimate goal for in vivo intracellular studies. Significant progress has been 
achieved by the continuous development of analyte-specific fluorescent probes, such as, organic 
dyes, semiconductor quantum dots and noble metal nanoparticles. However, the cytotoxicity of 
some available probes is a big problem and these moieties may affect immunological response of 
cells. Besides, non-specific binding and short lifetime of these molecular probes have to be 
considered as well. To overcome these problems, the integration of small molecule probes into 
other matrices such as polymers microgels could be a suitable choice. First, this matrix can 
minimize the toxicity of probes by protecting the cellular contents from the probes. The cell 
viability after sensor delivery can reach 99%, relative to control cells, indicating negligible 
physical and chemical perturbation to the cell. Second, microgels show some physical properties 
similar to living tissues, including a soft and rubbery consistency and low interfacial tension with 
water or biological fluids. The elastic nature of hydrated gels has been found to minimize 
irritation to the surrounding tissues after implantation. The low interfacial tension between the 
gel surface and body fluid minimizes protein adsorption and cell adhesion, which reduces the 
chances of a negative immune reaction. The inert protective matrix of the gel networks also 
eliminates interferences such as protein binding and/or membrane/organelle sequestration. Third, 
the specific functional groups on the microgel network chains enable the immobilization of 
optical moieties into the polymer gel networks, combining the properties from both optical 
moieties and polymer gels47. For example, the surface functionalization with targeting ligands on 
the environmentally responsive micro-/nanogels could target the delivery of optical probes to 




Generally, a hybrid micro-/nanogel-based optical probe is composed of two components: 
optical moieties and a three-dimensional polymer scaffold. Under this consideration, such hybrid 
micro-/nanogel probes can be classified into three types (Figure 1−9)49.  
 
Figure 1−9 Schematic diagrams showing three types of hybrid micro-/nanogel-based optical 
probes49: (A) Type 1 where the antibody or specific targeting ligand acts as a 
chemical/biochemical signal receiver; (B) Type 2 where an optical moiety acts directly as the 
chemical / biochemical signal receiver; and (C) Type 3 where a responsive polymer gel network 
chain acts as the chemical/biochemical signal receiver, which will undergo a volume phase 
transition, change the physicochemical environment of the optical moieties, and convert the 
received signal into an optical signal. 
 
In a Type 1 probe, the specific antibodies, aptamers, or other selective analyte-




the hybrid micro-/nanogels would not affect the optical properties of the optical moieties, but the 
apparent color may change upon colocalization of the probes. In a Type 2 probe, the optical 
moiety acts directly as the chemical/biochemical signal receiver. The optical properties of the 
optical moieties (such as indicator dye and conjugated polymer) would change upon the binding 
of analyte. In a Type 3 probe the stimuli-responsive polymer gel network chains act as the 
chemical/biochemical signal receiver. Upon receiving the external stimulus, the gel network will 
undergo a volume phase transition and change the physicochemical environment of the optical 
moieties, converting the received signal into optical signal.   
 
Temperature Sensor   
            Our group has synthesized a group of core-shell structure hybrid nanogels to achieve 
optical temperature sensing50. The nanogels were constructed by coating the Ag-Au bimetallic 
NP core with a thermo-responsive nonlinear poly(ethylene glycol) (PEG)-based hydrogel as shell. 
The Ag-Au NP core can emit strong visible fluorescence. The reversible thermo-responsive 
volume phase transition of the nonlinear PEG-based gel shell can modify the physicochemical 
environment of the Ag-Au NP core to manipulate the fluorescence intensity for sensing the 
environmental temperature change (Figure 1−10).  
 




Ions Sensor   
The polyacrylamide nanoparticle has been used exclusively for this type of ion sensor 
because of its neutral and hydrophilic nature, which allows ions to readily permeate polymer 
matrix and interact with the indicator dye. Sensors for cobalt, copper, hydrogen, nickel, 
potassium, silver, sodium, zinc, and chloride ions have been developed30. 
 
pH Sensor   
A pH sensor was developed by coating a pH-insensitive fluorescent polystyrene bead 
(200 nm in diameter) with a layer of polyaniline (PANI) of only a few nanometers thick51. Plain 
PANI films display no fluorescence in the visible and near-IR range, but they display 
characteristic pH-dependent absorption spectra that are due to protonation and deprotonation, 
respectively, of the emeraldine form of the PANI. Because of the fluorescence spectra of the 
beads being overlapped with the absorption spectra of PANI, the fluorescence intensity changes 
in accordance with the changes in pH.  
Our group also report a class of chitosan-based hybrid nanogels by in-situ immobilization 
of CdSe quantum dots (QDs) in the chitosan-poly(methacrylic acid) networks. The covalently 
crosslinked hybrid nanogels with chitosan chains semi-interpenetrating in the crosslinked 
poly(methacrylic acid) networks exhibit excellent colloidal and structural stability as well as 











Figure 1−11 Reversible fluorescence quenching and antiquenching of CdS QDs embedded in the 
interior of p(NIPAM-AAm-PBA) microgels in response to the change in glucose concentration53. 
 
For the application in glucose detection, CdS QDs immobilized PNIPAM-based glucose-
sensitive microgels have been designed as optical glucose sensor by our group (Figure 1−11). 
The photoluminescence (PL) intensity of CdS QDs can be quenched gradually when microgels 
gradually swelled up with the addition of D-glucose. Therefore, such hybrid microgels exhibit 
excellent sensitivity in physiologically important glucose concentration range (1−25 mM)53. Wu 
et al. in our group designed hybrid nanogels made of Ag NP cores covered by a copolymer gel 
shell of poly(4-vinylphenylboronic acid-co-2-(dimethylamino)ethyl acrylate)  as well. These 
hybrid microgels can also be used as optical glucose sensor and show regulate release of 
preloaded insulin at physiological pH54. 
 
1. 5. 3  Intelligent Drug Delivery Systems 
An increasing field of research is the development of devices that can control the release 




suffer from limitations of dose dumping, for example, the delivery of high dose of therapeutic in 
one go. Therefore, it is necessary to explore a new delivery system which can achieve an 
elevated therapeutic drug plasma concentration over a long period of time, known as controlled 
release30. Microgels are particularly attractive as drug delivery carriers with several advantages: 
tunable size from 100 nm to several micrometers, their porous interior network structure for the 
incorporation of drugs to protect the drug from hydrolysis, potential biocompatibility, and 
functionalized surface with receptor-specific molecules to achieve targeting ability. In addition, 
microgels carrying specific functional groups can undergo large swelling-deswelling transitions 
in response to changes in pH, ionic strength, or temperature, which commonly occur in many 
biological events. 
 
Figure 1−12 Model of triggerable drug release from the responsive microgels or shell-responsive 
core-shell structure microgels with drug in the core. 
 
            Generally, two systems could be applied in drug delivery (Figure 1−12). The first one is 
randomly functionalized microgels. Drug loaded microgels are able to undergo shrinkage or 
swelling when the environment is changed, which can trigger the release of the drug. The second 
one is core-shell structured microgels. In this case, the responsive shell of microgels act as a 




responsive shell starts to swell along with the increased pore size; hence, drugs can diffuse to 
exterior.  
          Several microgel-based drug delivery systems have been investigated. For example, a co-
polymer microgel of poly(NIPAM/butyl methacrylate/AA) has been applied as a delivery vehicle 
to carry insulin55. Currently, insulin has to be injected intravenously because passage through a 
low pH of the stomach degrades insulin, reducing its activity. The hydrophobic butyl 
methacrylate facilitate the uptake of insulin into the interior of the microgel, and the 
incorporation of AA sensitizes the microgel to pH via protonation and de-potonation of the 
carboxylic acid groups above and below its pKa (pH 4.4). The microgels adopt a closed network 
structure below the pKa of AA, within which insulin can be entrapped. When pH rises above the 
pKa, the conformation of microgel network chains changes to an open network structure because 
the intermolecular charge repulsion causes expansion. At this time, insulin is released from the 
open network structure via osmosis. This delivery system could be used for delivery of an oral 
therapeutic. The therapeutic can be protected from stomach acid (pH ≈ 2). When the drug-loaded 
microgels move out of the stomach into the gastrointestinal (GI) tract, they change conformation 
and release the therapeutic due to pH increase. 
          Our group has also contributed much effort to investigate the storage and delivery of 
chemotherapeutic agents using microgels as drug delivery carriers56−58. For example, a series of 
water-dispersible core-shell structured microgels with a hydrophobic polystyrene (PS) gel as 
core and a hydrophilic nonlinear PEG copolymer gel as shell have been successfully synthesized 
for intracellular delivery of hydrophobic curcumin drug. While the PS nanogel core is designed 
to provide strong hydrophobic interactions with curcumin for high drug loading yields, the 




the microgels and temperature triggerable release of the pre-loaded curcumin drug. A systematic 
physicochemical study on the resulted microgels was carried out to optimize the compositions 
and structural parameters of the microgels to achieve high curcumin loading capacity, 
responsiveness in physiologically important temperature range, and thermally controllable 
curcumin release. The curcumin molecules released from microgels still remain active to kill the 
cancer cells. Such designed core-shell structured microgel is well suited for drug uptake and 
release application and could be potentially extended to effectively deliver other hydrophobic 
therapeutic agents. 
 
1. 6      Conclusion 
Stimulus-responsive polymer microgels swell and shrink reversibly upon exposure to 
various environmental stimuli such as change in pH, temperature, glucose concentration, ionic 
strength or magnetic fields. They are usually synthesized by precipitation polymerization. Due to 
the stimuli responsive properties, they become ideal candidates for biomaterial applications, 
optical sensors and imaging agents, and primary carriers in site-specific and controlled drug 
delivery systems. Facile synthesis and functionalization of microgel particles provide a broad 
range of variables for tuning their properties and favorably distinguish microgels from other 
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Materials and Methods 
 
This chapter presents the basic synthetic and characterization methods used in this 
dissertation projects. The standard synthetic method for preparation of microgels by free radical 
precipitation polymerization is discussed. The typical method for preparation and 
characterization of inorganic nanoparticles that can be immobilized into the micro-/nanogels are 
also provided. 
 
2. 1      Preparation of Microgels 
2. 1. 1  Reagents 
D(+)-Glucose was purchased from ACROS and all other chemicals were purchased from 
Sigma-Aldrich. N-isopropylacrylamide (NIPAM) was purified by recrystallization from a 
hexane–acetone (1 : 1 volume ratio) mixture and dried in a vacuum. 2-(2-methoxyethoxy)ethyl 
methacrylate (MEO2MA, 95%), oligo(ethylene glycol)methyl ether methacrylate (Mn = 300 
g/mol, MEO5MA), 2-(Dimethulamino)ethyl acrylate (DMAEA) and poly(ethylene glycol) 




Curcumin was purified with anhydrous ethanol. 2-vinylanisole, 4-allylanisole, 4-
vinylphenylboronic acid (VPBA), divinylbenzene (DVB), N,N´-methylenebis(acrylamide) 
(MBAAm), 2,2′-azobis(2-methylpropionamidine) dihydrochloride (AAPH), ammonium 
persulfate (APS), sodium dodecylsulfate (SDS), anhydrous ethanol, dimethyl sulfoxide (DMSO), 
acridine orange (AO), ethidium bromide (EB), dulbecco's modified eagle medium (DMEM), 
fetal bovine serum (FBS), 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT), 
and the lyophilized fluorescein isothiocyanate-labeled insulin (FITC-insulin) from bovine 
pancreas (~ 5800 Da) were used as received without further purification. The water used in all 
experiments was of Millipore Milli-Q grade. Table 2−1 shows the structure and functions of the 















Table 2−1 Structures and function of reactants used in free radical precipitation polymerization 
for the synthesis of microgels in this work. 
 
Structure Name Function 
2-(2-methoxyethoxy)ethyl methacrylate  
                     (MEO2MA) 
           Major monomer 
Thermo-responsive component 
Oligo(ethylene glycol)methyl  
ether ethacrylate   (MEO5MA) 
Poly(ethylene glycol) dimethacrylate  
                (PEGDMA) 
Crosslinker 
Sodium dodecyl sulfate  
             (SDS) 
Surfactant 
Ammonium persulfate (APS) Initiator 
N-isopropylacrylamide(NIPAM)             Major monomer Thermo-responsive component 
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Acrylamide (AAm)  Comonomer 
 
N,N´-Methylenebis(acrylamide)  




          Major monomer 
Curcumin loading component 
 
           Major monomer 
Thermo-responsive component 
          Major monomer 
Curcumin loading component 
 
Divinylbenzene (DVB) Crosslinker 
           Major monomer 
Glucose-responsive component 
4-Vinylphenylboronic acid  
             (VPBA) 
2-(Dimethulamino)ethyl acrylate 









2. 1. 2  Synthesis of Microgels 
The microgels in this work were synthesized by free radical precipitation 
polymerization.1 This method is probably the most frequently used technique for microgel 
synthesis. The mechanism of free radical precipitation polymerization has been introduced in 
Chapter 1 (Section 1. 2. 2). Here, we describe a typical example using the precipitation 
polymerization technique for preparation of poly(NIPAM-co-AAm) microgels in this work. 
Typically, NIPAM (1.405 g), AAm (0.091 g), MBAAm, and SDS were dissolved in 100 mL 
deionized water in a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a 
condenser. The mixture was heated to 70 °C under a N2 purge. After 1 h, APS (0.104 g dissolved 
in 5.0 mL water) was added to the mixture to initiate the polymerization. The reaction was 
allowed to proceed for 5 h. The obtained products were purified by centrifugation (Thermo 
Electron Co. SORVALL® RC-6 PLUS superspeed centrifuge, 35 °C, 20 000 rpm, and 20 min) 
and 3 days of dialysis (Spectra/Por® molecular porous membrane tubing, cut off 12 000–14 000) 
against very frequently changed water at room temperature (∼22 °C). 
 
2. 1. 3  Purification of Microgels 
The solutions might contain surfactant molecules and a certain amount of linear or 
slightly branched polymer segments after polymerization. Generally, there are two ways to 
purify the microgels. First, effectively repeated centrifugation, decantation, and redispersion of 
the microgels in water can be applied. Depending on the property of microgels, centrifugation 
conditions may be varied (revolution, temperature, pH, and etc.).  Second, unreacted monomers 
and excess surfactant can be removed by dialysis against frequently changes of water for a long 




remove all linear polymers or sol from microgel dispersions, a combination of dialysis and 
repeated centrifugation, decantation and redispersion techniques under appropriate conditions 
can effectively remove linear polymers from a dispersion of microgels. In the present work, 
microgels were typically purified by first centrifugation and redispersion, and then followed by 
dialysis against frequently changed deionized water for 3−5 days.  
 
2. 2      Characterization of microgels 
2. 2. 1  Transmission electron microscopy 
The morphology of microgels was characterized with transmission electron microscopy 
(TEM). Detailed information on the theory of TEM can be found elsewhere2. Briefly, a beam of 
electrons are focused on a single, pinpoint spot or element on the sample being studied. The 
electrons interact with the sample and only those that go past unobstructed hit the phosphor 
screen on the other side. At this point, the electrons are converted to light and an image is formed. 
The basic set up for TEM is schematically shown in Figure 2−1. Approximately 10 µL of diluted 
microgel suspension in water was dropped on a carbon-coated copper grid and then air-dried at 
room temperature. The TEM images of the dried samples were taken on a FEI TECNAI 





Figure 2−1 Schematic illustration of Transmission Electron Microscope. 
The dark areas of the image correspond to areas on the specimen where fewer electrons 
are able to pass through (they are either absorbed or scattered upon impact); the lighter areas are 
where more electrons pass through, although the varying amounts of electrons in these areas 
enable the user to see structures and gradients. 
The 'lenses' in a TEM are not the same as lenses in a conventional microscope. These are 
actually the EM devices that can 'focus' the electron beam to the desired wavelength or size. In 
much the same way as a light microscope, however, the amount of power used to generate 




2. 2. 2  Size and Size Distribution 
A standard light scattering spectrometer (BI-200SM) equipped with a BI-9000 AT digital 
time correlator (Brookhaven Instrument, Inc.) was used to monitor the size and size distribution 
of the microgels under different conditions. The schematic layout of the instrument is shown in 
Figure 2−2. A Nd: YAG laser (150 mW, 532 nm) was used as the light source. The solutions 
were passed through 0.8 µm Millipore Millex-HV filters to remove dust. In Dynamic light 
scattering, the Laplace inversion of each measured intensity–intensity time correlated function 
can result in a characteristic line width distribution G(Γ). For a purely diffusive relaxation, Γ is 
related to the translational diffusion coefficient D by (Γ/q2)C→0,q→0 = D, where q = 
(4πn/λ)sin(θ/2), with n, λ, and θ being the solvent refractive index, the wavelength of the incident 
light in vacuum, and the scattering angle, respectively. G(Γ) can be further converted to a 
hydrodynamic radius (Rh) distribution by using the Stokes–Einstein equation, Rh = (kBT/6πη)D−1, 
where T, kB, and η are the absolute temperature, the Boltzmann constant, and the solvent 
viscosity, respectively3, 4. 
 





2. 2. 3 Confocal Microscopes 
           The cells incorporated with microgels were imaged using a confocal laser scanning 
microscopy (LEICA TCS SP2 APBSTM) equipped with an HC PL APO CS 20 × 0.7 DRY len. A 
UV (405 nm) light was used as the light source. The schematic layout of the instrument is shown 
in Figure 2−3. 
 
Figure 2−3 Schematic of confocal microscope.  
 
A laser is used to provide the excitation light (in order to get very high intensities). The 
laser light (blue) reflects off a dichroic mirror. From there, the laser hits two mirrors which are 
mounted on motors; these mirrors scan the laser across the sample. The labeling molecules (e.g., 
dye, quantum dots) in the sample fluoresce, and the emitted light (green) gets descanned by the 




passes through the dichroic and is focused onto the pinhole. The light that passes through the 
pinhole is measured by a detector5. 
 
2. 2. 4 Cell toxicity 
We used MTT assay to quantitatively evaluate the cell viability. MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a yellow tetrazole. The MTT assay is 
a colorimetric assay for measuring the activity of cellular enzymes that reduce the tetrazolium 
dye, MTT, to its insoluble formazan, giving a purple color6. A soluble solution (usually 
either dimethyl sulfoxide, an acidified ethanol solution, or a solution of the detergent sodium 
dodecyl sulfate in diluted hydrochloric acid) is added to dissolve the insoluble purple 
formazan product into a colored solution. The absorbance of this colored solution can be 
quantified by measuring at a certain wavelength (usually between 500 and 600 nm) by a Nikon 
fluorescence microscope fitted with a Spot digital camera. The absorption maximum is 
dependent on the solvent employed. 
            Other closely related tetrazolium dyes including XTT, MTS and the WSTs, are used in 
conjunction with the intermediate electron acceptor, 1-methoxy PMS. With WST-1, which is 
cell-impermeable, reduction occurs outside the cell via plasma membrane electron 
transport7. These assays measure cellular metabolic activity via NAD(P)H-dependent cellular 
oxidoreductase enzymes and may, under defined conditions, reflect the number of viable cells 
(cell proliferation). Tetrazolium dye assays can also be used to measure cytotoxicity (loss of 
viable cells) or cytostatic activity (shift from proliferative to resting status) of potential medicinal 





2. 3      Synthesis of inorganic nanoparticles (NPs) in the microgels 
2. 3. 1  Synthesis of Ag NPs 
            Citrate-stabilized Ag NPs were first prepared by dropwise addition of fresh NaBH4 
solution (10.6 mM, 2.5 mL) to an aqueous solution of AgNO3 (0.1 mM, 200 mL) in the presence 
of sodium citrate (0.1 mM) under vigorous stirring. The resultant solution was stirred for 1 h and 
aged for 7 days at ambient conditions before use. The long aging time is necessary for 
completely degrading the reducing agent of NaBH4. SDS stabilized Ag NPs were obtained by 
adding 0.053 g SDS into 100 mL of aqueous solution of citrate-stabilized Ag NPs in a 250 mL 
round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, and then aging the 
mixture for 10 h8. 
 
2. 3. 2  Synthesis of Fe3O4 NPs 
            In a 25 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, 5 
mmol of FeCl3, 2.5 mmol of FeCl2⋅4H2O, and 30 mL deionized water was heated to 80 °C, 
followed by addition of NaOH (5 mL, 10M) under stiring. This reaction was allowed to perform 
for 1 hour. Then the resulted solution was centrifuged three times at 6000 rpm (20 min, Thermo 
Electron Co. SORVALL RC-6 PLUS superspeed centrifuge) with the supernatant discarded and 
the precipitate was redispersed in 30 mL deionized water. SDS-stabilized Fe3O4 NPs were 
obtained by adding 0.1322 g SDS into 100 mL deionized water containing 0.125 mL Fe3O4 NPs 
in a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, and then 






2. 3. 3  Characterizations of NPs 
            The obtained Ag NPs in this work were characterized by TEM and spectrophotometers 
for both absorption and emission properties. The Fe3O4 NPs were characterized by TEM and a 
superconducting quantum interference device (SQUID) magnetometer (Quantum Design MPMS 
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A Colloidal Supra-structure of Responsive Microgels 
as a Potential Cell Scaffold 
 
3. 1      Introduction 
            After significant advances in the synthesis and modification of a wide variety of colloidal 
particles at the micro-/nanoscale, the scientific community has seen increasing interest in the 
construction of complex three-dimensional (3D) supra-structures with these colloidal particles as 
building blocks1–3. The distinct properties of the colloidal particles can be harnessed in 
suprastructures with new collective properties and fascinating applications in optics, electronics, 
magnetic storage, and biology4–9. In many aspects, colloidal particles dispersed in a liquid 
behave similarly to large idealized atoms that exhibit both fluid-like and solid-like phases, with 
the transition between the two phases taking different forms10, 11. Phase transitions in colloidal 
particle dispersions have been intensively studied as a result of their utility as models for 
addressing fundamental questions about the nature of molecular and atomic condensed phases12–




particles such as Ag, polystyrene, and polymethylacrylate1–3, 9, 14. However, relatively little 
attention has been paid to those soft particles which can respond to environmental stimuli like 
temperature.  
            Injectable macroscopic gels (macrogels) are highly desirable biomaterials for tissue 
engineering to repair or regenerate damaged and diseased tissues or serving as in vitro 3D 
models for drug screening and tumor studies15–17. Up to now, nearly all thermal gelling injectable 
scaffolds employ linear or branched polymers. On the other hand, the in situ formation of 
macrogels from the assembly of temperature-responsive microgel particles into colloidal supra-
structures could be a simple and effective alternative approach because precise control of the 
composition, size and size distribution, and volume phase transition temperature (VPTT) of 
microgels is relatively easy to achieve18–21, Potential advantages of microgel particles over linear 
or branched polymers include reduced viscosity and better mechanical properties at the same 
concentration. The use of microgel particles may also open the possibility to encapsulate growth 
factors or other bioactive molecules in the interior of the particles and release them in proper 
time to guide the differentiation of cells15–17. The thermo-driven gelling behavior of poly(N-
isopropylacrylamide) (polyNIPAM)-based microgel dispersions in NaCl solution or at high 
concentrations were  reported about a decade ago22, 23. However, to the best of our knowledge, 
only recently, Zhang’s group reported that the in situ gelable dispersions of poly(N-
isopropylacrylamide-co-2-hydroxyethyl methacrylate) and poly(N-isopropylacrylamide-co-
acrylic acid) microgels in electrolyte solutions of high ionic strength can be used as scaffolds for 
cell culture24–26. In a recent literature reported by Schmidt et al.27, polyNIPAM microgel layers 
were used as smart substrates for cell culture. It was proposed that the Young’s modulus of the 




            In this work, we studied the thermo-driven in situ gelation of poly(N-
isopropylacrylamide-co-acrylamide) (poly(NIPAM-co-AAm)) microgel particles for potential 
cell scaffolds (Scheme 3−1). Different from the previous examples in which the VPTTs of the 
poly-NIPAM-based microgels are much below 37 °C22–26, making them fully collapsed and 
possibly hard-sphere-like under physiological conditions, the presented poly(NIPAM-co-AAm) 
microgels with a VPTT ≈ 35 °C in water are partially swollen and soft under physiological 
conditions. The constructed colloidal supra-structures from these poly(NIPAM-co-AAm) 
microgels can be regarded as a model system for a new class of cell scaffolds. According to 
percolation theory28, the microgel particle arrangements in the supra-structure should depend on 
the fraction occupied by the microgel particles. As a proof-of-concept, we show that the size of 
microgel particles, a key parameter associated with the particle volume, could affect the thermo-
driven gelling behavior of microgel dispersions, alter the syneresis degree of the formed colloidal 
supra-structures, and tailor the cytocompatibility of the resulted colloidal suprastructures for cell 
scaffolds. The relationship between the size of the building microgel particles and the 
cytocompatibility of the constructed colloidal supra-structures could provide fundamental 
guidance for the construction of desirable cell scaffolds to regulate the cell proliferation rate16, a 





Scheme 3−1 The size of soft microgels can affect the thermo-driven sol-to-gel transition, the 
syneresis degree, and the cell proliferation rate of the constructed colloidal supra-structures for 
cell scaffolds. 
 
3. 2      Experimental 
3. 2. 1   Materials  
             All chemicals were purchased from Sigma-Aldrich. N-isopropylacrylamide (NIPAM) 
was purified by recrystallization from a hexane–acetone (1 : 1 volume ratio) mixture and dried in 
a vacuum. N,N´-Methylenebis(acrylamide) (MBAAm), acrylamide (AAm), ammonium 
persulfate (APS), sodium dodecyl sulfate (SDS), dimethyl sulfoxide (DMSO), acridine orange 
(AO), ethidium bromide (EB), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide 
(MTT) were used as received without further purification. The water used in all experiments was 






3. 2. 2   Synthesis of poly(NIPAM-co-AAm) microgels 
             A series of poly(NIPAM-co-AAm) microgels were synthesized by using free radical 
precipitation polymerization in an aqueous solution. Typically, NIPAM (1.405 g), AAm (0.091 
g), MBAAm, and SDS were dissolved in 100 mL deionized water in a 250 mL round-bottom 
flask equipped with a stirrer, a N2 gas inlet, and a condenser. The mixture was heated to 70 °C 
under a N2 purge. After 1 h, APS (0.104 g dissolved in 5.0 mL water) was added to the mixture 
to initiate the polymerization. The reaction was allowed to proceed for 5 h. The obtained 
products were purified by centrifugation (Thermo Electron Co. SORVALL® RC-6 PLUS 
superspeed centrifuge, 35 °C, 20 000 rpm, and 20 min) and 3 days of dialysis (Spectra/Por® 
molecular porous membrane tubing, cut off 12 000–14 000) against very frequently changed 
water at room temperature (∼22 °C). 
 
3. 2. 3   TEM characterization 
             Approximately 10 µL of diluted microgel suspension in water was dropped on a carbon-
coated copper grid and then air-dried at room temperature. The transmission electron microscopy 
(TEM) images of the dried samples were taken on a FEI TECNAI transmission electron 
microscope operating at an accelerating voltage of 120 kV. 
 
3. 2. 4   Dynamic light scattering (DLS) characterization 
             A standard laser light scattering spectrometer (BI-200SM) equipped with a BI-9000 AT 
digital time correlator (Brookhaven Instruments, Inc.) was used, with a Nd:YAG laser (150 mW, 
532 nm) as the light source. The extremely diluted microgel dispersion (∼5.0 × 10−3 wt%) in 




filters with a pore size of 0.80 µm to remove dust before DLS measurements. In DLS, the 
Laplace inversion of each measured intensity–intensity time correlated function can result in a 
characteristic line width distribution G(Γ). For a purely diffusive relaxation, G is related to the 
translational diffusion coefficient D by (Γ/q2)C→0,q→0 = D, where q = (4πn/λ)sin(θ/2) with n, λ, 
and θ being the solvent refractive index, the wavelength of the incident light in vacuo, and the 
scattering angle, respectively. G(Γ) can be further converted to a hydrodynamic radius (Rh) 
distribution by using the Stokes–Einstein equation, Rh = (kBT/6πη)D−1, where kB, T, and η are the 
absolute temperature, the Boltzmann constant, and the solvent viscosity, respectively29, 30. 
 
3. 2. 5   ζ-Potential characterization 
            Experiments of electrophoretic mobility µ𝐸  were carried out on a Malvern Zetasizer 
Nano S90 particle analyzer on the Zeta-Meter mode and calibrated with standard solutions. The 






=                                                                        (3−1) 
where ε0 is the permittivity of a vacuum, εr is the relative dielectric permittivity of the medium, 
and η is the viscosity of the dispersing phase. 
 
3. 2. 6   Rheological characterization 
            The purified microgel dispersion was centrifuged and redispersed into water to prepare 
the concentrated microgel dispersions of different concentrations. Dynamic rheological analysis 
of the concentrated microgel dispersions was performed on an AR2000ex 45 rheometer (TA 




sample gap was set to 1.0 mm. The temperature was controlled by using a water bath via 
connecting the bottom plate to a NESLAB RTE 7 circulating water bath circulator (Thermo 
Electron Co.). The temperature-dependent elastic (storage) modulus, G´, and viscous (loss) 
modulus, G′′ were recorded in a dynamic temperature ramp test (DTRT). The DTRT was 
conducted under a controlled stress of 0.05 Pa, frequency of 0.1 Hz, and temperature ramp rate 
of 1 °C min−1 from 10 °C to 50 °C. All the rheological experiments were performed within the 
linear viscoelastic region. 
 
3. 2. 7   Syneresis 
            The syneresis kinetics were studied by using a modified procedure on the basis of a 
literature method reported previously26, 32. Typically, equal amounts of 4.0 wt% microgel 
dispersion were added to small glass tubes with a diameter of 5 mm. They were brought to 37.0 
°C to form the colloidal supra-structures (macrogels). Then the change in the macrogel length 
with time (Lt) was followed and measured with the assistance of a Nikon optical microscope. 
 
3. 2. 8   Cell culture 
            B16F10 cell dispersion with a concentration of 2 × 105 cells per mL was mixed with an 
equal volume of 4.0 wt% microgel dispersion. To each well of a 48-well culture plate, 1 mL of 
the cell–microgel mixture was added. The mixtures were brought to 37 °C and gelated 
immediately. After 2 h, the cell/scaffold constructs were transferred to culture flasks and cultured 
in a media containing 89% Dulbecco’s Modified Eagle Medium (DMEM), 10% fetal bovine 
serum (FBS) and 1% penicillin–streptomycin. The cultures were maintained in an incubator at 37 




3. 2. 9   Cell viability 
          A live/dead assay was performed to evaluate the cell viability after 1, 4, 7, 14, and 21 days 
of cell seeding. Briefly, 0.5 mL of cell/scaffold constructs were transferred to 6-well culture plate 
with 3 mL of a media containing 89% DMEM, 10% FBS and 1% penicillin–streptomycin. The 
medium was changed every 1–3 days. The cultures were maintained in an incubator at 37 °C 
with a humidified atmosphere of 5% CO2 for a predetermined period. Then, the samples were 
stained with AO and EB. An upright Nikon fluorescence microscope fitted with a Spot digital 
camera was used to observe the appearance of the cells. 
 
3. 2. 10   Quantification of cell viability by using MTT assay 
              After cultured for a predetermined period (1, 4, 7, 14, and 21 days), the medium was 
aspirated and these wells were washed using fresh serum-free DMEM. Then, 100 mL of MTT 
solution (5 mg mL−1 in PBS) were added to the wells. After incubation for 2 h, the solution was 
aspirated. 500 mL of DMSO was then added to each well and the plate was sealed and incubated 
for 30 min at 37 °C with gentle mixing. Three portions of the solution obtained from each well 
were transferred to three respective wells of a 96-well plate (100 mL per well). Cell viability was 
measured using a microplate reader at 490 nm. Positive controls contained no microgels, and 
negative controls contained MTT. Parallel wells also contained only medium (no cells) and the 








3. 3       Results and discussion 
3. 3. 1   Synthesis of poly(NIPAM-co-AAm) microgels 
 
Figure 3−1 Typical TEM image of the poly(NIPAM-co-AAm) microgels. 
 
             The temperature-responsive poly(NIPAM-co-AAm) microgels were synthesized from 
the free radical precipitation copolymerization of NIPAM and AAm using MBAAm as a 
crosslinker. The reactivity ratio of NIPAM and AAm had been narrowly defined with the Q and 
e values being Q = 0.21, e = 0.43 for the former, and Q = 0.23, e = 0.54 for the latter, 
respectively33. With the similar monomer reactivity, the resulted poly(NIPAM-co-AAm) 
copolymer microgels should have randomly distributed polyNIPAM and polyAAm domains 
through the copolymer chains. It has been reported by our group and other groups that the 
contents of functional monomer AAm in poly(N-isopropylacrylamide-co-acrylic acid-co-
acrylamide) microgels and other polyNIPAM-based microgels are nearly equal to their feeding 
compositions19, 34. As shown in Figure 3−1, the resultant poly-(NIPAM-co-AAm) microgel 




poly(NIPAM-co-AAm) microgel particles is tunable by changing the synthetic conditions. The 
increase in the concentration of dispersing surfactant SDS or crosslinker can significantly reduce 
the size of microgel particles (Table 3−1). All obtained microgel particles have a very narrow 
size distribution with a polydispersity index of µ2/< Γ>2 ≤ 0.005 (Figure 3−2). The microgels are 
reproducible from batch to batch. 
 
Table 3−1 Dependence of microgel particle size (Rh) on feeding ratios of NIPAM/BIS/SDS. All 
measurements were made at 37.0 °C. 
Code NIPAM/BIS/SDS  (mol/mol/mol) Rh  (nm) 
NM1 100/2.57/2.57 110.4 
NM2 100/1.68/2.57 120.5 
NM3 100/2.57/1.54 143.7 
NM4 100/2.57/0.51 190.1 
NM5 100/2.57/0.26 230.4 
 
 
Figure 3−2 Size distribution of poly(NIPAM-co-AAm) microgels NM1 (■), NM2 (●), NM3 








Figure 3−3 (A) Temperature-dependent average Rh value of poly(NIPAM-co-AAm) microgels 
NM1 (■), NM2 (●), NM3 (▲), NM4 (▼), and NM5 (♦). (B) Size distributions of NM5 at 
different temperatures (♦: 24 °C; ▼: 33 °C; ▲: 37 °C; ●: 39 °C; and ■: 50 °C). All 







             Figure 3−3A shows the temperature-induced volume phase transition of the extremely 
diluted poly(NIPAM-co-AAm) microgel dispersions (∼5.0 × 10−3 wt%) in 0.005 M PBS of pH = 
7.4, in terms of the change of Rh measured at a scattering angle of θ = 45°. It is clear that the 
increase in temperature can lead to a significant decrease in the size of microgels due to the 
presence of temperature-responsive polyNIPAM segments. The driving force for such a 
temperature-induced volume phase transition is generally considered to be a subtle balance 
between the ability of the polymer to form hydrogen bonds with water and the inter and 
intramolecular hydrophobic forces35. In comparison with the pure polyNIPAM microgels that 
present a relatively sharp decrease in Rh at the VPTT of ∼32.5 °C36, all the poly(NIPAM-co-
AAm) copolymer microgels synthesized with the same AAm/NIPAM ratio of ∼0.11 exhibited a 
similar volume phase transition profile and displayed two evident effects: (a) a VPTT shift to a 
higher temperature of ∼35 °C; and (b) a broader volume phase transition temperature region. 
Both effects are likely attributed to the presence of the hydrophilic polyAAm segments, which 
can form extensive hydrogen bonds with water and lead to a higher VPTT. A gel network can be 
visualized as a set of subnetworks37. The poly(NIPAM-co-AAm) copolymer microgels should 
have randomly distributed polyNIPAM and polyAAm rich domains through the copolymer 
chains. As the temperature increases, the sub-network chains with shorter polyNIPAM segments 
will undergo the phase transition after the subnetworks with longer polyNIPAM segments. Thus, 
different parts of the gel network undergo the phase transition at different temperatures. 
Therefore, the volume phase transition of poly-(NIPAM-co-AAm) microgels should be 





Figure 3−4 ζ-potential of poly(NIPAM-co-AAm) microgels NM1 (■), NM2 (●), NM3 (▲), 
NM4 (▼), and NM5 (♦). All measurements were made at pH = 7.4. 
 
            It should be noted that the diluted poly(NIPAM-co-AAm) microgel dispersions (∼5.0 × 
10−3 wt%) are highly stable without aggregation even at a temperature much higher than VPTT, 
as revealed by a single peak with the polydispersity index µ2/< Γ>2 ≤ 0.005 being detected in 
DLS (Figure 3−3B). This may be attributed to the incorporation of the hydrophilic polyAAm 
segments, which can introduce the steric-hydration force, a short-range repulsion arising from 
the water structuring near hydrophilic surfaces38. Water molecules are strongly bound to the 
surface of the hydrophilic amide groups of polyAAm segments. As two microgel particles 
approach each other, the repulsion arises because of the energy needed to confine and dehydrate 
the hydrophilic groups. Moreover, the use of initiator APS at high concentrations (e.g., the 
APS/NIPAM molar ratio of 0.28) in the synthesis would create ionizable sulfate groups (pKa < 2) 




However, in our synthesis for poly(NIPAM-co-AAm) microgels, the APS/NIPAM molar ratio 
was only as low as 0.036. Although from a theoretical viewpoint the z-potential is electric 
potential in the interfacial double layer at the location of the slipping plane versus a point in the 
bulk solution away from the interface, the ζ-potential profiles (Figure 3−4) indicated a nearly 
neutral surface for our microgels. The small amount of sulfate groups may have a negligible 
effect on the stability of our microgels. This is further confirmed by DLS analysis. It is well 
known that if the colloidal particles are charged, the electrostatic interactions between the 
colloidal particles can be screened by adding salt, leading to a poor stability of the microgels at a 
high ionic strength40. In our poly(NIPAM-co-AAm) microgel system, the size and size 
distribution of the microgels were nearly independent of the ionic strength in the range of 0.005–
0.154 M. No aggregation of microgels was determined when heated. No cluster or suprastructure 
was formed in the diluted poly(NIPAM-co-AAm) microgel dispersions. 
 
3. 3. 3   Formation of a colloidal supra-structure of poly(NIPAM-co-AAm) microgels 
             The temperature-responsive poly(NIPAM-co-AAm) microgel particle can serve as 
building block for the construction of a solid-like colloidal supra-structure. Such a supra-
structure can be prepared by re-dispersion of the concentrated microgel particles into a 0.01 M 
PBS of pH = 7.4, whose ionic strength was subsequently adjusted to 0.154 M by adding NaCl to 
mimic physiological conditions, followed by heating to 37.0 °C. Figure 3−5 shows a typical 
dynamic stress sweep curve of a dispersion containing 4 wt% microgel particles (NM5: φeffective = 
0.04) at 37.0 °C and a frequency of 0.1 Hz. The formation of the solid-like colloidal supra-
structure can be readily demonstrated by the rheological characteristics that the storage modulus 




not change and thus can be defined as a linear viscoelastic region for this system. This solid-like 
colloidal suprastructure tends to respond strongly to an applied stress such that a solid-to-fluid 
transition occurs above a critical stress value. The stress-induced sharp decrease in dynamic 
modulus can be attributed to the sliding between the microgels41, which is expected because the 
interaction between the microgels is a weak physical force. At a stress above ∼0.4 Pa, G′′ is 
larger than G´, indicating that the system behaves in a liquid-like fashion. Interestingly, by 
simply cooling this liquid-like system to room temperature (∼25 °C) and then reheating to 37.0 
°C, the solidlike colloidal supra-structure was formed again. The reproducibility of the supra-
structure is clearly demonstrated by the good match of the dynamic stress sweep curves during 
the breakage/reconstruction cycles (Figure 3−5). 
 
 
Figure 3−5 Stress dependence of dynamic modulus (G′: ■, □; G′′: ●, ○) of a 4 wt% 
poly(NIPAM-co-AAm) microgel dispersion in the presence (ionic strength 0.154 M; solid 
symbols) and absence (ionic strength 0.005 M; open symbols) of NaCl, respectively. All 




            To examine the in situ thermo-driven formation process of the solid-like colloidal supra-
structure from the poly(NIPAM-co-AAm) microgel dispersion, a dynamic temperature ramp test 
has been carried out in the linear viscoelastic region (at a stress of 0.05 Pa and a frequency of 0.1 
Hz) to record the changes of dynamic modulus as a function of temperature. Figure 3−6 shows 
that the sol-to-gel transition of the concentrated microgel dispersions upon heating can elegantly 
occur at pH = 7.4. At low temperatures, G′′ is larger than G´, indicating that the dispersions are 
in the liquid-like state (sol). With an increase in temperature, both G´ and G′′ first decrease, 
which is attributed to the shrinking of the microgel particles. The shrinking of the microgel 
particles (Figure 3−3) can lead to a decrease in volume fraction φ, and thus a decrease in 
viscosity and elastic properties42. As temperature increases further, a sharp increase in both G´ 
and G′′ occurs. A crossover of G´ and G´´ was observed at the temperature of 35–36 °C. We 
define this temperature threshold for the formation of the solid-like colloidal supra-structure as 
the gelation temperature (Tgel). Above this temperature, G´ is generally larger than G′′, indicating 
the formation of a particle network that is able to transmit stresses28, i.e. a transition from sol to a 
physical macrogel. All five microgel dispersions displayed a similar Tgel, which is close to the 
corresponding VPTT, revealing that the driving force for the sol-to-gel transition of the microgel 
dispersions should be mainly the hydrophobic interactions among the shrunk microgels, which 
only emerge after the temperature reaches close to the VPTT. Similar to the negligible effect of 
electrostatic interactions on the phase transitions of the persulfateinitiated polyNIPAM microgel 
(the KPS/NIPAM molar ratio ≈ 0.017) dispersions12, we speculate that the electrostatic 
interaction should be also negligible in the gelation process of our poly(NIPAM-co-AAm) 
microgel dispersions, since the small amount of sulfate groups derived from APS in the synthesis 




demonstrated by the perfect match of the dynamic stress sweep curves of the microgel 
dispersions at a very low (0.005 M) and a high (0.154 M) ionic strength (Figure 3−5). 
    
    
 
Figure 3−6 Temperature dependence of dynamic modulus (G′: ■; G′′: ●) of 4 wt% 
poly(NIPAM-co-AAm) microgel dispersions (pH = 7.4, and ion strength = 0.154 M): (A) NM1, 
(B) NM2, (C) NM3, (D) NM4, and (E) NM5. All measurements were made at a stress of 0.05 Pa 







            To further understand the sol-to-gel phase transitions of the microgel dispersions, we 
determine the critical concentration of poly(NIPAM-co-AAm) microgel particles, above which 
the microgel dispersions are capable of forming a solid-like supra-structure at 37.0 °C. For hard-
sphere dispersions, the particle concentration is quantified by the volume fraction ϕ. However, 
because the microgel particles are deformable and their volume is not always a constant, ϕ is no 
longer a good measure of concentration. Instead, we use an effective volume fraction ϕeffective, 
which is always proportional to the polymer concentration, to describe the concentration of 
microgel particles. As shown in Figure 3−7, the microgels NM1, NM2, NM3, NM4, and NM5 of 
increased particle size displayed an increased critical ϕeffective. Generally, the pair potential 
between neutral or quasi-neutral microgel particles includes a short-range repulsion that is 
similar to the interaction between two polymer-coated surfaces, and a longer-ranged van der 
Waals-like attraction that arises from the difference in the Hamaker constants of the microgel 
particle and the solvent41. Because the phase diagram is not sensitive to the detailed function of 
the short-range forces42, Hu’s group proposed that the potential between microgel particles can 































                                                      (3−2) 
where σ is the effective diameter, r/σ denotes the reduced center-to-center distance, k is the 
Boltzmann constant, T is the absolute temperature, T0 is an empirical proportionality constant 
that has the unit of temperature, and σ0 is the particle diameter at a reference temperature where 
the conformation of the network chains is closest to that of unperturbed Gaussian chains. The m 
value can be assumed to be 8, in considering that the van der Waals attraction between microgel 




size).43 Thus, for the monodispersed poly(NIPAM-co-AAm) microgels of a stable radius Rh at a 























σ                                                          (3−3) 
where K` is a constant including all the physical parameters mentioned above. K` is always 
positive for two identical particles44, hence the interaction u(r) is always attractive. At the same 
center-to-center distance r between microgel particles, the interaction u(r) decreases inversely as 
the σ6. Therefore, it is reasonable that the motion of poly(NIPAM-co-AAm) microgels of a 
smaller particle size is constrained at a relatively higher degree, resulting in the sol-to-gel 
transition appearing at a relatively lower particle concentration. Further support for our 
observation comes from an investigation by Segre’s group on the gelation of poly(methyl 
methacrylate) spheres, which were stearically stabilized by thin layers of poly(12-hydroxystearic 
acid)45. Thus, it is confirmed both experimentally and theoretically that strong attraction yields 
particles/clusters loosely packed. The stronger the interaction among the particles is, the lower 
the critical concentration for sol-to-gel transition of the particle dispersion. These results can not 
only provide important insights into the role that the size of microgel particles plays in 
controlling the phase transition, but also foreshadow a novel class of colloidal supra-structures 






Figure 3−7. Observed phases of poly(NIPAM-co-AAm) microgel dispersions (pH = 7.4, and ion 
strength = 0.154 M) at 37.0 °C, showing the effect of particle size on the critical ϕeffective for sol-
to-gel transition.  
 
3. 3. 4   Syneresis of the collodial supra-structure 
            As-constructed colloidal supra-structures from the poly(NIPAM-co-AAm) microgel 
dispersions would shrink slightly accompanied with the expulsion of water from the 
networks, when brought above the corresponding VPTT of the microgel particles. As shown 
in Figure 3−8A, the collodial supra-structure built from the smallest microgels of NM1 
exhibited the largest degree of syneresis, at which the (L0-Lt)/L0 value can reach as high as 
0.26 within our experimental time window. This result is in line with the most loosely 
packed structure due to the highest interparticle interactions as described by Eq. (3−3). In 
general, the colloidal supra-structures constructed from the microgels with an increased 
particle size exhibited a decreased degree of synereis. Nevertheless, this syneresis 








Figure 3−8 (A) Syneresis kinetics of the colloidal supra-structures as-constructed from 4 wt% 
poly(NIPAM-co-AAm) microgel dispersions of pH 7.4 and ion strength 0.154 M: NM1 (■), 
NM2 (●), NM3 (▲), NM4 (▼), and NM5 (♦). All measurements were made at 37.0 oC. (B) 
Time dependence of ∆Lt/∆L0 during Syneresis. The solid lines are based on the fitting of Tanaka-






           The syneresis phenomenon of the collodial supra-structure should be attributed to a 
combination effect of the deswelling behaviors from both the chemical network inside the 
microgel particles and the physical network of the connected microgel particles. Tanaka’s 
group found that the rate of volume change of a gel is scaled as l−2, where l is the 
characteristic length  of a gel46. Thus, small gel particles should undergo a very fast volume 
phase transition. Indeed, nanosecond to microsecond (~100 ns) volume changes have been 
determined for individual temperature-sensitive polyNIPAM microgel particles in the size 
range of ~200-350 nm4. Considering the rapid volume phase transition of the individual 
microgel particles, we speculate that the kinetics of syneresis of the collodial supra-structure 
should predominantly lie on the deswelling of the physical network of the connected 
poly(NIPAM-co-AAm) microgel particles. Figure 3−8B shows that the syneresis kinetic 
profiles of the colloidal supra-structures fit well to Tanaka-Fillmore’s model, which is well 
established to describe the swelling/deswelling kinetics of hydrogels46: 
( ) ( )























∆                                                (3−4)  
where L∞ is the gel length at infinite time, and τ is the characteristic time of swelling. The 
fitting curves exhibit a quick decrease in the time region of 0 < t < ~75 min and then reach 
almost a plateau when time t > ~75 min. From the fitting lines, the characteristic time τ was 
estimated to be 23.01 min, 23.29 min, 23.57 min, 24.16 min, and 25.15 min, respectively, for 
the colloidal supra-structures built from the poly(NIPAM-co-AAm) microgels of NM1, NM2, 
NM3, NM4, and NM5 with a subsequently increased size. These results provide an further, 
though indirect, experimental proof that the designed physical networks of microgel particles 




colloidal supra-structures with tunable syneresis propeties should have great potential for 
many applications. 
 







Figure 3−9 Live/Dead assay of the colloidal supra-structures constructed from the poly(NIPAM-
co-AAm) microgels of (A) NM1, (B) NM2, (C) NM3, (D) NM4, and (E) NM5, respectively, 
after 1, 4, 7, 14, and 21 days’ of cell seeding. 
 











colloidal supra-structures of 3D crosslinked polymer-like nature, we carried out additional 
and independent tests on the designed colloidal supra-structures for cell scaffold application. 
B16F10 cells were selected as a model to evaluate the response of cells to the microgel-
assembled scaffolds. As seen in Figure 3−9, the colloidal supra-structures provided structural 
support for the attachment of B16F10 cells and most of the cells were viable after 21 days of 
culture, although it was noticed that the colloidal supra-structures started to disintegrate 
when cell culture was prolonged beyond this time regime. The seeded cells migrated and 
homogeneously distributed throughout the physical networks of microgel particles. A similar 
behavior was observed in the cases of the 3D networks of polymer chains15-17. Culture within 
a 3D gel environment can prevent dedifferentiation of the cells by maintaining these cells in 
a spindle-like morphology, as opposed to the spherical morphology found in two-
dimensional (2D) monolayer culture. Viable cells increase continuously from day-4 to day-
21, suggesting that the colloidal supra-structures can act as scaffolds to support cell 
proliferation. 
            An important feature is that the cell proliferation rate is highly depended on the 
colloidal supra-structure engaged. Typically, the colloidal supra-structures constructed from 
microgels of increased particle size displayed an increased cell proliferation rate. For 
example, after 7 days’ culture, it can be easily observed by naked eyes that cells cultured in 
the colloidal supra-structures built from larger microgels exhibited a much higher packing 
density (Figure 3−9). This result was further supported by MTT assay (Figure 3−10). To 
quantify the cell proliferation rate, the cell viability of the control group without any 
microgels at day-1 was assigned a value of 1, and the relative cell viability was determined 




cases, a greater enhancement in the relative cell viability was detected in the colloidal supra-
structures built from the larger microgel particles. We noted that the syneresis degree of the 
colloidal supra-structures reveals the opposite trend towards the change in the size of the 
building microgel particles (Figure 3−8). It is possible that a reduced syneresis degree is 
favourable to the proliferation of cells, since it should be easier to transport oxygen and 
nutrient, as well as metabolic waste, inside the networks.  The limited supply in nutrient and 
oxygen through the 3D networks may makes the cell proliferation become slower in 3D 
scaffolds than that in 2D cultures, where cells are directly exposed to the nutrient- and 
oxygen-rich media. This result is in accordance with the observation on hydrogels of 
crosslinked polymer chains, which demonstrated that an increased permeability can enhance 
cell proliferation15-17. Different polymers have been explored to form hydrogels with 
improved porosity and stiffness15-17. Herein, we demonstrate that the size of building 
microgel particles in the colloidal supra-structure can have important implications for 
cellular behavior. Cultured in the colloidal supra-structures constructed from the microgels 
NM1 or NM2 of small particle size (3D cultures), the proliferation rate of cells was slower 
than that of the control group (2D culture). An gradual increase in the size of building 
microgel particles (e.g., NM3, NM4, and NM5) could significantly enhance the cell 
proliferation (Figure 3−10). This result imply that the permeability of the colloidal supra-
structure could be simply modulated through the size control of microgel building blocks to 





Figure 3−10 Results of MTT assay, showing the cell viability with the colloidal supra-structures 
acting as cell scaffolds, which were constructed from 4 wt% of poly(NIPAM-co-AAm) 
microgels NM1 (■), NM2 (●), NM3 (▲), NM4 (▼), and NM5 (♦), respectively. The result of a 
control group without adding any microgels (□) is also presented for comparison. 
 
3. 4      Conclusion  
            We have demonstrated that the colloidal supra-structures could be constructed by the 
thermo-driven gelation of the colloidal dispersion of poly(NIPAM-co-AAm) microgels.  
Different from the previous examples in which the VPTT of the temperature-responsive 
microgels are much below 37 °C, making them fully collapsed and possibly hard-sphere-like 
under the physiological conditions, the presented poly(NIPAM-co-AAm) microgels exhibit a 
reversible and continuous volume transition in water with VPTT ≈ 35 °C and remain partially 
swollen and soft under physiological conditions. The constructed colloidal supra-structure 




found that the size of the microgel particles can affect the sol-to-gel phase transition of the 
microgel dispersions, alter the syneresis degree of the constructed colloidal supra-structures, 
and tailor the cytocompatibility when the colloidal supra-structures were used for cell 
scaffolds. The relationship between the size of the building microgel particles and the 
cytocompatibility of the constructed colloidal supra-structure could provide fundamental 
guidance for the construction of desirable scaffolds to regulate the cell proliferation rate. We 
anticipate that the aforementioned approach may serve as a good starting point for the design 
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Tailored Core-Shell Microgels for Highly Efficient 
Curcumin Delivery Carrier 
 
4. 1      Introduction 
        Curcumin, a yellow compound presented in spice turmeric (Curcuma longa), has drawn 
considerable attention of research in recent years by showing safety and diverse pharmacologic 
effects1-3. Curcumin can prevent carcinogen-induced tumorigenesis and inhibit growth of many 
tumor cell lines4-7. Unfortunately, clinical advancement of this promising compound has been 
hindered by its exceedingly low water solubility, rapid metabolism in the body, and low oral 
bioavailbility8-9. To bring this safe and affordable natural product to the forefront in the fight 
against cancers and other chronic diseases, it is critical to develop efficient delivery platforms 
that can carry sufficient curcumin molecules and attain pharmacological effect.  
        A variety of delivery vehicles have been recently pursued to enhance the curcumin 
delivery, including liposomes10-17, micelles18-22, phospholipid or cyclodextrin complexes23-27, 
polyelectrolyte microcapsules28, and polymer formulated nanoparticles (NPs) 29-47. Studies on 




curcumin in aqueous media, increase the curcumin stability, and enhance the cellular uptake. 
However, the development of NP systems for curcumin delivery is still in its infancy. First, the 
loading capacity of the currently developed nanocarriers for curcumin is still very low. Second, 
the nanocarriers based on the liposomes, micelles, and complexes from the association of 
surfactants, lipids, amphiphilic polymers or polysaccharides tend to be metastable. They may 
disassemble quickly in the body, thus limit the circulation time of curcumin carriers in vivo. 
Third, the currently developed nanocarriers are generally insensitive to the environmental 
condition change, thus cannot intelligently trigger the release of curcumin. A key attribute of 
drug delivery systems is their ability to regulate the drug release to improve therapeutic efficacy.  
         The use of microgels as drug delivery vehicle has opened new avenues for the biological 
and biomedical applications. As a drug delivery carrier, polymer microgels is one of the best 
candidates because of their tunable size from nanometers to micrometers, favorable 
biocompatibility, a large surface area for multivalent bioconjugation with targeting ligands, and 
an interior network for the incorporation and protection of therapeutics48. Furthermore, 
responsive polymer microgels can undergo stimuli-responsive volume transitions, which enable 
the fabrication of ‘‘smart’’ carrier systems that can release a drug in response to environmental 
stimuli, such as a change in pH, temperature, light and electrical field49−55. Microgels loaded with 
drugs by encapsulation, surface attachment or entrapment56 can efficiently penetrate into 
individual cells because of their small sizes. If stimuli applied, the microgels will change the 
swelling degree and release the drugs out, resulting in efficient drug accumulation at the target 
site. This process provides a prolonged release of the drug, minimizes unwanted side effects, 
thus improving the therapeutic efficacy of conventional pharmaceuticals57, 58. In addition, 




poor soluble or unstable therapeutic agents, which can sufficiently increase the aqueous 
solubility of drug, protect the drug from degradation, and thus improve the bioavailability of the 
drug56.  
          In this work, we report a novel type of core-shell structured microgels that exhibit 
monodispersed spherical bead morphology and tunable temperature sensitive volume phase 
transitions for highly efficient curcumin delivery carriers with high drug loading yields and 
fluorescence imaging ability of cancer cells. As shown in Figure 4−1, the core-shell microgels 
are composed of the poly(2-vinylanisole) (PVAS) nanogel as a core and the nonlinear 
poly(ethylene glycol) (PEG) copolymer gel as a hydrophilic shell. Considering the unique 
molecular structure of curcumin, we have selected the hydrophobic PVAS gel as a core so that 
the curcumin molecules can interact with the core nanogel effectively through the π-π stacking 
and other hydrophobic interactions due to the structural similarity, which is expected to enhance 
the drug loading capacity significantly. On the other hand, the nonlinear PEG polymers 
containing short oligo(ethylene glycol) side chains have been found to exhibit an interesting 
phase transition behavior in aqueous solution with a tunable lower critical solution temperature 
(LCST) through the control in the compositions of the oligo(ethylene glycol) side chains59−62. 
The longer the oligo(ethylene glycol) side chain, the higher the LCST of the nonlinear PEG 
polymers. Because of the thermo-sensitive, water-soluble and biocompatible properties60, these 
nonlinear PEG-based polymers are regarded as a very promising material for the construction of 
polymeric drug carriers. In order to enable the core-shell microgel drug carriers to be responsive 
in the physiologically important temperature range, we have selected the 2-(2-
methoxyethoxy)ethyl methacrylate (MEO2MA) and oligo(ethylene glycol) methyl ether 




nonlinear PEG gel shell.  The shell thickness can be well controlled through the core-shell 
feeding ratios in synthesis. We expect that the resulted PVAS@PEG core-shell structured 
microgels will exhibit excellent water dispersibility in the physiologically important temperature 
range or below, which allows the administration of curcumin in an aqueous medium. More 
importantly, the variation of temperature can control the release rate of curcumin from the 
microgel particles. The effects of shell thickness on the drug loading capacity, sustained drug 
release behavior, and cytotoxicity of the drug-free and drug-load microgels were evaluated. The 
results presented in this work shows that such rationally designed water dispersible PVAS@PEG 
core-shell microgels provide high curcumin loading capacity, triggerable sustained release of 
curcumin, good cell penetration ability, and high therapeutic efficacy as the drug delivery carrier. 
 
 
Figure 4−1 Typical Schematic illustration of curcumin-loaded core-shell microgels with PVAS 
gel as a core and the nonlinear PEG gel as a shell. The hydrophobic curcumin drug is 
encapsulated within the inner PVAS core, which is coated by an outer PEG-based shell to offer 
both stability in aqueous media and temperature sensitivity. Such designed core-shell microgels-
based drug delivery system has the potential to render the hydrophobic curcumin dispersible in 





4. 2      Experimental 
4. 2. 1   Materials  
            All chemicals were purchased from Aldrich. 2-(2-methoxyethoxy)ethyl methacrylate 
(MEO2MA, 95%), oligo(ethylene glycol)methyl ether methacrylate (MEO5MA, Mn = 300 g/mol) 
and poly(ethylene glycol) dimethacrylate (PEGDMA, Mn ≈ 550 g/mol) were purified with 
neutral Al2O3. Curcumin was purified with anhydrous ethanol. Anhydrous ethanol, 2-
vinylanisole, divinylbenzene (DVB), 2,2′-azobis(2-methylpropionamidine) dihydrochloride 
(AAPH), sodium dodecyl sulfate (SDS), Dulbecco's Modified Eagle Medium (DMEM), and 
Fetal bovine serum (FBS) were used as received without further purification. The water used in 
all experiments was of Millipore Milli-Q grade. 
 
4. 2. 2   Synthesis of poly(2-vinylanisole) core microgels 
             The core microgels were prepared by free radical precipitation copolymerization of 2-
vinylanisole using AAPH as an initiator. A mixture of 2-vinylanisole (5.96 × 10−4 mol), DVB 
(5.61 × 10−5 mol), SDS (3.46 × 10−4 mol), and water (95 mL) was poured into a 250 mL three-
neck round-bottom flask equipped with a stirrer, a nitrogen gas inlet, and a condenser. After 30 
min, the temperature was raised to 70 °C and the polymerization was initiated by adding 1 mL of 
AAPH (0.105 M). The polymerization was allowed to proceed for 5 h. The resulted solution was 
centrifuged three times at 10,000 rpm (30 min, Thermo Electron Co. SORVALL® RC-6 PLUS 
superspeed centrifuge) with supernatant discarded and the precipitate redispersed in 200 mL 
deionized water. The resultant poly(2-vinylanisole) (abbreviated to PVAS) microgels were used 
as nuclei for subsequent precipitation polymerization to add the nonlinear PEG copolymer gel 




4. 2. 3   Synthesis of PVAS@PEG core-shell microgels 
            The outer shell precursors of MEO2MA and MEO5MA comonomers mixture in 1:2 molar 
ratio and PEGDMA crosslinker were dissolved into the 100 mL purified PVAS nanogel 
dispersion. The mixture was heated to 70 °C under a N2 purge. After 30 min, 1 mL of AAPH 
(0.105 M) initiator was added to start the polymerization. The synthesis was allowed to proceed 
to total 5 h. The resulted PVAS@PEG core-shell microgels were purified with 
centrifugation/redispersion in water for three cycles, followed by 3 days of dialysis (Spectra/Pro® 
molecularporous membrane tubing, cutoff 12,000−14,000) against very frequently changed 
water at room temperature (~22 °C). Different feeding compositions for the synthesis of the 
PVAS@PEG core-shell microgels are listed in Table 4−1 to control the different shell thickness. 
The PVAS@PEG core-shell microgels are coded as VEM. 
 
Table 4−1  
Feeding compositions and hydrodynamic radius (Rh) for synthesis of the core-shell microgels 
Sample Core Solution (mmol) 
PVA 
Shell Solution (mmol) Rha (nm) 
 MEO2MA  MEO5MA PEGDMA  
PVA core microgel 0.594   70 
PEG-based shell microgel  0.75             1.50 2.26×10−2 – 
VEM1 0.594 0.20             0.40 0.60×10−2 101 
VEM2 0.594 0.25             0.50 0.75×10−2 110 
VEM3 0.594 0.50             1.00 1.51×10−2 138 
VEM4 0.594 0.75             1.50 2.26×10−2 165 
a Hydrodynamic Radius (Rh) measured by Dynamic light scattering (DLS) method at 22 °C and a 




4. 2. 4   Drug loading and release 
            Curcumin was loaded into the microgels mainly driven by hydrophobic interactions. 5 
mL microgel dispersion was stirred in an ice water bath for 30 min. 4 mL fresh curcumin 
solution of 1mg/mL in anhydrous ethanol was then added dropwisely to the vial. After stirring 
overnight, the suspension was centrifuged at 10,000 rpm for 15 min at 22 °C. To remove free 
curcumin, the precipitate was redispersed in 5 mL water, and further purified by repeated 
centrifugation and washing for at least six times. All the upper clear solutions were collected, 
and the concentration of free curcumin was determined by UV-vis spectrometry at 435 nm. The 
emission intensity at 566 nm with the excitation wavelength of 420 nm on the upper clear 
solutions was also recorded to confirm the loading amount. Optical signal was converted to 
concentration based on the linear calibration curve R2 > 0.99 measured using the curcumin 
solution with known concentrations under the same condition. The amount of loaded curcumin in 
the microgels was calculated by deducting curcumin amount in upper clear solution from the 
total curcumin amount (4 mg). The loading capacity is expressed as the mass of loaded drug per 
unit weight of dried microgels. The loading experiments at physiological temperature 37 °C were 
also performed by using the same procedure as that at 22 °C. 
            The in vitro release test of curcumin from the microgels was evaluated by the dialysis 
method. The curcumin-loaded microgel dispersion was diluted to 0.15 mg/mL for the release 
experiments. A dialysis bag (Spectra/Pro® molecularporous membrane tubing, cutoff 
12,000−14,000) filled with 1 mL diluted curcumin-loaded microgels was immersed in 50 mL 
0.005 M phosphate buffer solutions (PBS) of pH = 6.15 at different temperatures. The released 




fluorescence spectrophotometer at 566 nm upon excitation at 420 nm. Cumulative release is 
expressed as the total percentage of drug released through the dialysis membrane over time. 
 
4. 2. 5   Incorporation of microgels into mouse melanoma cells B16F10 
            The microgels pre-loaded with curcumin undergo a releasing experiment at 37 °C for 7 
days until no curcumin would further release out from the microgels, in which about 20% of 
curcumin was still entrapped to provide fluorescence signal for cellular imaging.  
            Round glass coverslips were placed in wells of a 24-well plate and treated with 0.1% 
poly-ʟ -lysine in 100 mM PBS for 40 min. Following the treatment, the solution was aspirated 
and the wells were washed with PBS 3 times each. Next, B16F10 cells were plated on the glass 
coverslips at 80% confluence in DMEM containing 10% FBS and 1% penicillin-streptomycin. 
After 24 h, 500 µL of different curcumin-loaded microgels (0.3 µg/mL) in serum-free DMEM 
were added into the wells respectively. The plate was incubated at 37 °C for 2 h. The medium 
was then aspirated and fresh serum-free DMEM was added to each well. Finally, the coverslips 
with cells were removed from the wells and mounted onto slides for confocal microscopy study. 
 
4. 2. 6   In vitro cytotoxicity 
            B16F10 cells (6 × 103 cell/well) were cultured in DMEM containing 10% FBS and 1% 
penicillin-streptomycin in a 96-well plate, and exposed to free curcumin, curcumin-free 
microgels, and curcumin-loaded microgels, respectively. The plate was washed three times using 
fresh serum-free DMEM. The plate was incubated at 37 °C for 2 h. After that, 25 µL of 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) solution (5 mg/mL in phosphate 




aspirated and 100 µL of DMSO was added to each well to dissolve the formazan crystal, and the 
plate was sealed and incubated overnight at 37 °C with gentle mixing. Three portions of the 
solution obtained from each well were transferred to three respective wells of a 96-well plate. 
Cell viability was measured using a microplate reader at 570 nm. Positive controls contained no 
drug or microgels, and negative controls contained MTT.  
 
4. 2. 7   Characterization 
            The morphology of the core-shell microgels was characterized with transmission electron 
microscopy (TEM). The TEM images were taken on a FEI TECNAI transmission electron 
microscope at an accelerating voltage of 120 kV. Approximately 10 µL of diluted microgel 
suspension was dropped on a Formvarcovered copper grid (300 meshes) and then air-dried at 
room temperature for the TEM measurements. The UV-vis absorption spectra were obtained on a 
Thermo Electron Co. Helios β UV-vis Spectrometer. The PL spectra were respectively obtained 
on a JOBIN YVON Co.FluoroMax®-3 Spectrofluorometer equipped with a Hamamatsu R928P 
photomultiplier tube, calibrated photodiode for excitation reference correction from 200 to 980 
nm, and an integration time of 1 s. The pH values were obtained on a METTLER TOLEDO 
SevenEasy pH meter. The B16F10 cells incorporated with microgels were imaged using a 
confocal laser scanning microscopy (LEICA TCS SP2 AOBSTM) equipped with an HC PL APO 
CS 20 × 0.7 DRY len. A UV (405 nm) light was used as the light source.  
            Dynamic light scattering (DLS) was performed on a standard laser light scattering 
spectrometer (BI-200SM) equipped with a BI-9000 AT digital time correlator (Brookhaven 
Instruments, Inc.). A Nd:YAG laser (150 mW, 532 nm) was used as the light source. All 




to remove dust before the DLS measurements. In DLS, the Laplace inversion of each measured 
intensity-intensity time correlated function can result in a characteristic line width distribution 
G(Γ)63. For a purely dissuasive relaxation, Γ is related to the translational diffusion coefficient D 
by (Γ/q2)C→0,q→0 = D, where q = (4πn/λ)sin(θ/2) with n, λ, and θ being the solvent refractive 
index, the wavelength of the incident light in vacuo, and the scattering angle, respectively. G(Γ) 
can be further converted to a hydrodynamic radius (Rh) distribution by using the Stokes-Einstein 
equation, Rh = (kBT/6πη)D−1, where kB, T, and η are the Boltzmann constant, the absolute 
temperature, and the solvent viscosity, respectively. 
 
4. 3       Results and discussion 
4. 3. 1   Synthesis and structure of PVAS@PEG core-shell microgels 
            Our strategy to prepare the PVAS@PEG core-shell microgels involves the first synthesis 
of a PVAS core microgel, followed by the synthesis of the nonlinear PEG gel layer on the core 
microgel. The PVAS core microgels were synthesized based on the well-established precipitation 
polymerization method. Because of low solubility of 2-vinylanisole in water, the PVAS 
fragments formed at the early stage of reaction would nucleate and precipitate into the 
hydrophobic alkyl chain regions of the SDS molecules. With the proceeding of polymerization 
reaction, more PVAS fragments were added onto the initially formed hydrophobic gel layer, 
leading to a continuous growth in size until the polymerization reaction was completed. The as-
synthesized hydrophobic PVAS core microgels with Rh = 70 nm at 22 °C were used as a seed for 
further polymerization to form the outer shell layer of nonlinear PEG-based gel, which consists 
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Figure 4−2 Hydrodynamic radius distribution of PVAS@PEG core-shell microgels VEM1 (■), 
VEM2 (●), VEM3 (▲), and VEM4 (▼), measured at 22 °C and a scattering angle of θ = 45°. 
 
             Figure 4−2 shows the size distributions of the PVAS@PEG core-shell microgels, in 
terms of the hydrodynamic radius (Rh) measured at T = 22 °C and θ = 45°, synthesized with 
different feeding amount of MEO2MA and MEO5MA but at the same MEO2MA : MEO5MA 
molar ratio (1:2). All the obtained PVAS@PEG core-shell microgels have a very narrow size 
distribution. The DLS characterization indicates that the obtained microgels are nearly 
monodispersed with a polydispersity index of µ2/<Γ>2 = 0.001. As can be seen in Table 4−1, the 
hydrodynamic radius (Rh) of the core-shell microgels VEM1, VEM2, VEM3, and VEM4 
synthesized using the same core microgel template are 101, 110, 138, and 165 nm,  respectively, 
indicating that the microgel particle size increases with the increase in the feeding amount of 
shell precursors of MEO2MA and MEO5MA. This result indicates that the shell thickness and 
size of the core-shell microgel can be controlled by a simple change of the feeding amount of 






Figure 4−3 Typical TEM images of PVAS@PEG core-shell microgels VEM2 (A) and VEM3 
(B). 
 
            Figure 4−3 shows the typical TEM images of the dried core-shell microgels VEM2 and 
VEM3 (see Table 4−1). Both microgels exhibit monodispersed spherical bead morphology and a 
well-defined core-shell architecture with a clear boundary between the core and shell. The core-
shell structure can be clearly observed with a dark condensed core and a light contrast shell. The 
dark core can be attributed to the higher electron density of the PVAS chains and the shorter 
crosslinker DVB (equivalent to higher crosslinker density) than the oligo-PEG crosslinked 
nonlinear PEG gel shell. The clear core-shell structure is associated with the fact that the 
hydrophobic densely crosslinked PVAS core can hinder the relatively hydrophilic nonlinear 
PEG-based chains of the outer shell from interpenetrating into the inner core area64. The TEM 





VEM3 microgel, further proving that the shell thickness of the core-shell microgels can be tuned 
by simply adjusting the feeding ratio of the shell precursors to PVAS core in the synthesis. 
 
4. 3. 2   Temperature-responsive volume phase transitions of the core-shell microgels 
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Figure 4−4 Temperature dependence of the average Rh values of PVAA@PEG core-shell 
microgels VEM1 (■), VEM2 (●), VEM3 (▲), and VEM4 (▼), measured at a scattering angle θ 
= 45°. 
 
            Figure 4−4 shows the temperature-induced volume phase transitions of the PVAS@PEG 
core-shell microgels in terms of the change of Rh measured at a scattering angle of θ = 45°. It is 
clear that the increase in temperature of dispersion medium can induce a significant shrinkage of 
the core-shell microgels. The hydrophobic PVAS core would not undergo conformational and 
chemical changes in water when giving external stimuli of temperature change. The observed 




the nonlinear PEG gel shell containing P(MEO2MA-co-MEO5MA) chains. It is believed that the 
water solubility of this type of nonlinear PEG-based copolymer comes from the formation of 
hydrogen-bonds between ether oxygen of the side PEG chains and the hydrogen of water. On the 
other hand, the hydrophobicity of the apolar backbone would counterbalance this favorable 
effect in water59, 64. This counterbalance of the hydrophilic and hydrophobic forces results in the 
swelling/deswelling characteristic of our microgels. The critical volume phase transition 
temperature (VPTT) of the core-shell microgels can be controlled by the feeding molar ratio rmol 
= nMEO2MA/nMEO5MA in shell gel synthesis.  The lower the rmol, the higher the VPTT of the 
microgels will be64.  Figure 4−4 indicates that the proper feeding molar ratio of 1:2 between the 
two macromonomers of MEO2MA and MEO5MA has led to a continuous change in 
hydrodynamic radius (Rh) with tunable slopes across the physiologically important temperature 
range of 37–42 °C, which are typical abnormal temperature range found in many pathological 
zones such as tumors65−67. Additionally, the microgels did not reach a fully collapsed state at the 
experimental temperature limit up to 50 °C, thus the partially swollen PEG-based outer gel layer 
is still hydrophilic at temperature below 50 °C. This hydrophilic gel shell makes the 
PVAS@PEG core-shell microgels very stable in water. Even after few months, no sediment was 
observed in the microgel solutions, which is very important to serve as a drug carrier for delivery 
of hydrophobic drugs. While the inner PVAS core provides hydrophobic region for the storage 
of hydrophobic drugs, the hydrophilic outer PEG-based gel shell can enable the microgels to 
disperse in cell culture medium and further penetrate into the cells. The thermo-responsive outer 
PEG-based gel shell can be utilized to regulate the transport of the drug molecules from the inner 





4. 3. 3   Drug loading capacity of the PVAS@PEG core-shell microgels 
            The hydrophobic PVAS core of the core-shell microgels offers the capability for storage 
of hydrophobic drugs. We expect that the PVAS core with similar structural units to the 
curcumin molecules should have strong hydrophobic interactions to attract the curcumin 
molecules into the core region. Curcumin is poorly soluble in water at acidic or neutral pH with 
the macroscopic undissolved flakes visible in the solution1, while at pH above neutral value it 
would undergo rapid hydrolytic degradation8, 68, 69 and thus lose the pharmaceutical effects. It has 
been determined that the half-time for the hydrolytic degradation of curcumin in aqueous 
solution containing 10% organic solvent at pH ≈ 6, 7, and 8 is 4.2 ×103 h, 15 h and 3.5 × 10-2 h, 
respectively69. Therefore, we loaded the curcumin molecules into the PVAS@PEG core-shell 
microgels dispersed in distilled water at pH = 5.7, where the curcumin molecules should have no 
significant degradation occurred.  
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Figure 4−5 Curcumin loading capacity of the PVAS@PEG core-shell microgels as a function of 




            Figure 4−5 shows the effect of shell thickness on the drug loading capacity of the core-
shell microgels measured at 22 °C. For PVAS core, VEM1, VEM2, VEM3, and VEM4 core-
shell microgels, the loading capacity was determined as 18.5 wt%, 29.3 wt%, 31.9 wt%, 35.5 
wt%, and 38.0 wt%, respectively. The thicker the outer PEG-based gel shell, the higher the 
loading capacity of the core-shell microgels. When the shell thickness is above 40 nm, the 
loading capacity still increases with the increase in shell thickness, but with a slower pace. If we 
further increase the shell thickness, the loading capacity would increase at a much slower pace. 
This result indicates that very little curcumin molecules were associated with PEG-based gel 
shell. Indeed, this was confirmed by the extremely low loading capacity of pure PEG-based 
microgels (see Table 4−1) of 1.52 wt%. In contrast, the pure PVAS core demonstrates a much 
higher curcumin loading capacity (18.5 wt%) than the pure nonlinear PEG-based microgels with 
the same composition as the gel shell. Thus, the drug loading is mainly contributed by the PVAS 
core, whose hydrophobic aromatic groups can form strong hydrophobic associations with the 
aromatic phenols in curcumin molecules to form intermolecular complexes, resulting in relative 
high drug loading capacity. Nevertheless, it should be noticed that the curcumin loading capacity 
of the pure PVAS core microgels is much lower than that of the PVAS@PEG core-shell 
structured microgels. The high curcumin loading capacity of the core-shell structured microgels 
implies that there must be another important factor to enhance the drug loading capacity, which 
should be the collapsing degree (mesh size of network) of the PVAS core microgels. The PVAS 
core microgels are hydrophobic and densely shrunk together. Such a collapsed structure has 
limited space to hold the curcumin drug molecules. However, in the core-shell nanostructured 
microgels, the introduction of the hydrophilic and swollen gel shell layer can restrict the PVAS 




make a bigger mesh size even though the core network chains are still hydrophobic. In this case, 
the open network with large mesh size of the hydrophobic PVAS core could hole much more 
hydrophobic curcumin molecules. The thicker the swollen nonlinear PEG gel shell, the larger the 
pulling force to restrict the collapsing of the hydrophobic PVAS core chain network, resulting in 
higher curcumin loading capacity of the core-shell microgels. When the shell thickness is 
increased to a certain value, the mesh size of the hydrophobic PVAS core network chains will no 
longer increase due to the limitation of chemical crosslinking. At that moment, the drug loading 
capacity of the core should reach to a maximum value.  The further increase in the thickness of 
PEG gel shell would only increase the overall loading capacity of the core-shell microgels 

















4. 3. 4   In vitro release studies 














































































Time  /  hour



























Figure 4−6 Releasing profiles of curcumin from the core-shell microgels VEM1 (A), VEM2 (B), 
VEM3 (C), and VEM4 (D) at different temperatures. Curcumin has been pre-loaded into core-
shell microgel at 22 ℃. In the blank (◊), 1 mL diluted solution of free curcumin (containing 5% 
ethanol) with an equivalent amount of drug to the trapped in VEM1 was performed at 41 ℃. All 







            Figure 4−6 shows the release kinetics of curcumin from the VEM1, VEM2, VEM3, and 
VEM4 core-shell microgels. The in vitro release test was carried out in a PBS of pH = 6.15 to 
avoid the evident degradation of curcumin from the long time exposure in water. A blank release 
experiment of free curcumin (D ≈ 379 Da) solution (containing ~5% ethanol) with an equivalent 
amount of drug to that trapped in VEM1 was also performed, showing that the dialysis 
membrane (cutoff 12000 – 14000 Da) played a negligible role in the release kinetics (Figure 
4−6A). Three features should be noted. Firstly, the curcumin release from the core-shell 
microgels is much slower than from the free curcumin solution, indicating a sustained release of 
curcumin from the core-shell microgels. Secondly, the release kinetics of curcumin from the 
core-shell microgels was temperature dependent. The release of curcumin could be significantly 
speeded up by increasing temperature for all the VEM1, VEM2, VEM3 and VEM4 core-shell 
microgels. For instance, only 16.1% of curcumin was released from VEM1 at 22 ℃ for 72 h. 
When temperature of medium increased to 37, 39, and 41 ℃, the percentage of curcumin 
released from VEM1 reached to 44.4%, 65.3%, and 80.4% during the same time period (72 h). 
This temperature dependence of curcumin release should be attributed to thermo-responsive 
nonlinear PEG gel shell. The increase in temperature induced a gradual shrinking of the PEG gel 
shell and thus reduced the pulling force of shell to restrict the collapsing of hydrophobic core, 
which compressed the core space and thus squashed out the curcumin molecules. Meanwhile, the 
shrunk PEG gel shell could also reduce the restricted diffusion path length of curcumin 
molecules from the core region to the medium outside the microgels. The higher the temperature 
of the dispersion medium, the thinner the PEG gel shell, which compressed more on the PVAS 
core, thus more curcumin molecules could be released out from the core-shell microgel. Thirdly, 




microgels with thinner PEG-based shell. For example, the percentage of curcumin released from 
VEM1, VEM2, VEM3 and VEM4 at 41 °C for 72 h was 80.4%, 78.0 %, 75.9%, and 73.7%, 
correspondingly. This result could be also attributed to the factor that the thin gel shell can 
shorten the restricted diffusion path of the curcumin from the core to external dispersion medium.  
 



















































Figure 4−7 Releasing profiles of curcumin from the core-shell microgels VEM2 (A) and VEM3 
(B) at different temperatures. Curcumin has been pre-loaded into core-shell microgel at 37 °C. 
All releasing experiments were carried out in 50 mL PBS (0.005M) of pH = 6.15. 
 
            In practical applications, the drug carriers should have a minimum release of drug at 
normal body temperature of 37 °C. The core-shell microgels loaded with curcumin at 22°C 
demonstrate a significant release of curcumin at 37 °C. To further explore the drug releasing 
property of the core-shell microgels at physiologically important temperature range of 37−42 °C, 
we loaded the curcumin into the core-shell microgels at 37 °C and then did the in vitro releasing 
test at different temperature of 37, 39 and 41 °C, respectively. Figure 4−7 shows the release 





°C. While the general trend of temperature-triggerable drug release remains the same as observed 
in Figure 4−6, only 15.6% and 12.9% curcumin was respectively released from VEM2 and 
VEM3 at 37 °C, which is very important to minimize the drug release at normal condition. When 
the temperature of releasing medium was increased to physiologically abnormal temperature of 
39 °C and 41 °C, the release of curcumin was significantly increased. Thus, the temperature-
regulated drug release could be exploited for intelligent drug delivery applications through 
environmental stimuli. The abnormal temperature rise in pathological zones could facilitate 
active drug release from the core-shell microgels. 
 
4. 3. 5   Hydrolytic Degradation of Curcumin 
            Studies have shown that the hydrolytic degradation process of curcumin occurs rapidly at 
a pH above neutral69. Wang et al. have used high performance liquid chromatography (HPLC) 
and mass spectrometry to show that curcumin is partially deprotonated initially, which is 
followed by fragmentation into trans-6-(4′-hydroxy-3′-methoxyphenyl)-2,4-dioxo-5-hexanal as 
the main product, then further decomposed to vanillin, ferulic acid, and feruloyl methane.70 
Mandy et al. have determined that the condensation products contribute negligible to the total 
absorption signal71. Thus the degradation of curcumin can be determined from the decrease of 
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Figure 4−8 Fluorescence spectra of curcumin in pH = 7.4 PBS buffer (A) and curcumin-loaded 
VEM3 (B) over a course of 180 min. The decays of the curcumin at the absorption maxima are 
shown in C (●: curcumin-loaded VEM3，■: pH = 7.4 PBS buffer). All experiments were carried 
out at 37 °C. 
 
            Degradation of curcumin was recorded over 180 min at 37 °C and 15 min intervals by 
monitoring the decrease in the absorption maximum and the results are shown in Figure 4−8. In 
pH = 7.4 PBS buffer solution (Figure 4−8A), the absorption maximum decays to approximately 






are significantly lower (Figure 4−8B), where the absorption at maximum decreases to about 85% 
of initial value. Furthermore, we showed before that about 10% of curcumin had been released 
out from VEM3 after 3 h at 37 °C (Figure 4−6C), which might degrade in PBS solution. These 
results indicated the PVAS@PEG core-shell microgels can significantly restrict the degradation 
of curcumin and improve therapeutic efficacy. 
 
4. 3. 6   Tumor cell imaging 
 
 
Figure 4−9 Scanning confocal fluorescence images of mouse melanoma B16F10 cells upon 
staining with curcumin loaded core-shell microgels VEM1 (A), VEM2 (B), VEM3(C), and 







            Curcumin can emit strong visible fluorescence under the physiological conditions, which 
renders them useful for biomedical detection of the drug carriers and imaging diagnosis. We 
loaded curcumin to core-shell microgels and then release them at 37 °C for 7 days. This 
procedure ensured no free curcumin molecules would further release out from the core-shell 
microgels when we incorporate these microgels into the tumor cells, while the curcumin 
molecules still trapped in the core of microgels can emit fluorescence signals for cellular imaging 
to examine whether these core-shell microgel particles can permeate into the cells. Figure 4−9 
shows the scanning confocal fluorescence images of the mouse melanoma cells B16F10 after 
stained with curcumin-loaded core-shell microgels for 2 h, obtained from the laser confocal 
microscopy.  The bright spots are attributed to the curcumin molecules encapsulated inside the 
core-shell microgels. To confirm that the microgels are not just distributed on the surface of cells, 
the Z-scanning confocal fluorescence transmission images were taken for the B16F10 cells 
(Figure 4−10), which indicate that the curcumin-trapped core-shell microgels indeed illuminate 
the entire cell, but mainly distributed in the cytoplasm and perinuclear region of the cells. It is 















Figure 4−10 Z-Scanning confocal fluorescence transmission images of mouse melanoma cells 
B16F10 incubated with curcumin loaded core-shell microgels VEM3. 
 
4. 3. 7    In vitro cytotoxicity 
            For future biological applications, especially clinical applications, material must be non-
cytotoxic or low-cytotoxic. As shown in Figure 4−9, almost no signs of morphological damage 
to the cells were observed upon the treatment with microgels, demonstrating the minimal 
cytotoxicity of the microgels. To further evaluate the cytotoxicity of the empty microgels and to 





tests were elaborately conducted against B16F10 cells. The studied concentrations were set on 
the base of potential drug loading capacity of microgels in order to compare the cytotoxicity of 
the empty microgels with the drug-loaded ones. Figure 4−11 shows that the empty microgels 
were non-cytotoxic to B16F10 cells in concentrations of up to 428 µg/mL and 480 µg/mL for 
VEM1 and VEM4, respectively. These results indicate that our microgels based on the PVAS 
core and nonlinear PEG gel shell exhibit an excellent in vitro biocompatibility. In contrast, when 
the cells were incubated with curcumin-loaded microgels, the cell viability drastically decreased 
even at a concentration as low as 143.7 µg/mL and 106.9 µg/mL for VEM1 and VEM4, 
respectively (equivalent to about 40.7 µg/mL free curcumin in both systems). These results 
indicate that the curcumin-loaded microgels provide high anticancer activity. The lower 
cytotoxicity of curcumin-loaded microgels than the free curcumin solutions is reasonable due to 
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Figure 4−11 Comparison of B16F10 cell survivability following treatments with core-shell 
microgels VEM1 and VEM4 as drug carriers, respectively; （●: curcumin-loaded VEM1，■: 
curcumin-loaded VEM4). B16F10 cell survivability after treated with free microgels (○: VEM1; 
□: VEM4) and free curcumin solutions (♦). 
 
4. 4      Conclusion  
            Well-defined thermo-responsive PVAS@PEG core-shell microgels with the PVAS 
microgels as hydrophobic core and the nonlinear PEG gel as a hydrophilic shell could be 
successfully synthesized via precipitation polymerization. The rationally designed PVAS core 
chain networks can effectively store the hydrophobic curcumin drug molecules via hydrophobic 
interactions, thus provide high drug loading capacity. The nonlinear PEG gel shell composed of 
the copolymer P(MEO2MA-co-MEO5MA) with the comonomer ratio of MEO2MA:MEO5MA = 




but also prevent the PVAS hydrophobic core network from collapsing. This designed structure of 
hydrophobic core with a large mesh size in the core-shell microgels can load hydrophobic drug 
molecules much more effectively, which indicates that both the drug-core hydrophobic 
interactions and the mesh size of core networks are important to determine the drug loading 
capacity. The thermo-sensitive nonlinear PEG gel shell of the microgels could trigger the drug 
release by local temperature change, offering sustained drug release profiles. Although curcumin 
was selected as a specific model drug in this text, the core-shell nanostructured microgels can be 
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Chapter 5   
Water-dispersible Core-Shell Structured Magnetic-
Polymer Hybrid Nanogels for Curcumin Delivery 
 
5. 1      Introduction 
            Magnetic nanoparticles (NPs) have attracted considerable attention in the past because of 
their exclusive advantage for targeted drug delivery, magnetic resonance imaging (MRI), 
bioseparation, biosensor, and hyperthermia1−5. Superparamagnetic iron oxide NPs (e.g. 
maghemite Fe3O4), as the typical magnetic NPs appear to be quite suitable for a drug targeted 
carrier, due to their capability of delivering pharmaceuticals to a specific site of the body by 
means of a gradient magnetic field6−8. However, bare superparamagnetic iron oxide NPs are 
toxic and very easy to aggregate. The surface modifications of the as-prepared Fe3O4 NPs by 
polymers, proteins, or other biomolecules were carried out to achieve their biomedical 
applications. Biopolymer-coated magnetic NPs would be more suitable as drug carriers, because 
of their high physiological stability, biocompatibility, bio/magnetic targeting, and therapeutic 
functionalities9−11. Recently, many studies have focused on the fabrication of versatile core-shell 




magnetic NPs have been specifically designed to deliver curcumin molecules, a traditional anti-
tumor drug.  
            Curcumin is a yellow compound presented in spice turmeric (Curcuma longa), which can 
prevent carcinogen-induced tumorigenesis and inhibit growth of many tumor cell lines15−18. 
Unfortunately, its exceedingly low water solubility, rapid metabolism in body, and low oral 
bioavailability has hindered clinical advancement to bring this safe and affordable natural 
product to the forefront against cancers and other chronic diseases19−20. It is expected that the 
polymer-grafted magnetic NPs as drug delivery carriers can be guided and concentrated in 
anticipated target site by application of an external magnetic field, consequently minimize severe 
side effects and enhance the therapeutic effects of drugs21−22. On the other hand, the responsive 
polymer shell that can undergo stimuli-responsive volume phase transitions should trigger the 
drug release in response to environmental stimuli, such as pH, temperature, light, and electrical 
field change23. Among these smart materials, magnetic NPs coated with temperature-sensitive 
nanogels have been studied for controlled and targeted drug releasing systems24−25. After guiding 
nanogels to a disease site by external magnetic field, these smart hybrid nanogels can efficiently 
penetrate into individual cells by encapsulation, surface attachment or entrapment26 due to their 
small size. When temperature increases, the nanogel will change the swelling degree and release 
out the drugs, resulting in an efficient drug accumulation at the targeted site. So far, magnetic 
NPs coated with poly(N-isopropylacrylamide) (PNIPAM) were most extensively studied because 
of their responsiveness to temperature stimuli and enhanced drug-loading ability27−28. However, 
the well-studied PNIPAM-coated magnetic NPs have not been translated into a biomedical 
breakthrough due to the general concerns on the toxicity of NIPAM monomers. To meet the 




important challenge is to develop biocompatible thermo-responsive polymers. The recently 
developed nonlinear poly(ethylene glycol) (PEG) polymers containing short oligo(ethylene 
glycol) side chains have attracted tremendous interests for the construction of polymeric drug 
carriers and other biomaterials applications due to their thermo-sensitive, water-soluble, and 
biocompatible properties29-32. Another advantage of this new type of nonlinear PEG polymers is 
that their lower critical solution temperature (LCST) in aqueous solution is tunable through the 
control in the compositions of the oligo(ethylene glycol) side chains29−32. The longer the 
oligo(ethylene glycol) side chains, the higher the LCST of the resultant nonlinear PEG polymers.  
 
Scheme 5−1 Schematic illustration of curcumin-loaded Fe3O4@poly(4-allylanisole)-PEG hybrid 
nanogels with small Fe3O4 NP as core embedded in the poly(4-allylanisole)-PEG double-layer 
gel shell. The hydrophobic curcumin drug is mainly encapsulated within the inner hyrdophobic 
poly(4-allylanisole) shell, which is coated by an outer PEG-based shell to offer biocompatibility, 
stability in aqueous media, and temperature responsiveness. When temperature increases, the 
hybrid nanogels shrink and the loaded curcumin molecules are released out. 
 
            In this work, we design a novel type of magnetic core-shell structured hybrid nanogel for 
highly efficient curcumin delivery carriers. As shown in Scheme 5−1, the newly designed core-




allylanisole) gel layer as inner shell, and a hydrophilic, biocompatible, and thermo-responsive 
nonlinear PEG gel as outer shell. The magnetite Fe3O4 NPs are designed to provide the hybrid 
nanogels with fast magnetic response, magnetic site-targeting ability and magnetic resonance 
imaging function. The inner poly(4-allylanisole) gel shell is particularly designed to improve the 
drug loading yields for the very hydrophobic and delicate curcumin molecules. 4-Allylanisole is 
a natural organic compound produced by many conifers and herbs33. It is usually used in the 
preparation of fragrances34 and a flavoring additive of bakery products, both alcoholic and 
nonalcoholic beverages, chewing gum, confections, fish, ice cream, salad, sauces, and vinegar35. 
Considering its structural similarity to the structural units of curcumin molecules, we expect that 
the poly(4-allylanisole) gel network chains can interact with curcumin molecules effectively 
through the π-π stacking and other hydrophobic interactions, thus enhance the curcumin drug 
loading capacity significantly. The outer nonlinear PEG gel shell is designed to provide the water 
dispersibility and biocompatibility for the hybrid nanogels as well as the thermo-triggerable drug 
release. The nonlinear PEG gel shell can be synthesized by polymerizing and crosslinking the 
comonomers of 2-(2-methoxyethoxy)ethyl methacrylate (MEO2MA) and oligo(ethylene glycol) 
methyl ether methacrylate (Mn = 300 g/mol, MEO5MA) at a molar ratio of 1:2. Our previous 
reports proved that this rational ratio of PEG comonomers can lead the resultant nonlinear PEG 
nanogel to a continuous thermo-responsive volume phase transition with tunable slopes across 
the physiologically important temperature range of 37–42 °C, which are typical abnormal 
temperature range found in many pathological zones such as tumors37−39. Table 5−1 display 
chemical structures of all the monomers, crosslinkers, and curcumin molecules. For drug carrier 
applications, the size of the hybrid nanogels is another critical parameter. In our design, the core-




inner/outer polymer gel shell thickness and the overall size of the hybrid nanogels can be well 
controlled through the feeding ratios of shell precursors to the core template NPs amount during 
synthesis. The effects of inner and outer shell thickness on the magnetic properties, drug loading 
capacity, sustained drug release behavior, and cytotoxicity of the drug-free and drug-load hybrid 
nanogels will be evaluated. The combination of the characteristic functions from the each 
component designed in the hybrid nanogels would enable the magnetic hybrid nanogels to 
become a highly efficient smart curcumin delivery carrier with magnetic site-targeting ability, 
magnetic resonance imaging contrasting ability, high curcumin loading capacity, triggerable 
sustained release, good cell penetration ability, and high therapeutic efficacy. 













Table 5−1 Structures and function of all the monomers, crosslinkers, and curcumin molecules 
using in this work. 
 
 
5. 2      Experimental 
5. 2. 1  Materials 
            All chemicals were purchased from Aldrich. 2-(2-methoxyethoxy)ethyl methacrylate 
(MEO2MA, 95%), oligo(ethylene glycol)methyl ether methacrylate (MEO5MA, Mn = 300 g/mol) 
and poly(ethylene glycol) dimethacrylate (PEGDMA, Mn ≈ 550 g/mol) were purified with 
Structure Name Function 
2-(2-methoxyethoxy)ethyl methacrylate  
                     (MEO2MA) 
           Major monomer 
Thermo-responsive component 
Oligo(ethylene glycol)methyl  
ether ethacrylate   (MEO5MA) 
Sodium dodecyl sulfate  
             (SDS) 
Surfactant 
H 2 C 
C H 3 
O 
O 
O C H 3 
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H 2 C O 
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C H 3 
4-Allylanisole 
           Major monomer 
Thermo-responsive component 
          Major monomer 
Curcumin loading component 
 




Poly(ethylene glycol) dimethacrylate  
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neutral Al2O3. Curcumin was purified with anhydrous ethanol. Iron (Ш) chloride (FeCl3), Iron 
(П) chloride tetrahydrate (FeCl2⋅4H2O), 4-allylanisole, divinylbenzene (DVB), 2,2′-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), sodium dodecyl sulfate (SDS), anhydrous 
ethanol, Dulbecco's Modified Eagle Medium (DMEM), and Fetal bovine serum (FBS) were used 
as received without further purification. The water used in all experiments was of Millipore 
Milli-Q grade. 
 
5. 2. 2  Synthesis of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels 
5. 2. 2. 1 Synthesis of Fe3O4 nanoparticles 
            In a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, 
FeCl3 (5 mM), FeCl2⋅4H2O (2.5 mM), and 30 mL distilled water were heated to 80 °C. Then 5 
mL of NaOH (10 M) were added. The reaction was allowed to proceed for 1 h. The solution was 
centrifuged at 6000 rpm (20 min, Thermo Electron Co. SORVALL® RC-6 PLUS superspeed 
centrifuge) with the supernatant discarded and the precipitate was redispersed in 30 mL 
deionized water. SDS-stabilized Fe3O4 nanoparticles were obtained by adding 4.6 × 10-4 mol 
SDS into 0.125 mL aqueous solution of Fe3O4 nanoparticles and 100 mL distilled water. The 
mixture was stirred and aged overnight under N2 atmosphere. 
 
5. 2. 2. 2 Synthesis of Fe3O4@poly(4-allylanisole) nanogels 
            The Fe3O4@poly(4-allylanisole) nanogels were prepared according to the recipes listed in 
Table 5−2. In a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a 
condenser, 100 mL as-prepared aqueous solution of SDS-stabilized Fe3O4 NPs was heated to 30 




Different feeding compositions for the synthesis of the Fe3O4@poly(4-allylanisole) hybrid 
nanogels are listed in Table 5−2 to control the different inner shell thickness. After 30 min, the 
temperature was raised to 70 °C and polymerization was initiated by adding 1 mL of 0.105 M 
AAPH. The polymerization was allowed to react for 5 h. The resulted suspension was 
centrifuged three times at 10,000 rpm (30 min, Thermo Electron Co. SORVALL® RC-6 PLUS 
super-speed centrifuge) with supernatant discarded and the precipitate was redispersed in 100 
mL deionized water. The resultant Fe3O4@poly(4-allylanisole) nanogels were used as template 
particles for subsequent precipitation polymerization to add the outer shell of nonlinear PEG 
copolymer gel of P(MEO2MA-co-MEO5MA). The Fe3O4@poly(4-allylanisole) nanogels are 


















Feeding compositions for synthesis and hydrodynamic radius (Rh) of the Fe3O4@poly(4-
allylanisole)-PEG hybrid nanogels 




4-Allylanisole DVB MEO2MA MEO5MA PEGDMA   
FA−1 0.594 5.61 × 10−2    97.5  
FAE−1 0.594 5.61 × 10−2 0.75 1.50 2.25 × 10−2 167.3 69.8 
FAE−2 0.594 5.61 × 10−2 0.50 1.00 1.50 × 10−2 145.6 48.1 
FAE−3 0.594 5.61 × 10−2 0.25 0.50 0.75 × 10−2 136.7 39.2 
FA−2 0.891 8.42 × 10−2    136.5  
FAE−4 0.891 8.42 × 10−2 0.75 1.50 2.25 × 10−2 174.0 37.5 
a Hydrodynamic Radius (Rh) measured by Dynamic light scattering (DLS) method at 18 °C and a 
scattering angle of θ = 30°. 
b Outer shell thickness is equal to Rh of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels (FAE) 
subtracted by Rh of corresponding Fe3O4@poly(4-allylanisole) nanogels (FA). 
 
5. 2. 2. 3 Synthesis of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels 
            The outer shell precursors of MEO2MA and MEO5MA comonomers mixture in 1:2 molar 
ratio and PEGDMA crosslinker were dissolved into 100 mL purified Fe3O4@poly(4-allylanisole) 
nanogels dispersion. The mixture was heated to 70 °C under a N2 purge. After 30 min, 1 mL of 
AAPH (0.105 M) initiator was added to start the polymerization. The synthesis was allowed to 




purified with centrifugation/redispersion in water for three cycles, followed by 3 days of dialysis 
(Spectra/Pro® molecularporous membrane tubing, cutoff 12,000−14,000) against very frequently 
changed water at room temperature (~22 °C). Different feeding compositions for the synthesis of 
the Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels are listed in Table 5−2 to control the 
different outer shell thickness. The Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels are coded 
as FAE. 
 
5. 2. 3  In vitro magnetic manipulation 
            15 mL of the hybrid nanogel dispersions of different pH values were placed in ∅25 × 
H45 mm bottles, respectively. A permanent magnet was placed next to the bottle to provide a 
magnetic field of 0.1 T. The hybrid nanogel dispersions were sampled in the center region of the 
volume at defined time period and assayed by UV-vis spectrometry at 440 nm. 
 
5. 2. 4  Curcumin loading and release 
            Curcumin was loaded into the porous hybrid nanogels mainly driven by hydrophobic 
interactions. 5 mL Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels dispersion was stirred in an 
ice water bath for 30 min. 4 mL fresh curcumin solution of 1mg/mL in anhydrous ethanol was 
then added dropwise to the vial. After stirring overnight, the suspension was centrifuged at 
10,000 rpm for 15 min at 22 °C. To remove free curcumin, the precipitate was redispersed in 5 
mL water, and further purified by repeated centrifugation and washing for at least six times. All 
the upper clear solutions were collected, and the concentration of free curcumin was determined 
by UV-vis spectrometry at 435 nm. The emission intensity at 566 nm with the excitation 




amount. Optical signal was converted to concentration based on the linear calibration curve with 
R2 > 0.99 measured using the curcumin solution with known concentrations under the same 
condition. The amount of loaded curcumin in the hybrid nanogels was calculated by deducting 
the total curcumin amount in upper clear solution from the total curcumin amount (4 mg) in the 
initial solution. The loading capacity is expressed as the mass of loaded drug per unit weight of 
dried hybrid nanogels. 
            The in vitro release test of curcumin from the hybrid nanogels was evaluated by the 
dialysis method. The curcumin-loaded nanogel dispersion was diluted to 0.15 mg/mL for the 
release experiments. A dialysis bag (Spectra/Pro® molecularporous membrane tubing, cutoff 
12,000−14,000) filled with 1 mL diluted curcumin-loaded hybrid nanogels was immersed in 50 
mL 0.005 M phosphate buffer solutions (PBS) of pH = 6.15 at different temperatures. The 
released curcumin outside of the dialysis bag was sampled at defined time period and assayed by 
fluorescence spectrophotometer at 566 nm upon excitation at 420 nm. Cumulative release is 
expressed as the total percentage of drug released through the dialysis membrane over time. 
 
5. 2. 5  In vitro cytotoxicity 
            B16F10 cells (2000 cell/well) were cultured in DMEM containing 10% FBS and 1% 
penicillin-streptomycin in a 96-well plate, and exposed to hybrid nanogels FAE−(1−4) 
respectively. To cover the high concentrations, the hybrid nanogels were concentrated and 
adjusted to an appropriate concentration in DMEM right before feeding into the wells. The plate 
was incubated at 37 °C for 24 h. The medium was then aspirated, and these wells were washed 
using fresh serum-free DMEM. After that, 25 µL of 3-(4,5-dimethyl-2-thiazolyl)-2,5-




incubation for 2 h, the solution was aspirated and 100 µL of dimethyl sulfoxide (DMSO) was 
added to each well, and the plate was sealed and incubated for 30 min at 37 °C with gentle 
mixing. Three portions of the solution obtained from each well were transferred to three 
respective well of a 96-well plate. Cell viability was measured using a microplate reader at 570 
nm. Positive controls contained no nanogels, and negative controls contained MTT. 
 
5. 2. 6  Characterization 
            The PL spectra were obtained on a JOBIN YVON Co. FluoroMax®-3 Spectrofluorometer 
equipped with a Hamamatsu R928P photomultiplier tube, calibrated photodiode for excitation 
reference correction from 200 to 980 nm, and an integration time of 1 s. The morphology of the 
hybrid nanogels was characterized with transmission electron microscopy (TEM). The TEM 
images were taken on a FEI TECNAI transmission electron microscope at an accelerating 
voltage of 120 kV. Approximately 10 µL of diluted hybrid nanogel suspension was dropped on a 
Formvarcovered copper grid (300 meshes) and then air-dried at room temperature for the TEM 
measurements. The pH values were obtained on a METTLER TOLEDO SevenEasy pH meter. 
            Dynamic light scattering (DLS) was performed on a standard laser light scattering 
spectrometer (BI-200SM) equipped with a BI-9000 AT digital time correlator (Brookhaven 
Instruments, Inc.). A He-Ne laser (35 mW, 633 nm) was used as the light source. All nanogel 
solutions were passed through Millipore Millex-HV filter with a pore size of 0.80 µm to remove 
dust before the DLS measurements. In DLS, the Laplace inversion of each measured intensity-
intensity time correlated function can result in a characteristic line width distribution G(Γ). For a 
purely diffusive relaxation, Γ is related to the translational diffusion coefficient D by 




the wavelength of the incident light in vacuo, and the scattering angle, respectively. G(Γ) can be 
further converted to a hydrodynamic radius (Rh) distribution by using the Stokes-Einstein 
equation, Rh = (kBT/6πη)D−1, where kB, T, and η are the Boltzmann constant, the absolute 
temperature, and the solvent viscosity, respectively. 
 
5. 3       Results and Discussion 
5. 3. 1   Synthesis of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels 
            The synthesis strategy of the hybrid nanogels with hydrophobic-hydrophilic double-layer 
polymer gel as shell and Fe3O4 NPs as core involves the first synthesis of Fe3O4 NPs as core 
template, followed by coating the hydrophobic inner poly(4-allylanisole) gel shell and then the 
hydrophilic thermo-responsive nonlinear PEG gel outer layer, respectively. The magnetite 
(Fe3O4) NPs were prepared by the coprecipitation of Fe(II) and Fe(III) salts with a molecular 
ratio of 1:2 in aqueous solutions at pH = 11−12 under N2 for 1 h40. The reaction step is as follows: 




The resulting black product was isolated by centrifugation (6000 rpm, 20 min) with the 
supernatant discarded and the precipitate was redispersed in 30 mL deionized water. In order to 
stabilize the Fe3O4 NPs dispersed in aqueous solution, The SDS surfactant molecules were added 
to cap the Fe3O4 NPs. The SDS molecules might assemble to form a bi-layer at the surface of 
Fe3O4 NPs4. The first monolayer binds with the anionic head groups pointed down toward the 
surface of Fe3O4 NPs. The exposure of the alkyl chains to the aqueous solvent is energetically 




facing toward the water. In turn, the bi-layer capping of SDS molecules would inhibit the 
aggregation and provide additional stability for Fe3O4 NPs. 
          With the SDS-stabilized Fe3O4 NPs as core template, the polymer gel shell can be added 
through the precipitation polymerization. After the addition of initiator, the 4-allylanisole 
monomers will start to polymerize and grow into poly(4-allylanisole) segments, which are very 
hydrophobic and will precipitate into the hydrophobic area of the SDS-capped Fe3O4 NPs. The 
continuous polymerization and crosslinking of the 4-allylanisole monomers will lead more and 
more poly(4-allylanisole) segments deposited into the hydrophobic zone and thus increase the  
thickness of the poly(4-allylanisole) gel layer until all the monomers are polymerized.  The 
resulting SDS-stabilized poly(4-allylanisole)-coated Fe3O4 NPs can be continuously used as a 
seed for the subsequent precipitation polymerization to coat the thermo-responsive P(MEO2MA-
co-MEO5MA) copolymer gel outer layer. Although the comonomers of the MEO2MA and 
MEO5MA are quite water soluble, their corresponding polymers of P(MEO2MA) and 
P(MEO5MA) exhibit a lower critical solution temperature (LCST) around 20 and 61 °C, 
respectively41. A proper control on the feeding ratio of these two PEG oligomer-based monomers 
can tune the LCST of their copolymer into the physiologically important temperature range42. 
Therefore, at the synthetic temperature (70 °C) above the LCST of the copolymer, the resultant 
P(MEO2MA-co-MEO5MA) copolymer segments are hydrophobic and will  precipitate into the 
hydrophobic zone of the SDS-stabilized poly(4-allylanisole)-coated Fe3O4 NPs, resulting a core-
shell-shell structured hybrid nanogel. At the physiological temperature range or below, the outer 
P(MEO2MA-co-MEO5MA) copolymer gel layer is hydrophilic, thus enable the resultant 
Fe3O4@poly(4-allylanisole)-PEG core-shell-shell hybrid nanogels being dispersed in aqueous 




(FAE−1) shown in Figure 5−1 confirms that the resulted hybrid nanogels possess a spherical 
morphology and an uniform distribution of particle size. A boundary between a dark core and a 
light contrast shell can be clearly observed. The high contrast of core with ca. 10 ± 3 nm in 
diameter is due to the markedly high electron density of Fe3O4 NPs, while the low contrast of the 
thick shell is owing to the polymer gel layers of poly(4-allylanisole) and P(MEO2MA-co-
MEO5MA) copolymers. Furthermore, a careful view on the magnified image of the FAE−1 
hybrid nanogel particle, shown in the inset of Figure 5−1, indicates a clear boundary between the 
inner and outer polymer gel layers, confirming the double-layer polymer gel shell structure. The 
contrast distinction between the double-layer shell is associated with the electron density 
difference of the poly(4-allylanisole) gel and P(MEO2MA-co-MEO5MA) copolymer gels. At the 
synthetic temperature of 70 °C, the inner crosslinked poly(4-allylanisole) chain networks are 
very hydrophobic and densely packed, which can hinder the newly deposited nonlinear PEG-
based chain segments penetrating into the inner shell area, resulting an outer gel shell mainly 
from the nonlinear PEG copolymer network chains43. 
 




            For drug delivery carriers, it is very important that the size and polymer shell thickness of 
the hybrid nanogels can be controlled in synthesis to meet the application needs. In our synthetic 
strategy, the simple change in the feeding ratios of the shell monomers to the template core NPs 
can control the thickness of the polymer gel shell. As shown in Table 5−2, with the same amount 
of Fe3O4 NPs as core template, the increase in the feeding of 4-allylanisole monomer and DVB 
crosslinker by 50% can significantly increase the poly(4-allylanisole) gel shell thickness by 40 
nm (Rh values for FA-1 and FA-2 are 97.5 and 136.5 nm, respectively). Figure 5−2 shows the 
size distributions, in terms of the Rh measured at T = 24 °C and θ = 30°, of the Fe3O4@poly(4-
allylanisole)-PEG hybrid nanogels FAE−(1−4) synthesized under different feeding ratios of shell 
monomers to core template NPs (See Table 5−2). First, these resultant Fe3O4@poly(4-
allylanisole)-PEG hybrid nanogels have a very narrow size distribution with a polydispersity 
index of µ2/<Γ>2 = 0.005. Second, the hybrid nanogels FAE−(1−3), synthesized using the same 
amount of Fe3O4@poly(4-allylanisole) NPs (FA−1) as core template but with the gradually 
decreased feeding amount of shell precursors of MEO2MA and MEO5MA, exhibit a gradually 
decreased size and outer shell thickness with the Rh being 166.8 nm, 144.7 nm, and 136.6 nm, 
respectively. Clearly, if we use the same core template NPs, the shell thickness can be tuned by a 
simple change in the feeding amount of shell precursors. On the other hand, the results shown in 
Table 5−2 indicate that the shell thickness can also be controlled by the size of core template 
NPs. For example, when we use the same amount of nonlinear PEG shell precursors but larger 
Fe3O4@poly(4-allylanisole) NPs (FA−2) as core template, the outer shell is thinner than that 
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Figure 5−2 Hydrodynamic radius distributions of Fe3O4@poly(4-allylanisole)-PEG hybrid 
nanogels FAE−1 (■), FAE−2 (●), FAE−3 (▲), and FAE−4 (▼),  measured at 24 °C and a 
scattering angle of θ = 30°. 
 
5. 3. 2   Temperature induced volume phase transition 
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Figure 5−3 Temperature dependence of the average Rh values of Fe3O4@poly(4-allylanisole)-
PEG hybrid nanogels FAE−1 (■), FAE−2 (●), FAE−3 (▲), and FAE−4 (▼), measured at a 




            Figure 5−3 shows the temperature-induced volume phase transition of the diluted 
Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels dispersions (∼5.0 × 10−3 wt%) in PBS solution 
(0.005 M, pH = 7.4), in terms of the change of Rh measured at a scattering angle of θ = 30°. It is 
clear that the increase in temperature can lead to a significant decrease in the size of the hybrid 
nanogels. The driving force for such a temperature-induced volume phase transition is believed 
to be a subtle balance between the ability of the polymer to form hydrogen bonds with water and 
the inter-/intra-molecular hydrophobic forces44. In our studied temperature range, the crosslinked 
poly(4-allylanisole) chain networks are very hydrophobic and exhibit no conformational 
response to the external stimulus of temperature change. The observed temperature-induced 
volume phase transition of the hybrid nanogels should be contributed from the outer nonlinear 
PEG gel shell composed of P(MEO2MA-co-MEO5MA) copolymer chain networks. The 
formation of hydrogen-bonds between the ether oxygens of the side PEG chains and the 
hydrogen of water is generally considered to be one of the key factors responsible for the unusual 
water solubility of this type of nonlinear PEG polymers. On the other hand, the hydrophobicity 
of the apolar backbone would counterbalance this favorable effect in water29, 43. The proper 
feeding ratio of 1:2 between the two monomers of MEO2MA and MEO5MA can lead to a 
volume phase transition region across the physiologically important temperature range (37−42 
°C), which are typical abnormal temperature range found in many pathological zones such as 
tumor37, 38, 39.  
            It should be noted that the diluted Fe3O4@poly(4-allylanisole)-PEG hybrid nanogel 
dispersions (∼ 5.0 × 10−3 wt%) are highly stable without aggregation in the studied temperature 
range of 24−45 °C, as revealed by the single narrow Rh distribution peak with the polydispersity 




even after a few months. The excellent stability of the hybrid nanogels in water is very important 
to serve as a drug carrier. Considering that most of the anti-cancer drug molecules are very 
hydrophobic, our newly designed hydrophobic-hydrophilic double shell structured hybrid 
nanogels should be desirable for anti-cancer drug carriers. While the inner hydrophobic poly(4-
allylanisole) inner shell can provide high drug loading capacity for the hydrophobic anti-cancer 
drugs, the hydrophilic outer PEG-based gel shell can enable the hybrid nanogels to be dispersed 
well in physiological medium and further penetrate into the cells. Furthermore, the thermo-
responsive nonlinear PEG outer shell can control the release of the drug molecules under a 
temperature stimulus. 
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Figure 5−4 Size distribution of Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels FAE−1 at 
different temperatures (■: 24 °C; ●: 33 °C; ▲:37.5 °C; and ▼: 45 °C). All measurements were 





5. 3. 3   Magnetic properties of the Fe3O4@poly(4-allylanisole) and Fe3O4@poly(4-





Figure 5−5 Typical digital photographs of the Fe3O4@poly(4-allylanisole) hybrid nanogels 
(FA−1, A) and Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels (FAE−1, B) before and after 
placing a permanent magnet next to it. The FAE−1 hybrid nanogels can also be easily 
redispersed into water again after the removal of the external magnet and a gentle shaking (right 






            Figure 5−5 shows the digital photographs of the Fe3O4@poly(4-allylanisole) hybrid 
nanogels (FA−1, A) and Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels (FAE−1, B) before 
and after placing a permanent magnet next to it. The magnetic hybrid nanogels are uniformly 
dispersed in water with no visible aggregates or precipitates formed.  The hybrid nanogel 
particles can be quickly separated and collected from the aqueous suspension under the 0.1 T 
external magnetic field, demonstrating that the FAE−1 hybrid nanogels possess a quick magnetic 
response. The FAE−1 hybrid nanogels can be easily redispersed into water again after the 
removal of the external magnet and a gentle shaking (right photo in B). The quick magnetic 
response of these Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels provides advantages as drug 
carriers for separation and magnetic-targeted on site drug delivery.  
 
























Figure 5−6 Typical hysteresis loop measured at 300 K of the Fe3O4 core NPs, Fe3O4@poly(4-
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Figure 5−7 Zero-field-cooling (ZFC) and field-cooling (FC) curves of the Fe3O4 core NPs, 
Fe3O4@poly(4-allylanisole) hybrid nanogels (FA−1), and Fe3O4@poly(4-allylanisole)-PEG 
hybrid nanogels (FAE−1), respectively,  measured in an applied field of 50 Oe. 
 
            The Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels possess the magnetic properties 
from the Fe3O4 NP cores. While a detailed analysis of the magnetic properties is out of the scope 
of this project, we show in Figure 5−6 the magnetization cycles of the dried hybrid nanogels 
recorded at 300 K in an applied magnetic field up to 40 000 Oe. The loop presents hysteresis, 
revealing the ferromagnetic nature of the hybrid nanogels45. The results for the hard core Fe3O4 
NPs and the Fe3O4@poly(4-allylanisole) nanogels (FA−1) are also presented for comparison. 
Obviously, the growth of poly(4-allylanisole) gel shell onto the Fe3O4 NP templates led to a 
significant decrease in the values of saturation magnetization (Ms) and remnant magnetization 
(Mr). The addition of the outer nonlinear PEG gel shell further decreases the Ms and Mr values 
(FAE−1 vs. FA−1). The reason should be attributed to the significant decrease in the content of 




The temperature dependence of zero-field-cooled (ZFC) and field-cooled (FC) magnetization for 
the Fe3O4 NPs, FA−1 and FAE−1 are presented in Figure 5−7. ZFC and FC curves separate from 
each other from 5 to 325 K, and no transition from ferromagnetism to superparamagnetism can 
be observed. These results further confirm the ferromagnetism of the hybrid nanogels at room 
temperature46. The ferromagnetism of the hybrid nanogels could provide the contrast ability for 
magnetic resonance imaging function.  
 
5. 3. 4   Drug loading capacity of the Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels 
            Curcumin is poorly soluble in water at neutral pH with the macroscopic undissolved 
flakes visible in the solution36. It also has been determined that the half-time for the hydrolytic 
degradation of curcumin in aqueous solution containing 10% organic solvent at pH ≈ 6, 7, and 8 
is 4.2 ×103 h, 15 h and 3.5 × 10−2 h, respectively47. Thus curcumin would undergo rapid 
hydrolytic degradation at neutral or basic pH values19, 47, 48, resulting in the loss of 
pharmaceutical activities. In order to avoid the curcumin molecular degradation, we loaded the 
curcumin drug into the Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels in aqueous dispersion 
at pH = 5.7. Since the poly(4-allylanisole) has similar structural units to the curcumin molecules, 
we expect that the curcumin molecules diffused into the gel networks should have hydrophobic 
and π –π interactions with the poly(4-allylanisole) chains, thus curcumin molecules can build up 
in the interior of the poly(4-allylanisole) gel networks, resulting in high drug loading content. 
 
Table 5−3. Curcumin loading capacity of the Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels 
Samples FAE-1 FAE-2 FAE-3 FAE-4 Fe3O4@ 
poly(4-allylanisole) 
Fe3O4@nonlinear 
PEG hybrid nanogels 
Curcumin loading 




            Table 5−3 compares the loading capacity of the hybrid nanogels FAE−(1−4) for 
curcumin drugs. Two features should be noted. First, the thicker the inner poly(4-allylanisole) 
gel layer, the higher the loading capacity of the resultant hybrid nanogels. As shown in Table 
5−2, the hybrid nanogels of FAE−1 and FAE−4 contains the same amount of outer nonlinear 
PEG shell components, but FAE−4 has thinner PEG outer shell and thicker inner poly(4-
allylanisole) gel shell compared to FAE−1. The results in Table 5−3 indicate that FAE−4 hybrid 
nanogels actually exhibits higher drug loading capacity for curcumin (37.8 wt%) than the FAE−1 
does (35.3 wt%). When the outer PEG gel shell has a similar thickness (37.5 nm for FAE−4 and 
39.2 nm for FAE−3), the effect of the inner poly(4-allylanisole) gel shell thickness on the 
curcumin loading content is even more significant. For example, the FAE−4 with thicker inner 
poly(4-allylanisole) gel shell demonstrate much higher curcumin loading capacity (37.5 wt%) in 
comparison with the FAE−3 hybrid nanogels with a curcumin loading content of 30.5 wt%. 
Second, for the hybrid nanogels with the same thickness of inner poly(4-allylanisole) gel layer, 
the thickness of the hydrophilic nonlinear PEG gel outer shell could also affect the curcumin 
loading capacity. For example, the FAE−1, FAE−2, and FAE−3 hybrid nanogels have the same 
inner poly(4-allylanisole) gel thickness but a gradually decreased outer PEG gel shell thickness. 
The corresponding curcumin loading capacity for FAE−1 (35.3 wt%), FAE−2 (32.1 wt%), and 
FAE−3 (30.5 wt%) also demonstrates a gradually decreased trend. This result seems hard to 
understand because the hydrophilic nonlinear PEG chains in the outer shell should have weak 
interactions and should not be able to hold significant amount of hydrophobic curcumin 
molecules. In principle, the hydrophobic curcumin molecules should mainly stay in the inner 
hydrophobic poly(4-allylanisole) gel network due to the hydrophobic intermolecular 




However, the gel network structures of the core and shell are dependent on each other in the 
core-shell nanostructured nanogels. The inner poly(4-allylanisole) gel shell is quite hydrophobic 
and densely shrunk at the studied temperatures, which limits the mesh size (or space) of the inner 
gel network to hold the hydrophobic curcumin molecules. The introduction of the hydrophilic 
and swollen outer PEG gel shell can restrict the inner poly(4-allylanisole) gel network from 
collapsing. Even though the inner poly(4-allylanisole) gel shell is hydrophobic and shrunk, the 
swollen PEG shell can pull up and stretch the inner poly(4-allylanisole) network, resulting in a 
bigger mesh size. The open network with larger mesh size of the inner poly(4-allylanisole) gel 
shell could hold more hydrophobic curcumin molecules. The thicker the swollen nonlinear PEG 
gel outer shell, the larger the pulling force to restrict the collapsing of the inner poly(4-
allylanisole) gel network, thus the larger the mesh size and capacity of the inner gel shell to load 
the hydrophobic curcumin drug molecules.   
            Calculating from the approximate concentrations of the hybrid nanogels in aqueous 
dispersion, the loading capabilities are equivalent to 1.73, 1.57, 1.49, and 1.85 mM curcumin in 
water for FAE−1, FAE−2, FAE−3, and FAE−4, respectively. These concentrations of curcumin 
loaded in the hybrid nanogels are about two orders of magnitudes higher than the solubility of 
free curcumin in water at acidic or physiological pH (∼ 20.1 µM)48, 49. Furthermore, these hybrid 
nanogels can be further concentrated by a simple and fast magnetic separation, which makes it 
possible to realize a much higher curcumin dose. It should be noted that the curcumin-loaded 
hybrid nanogels are very stable in aqueous media. No sediment was observed after setting for a 
few weeks due to the high hydrophilicity of the outer PEG-based gel shell. Compared to the free 
curcumin molecules in aqueous media, the protection of the polymer gel network should also 




5. 3. 5   In vitro release studies 




































































































Release Time  /  hour  
Figure 5−8 Releasing profiles of curcumin from the Fe3O4@poly(4-allylanisole)-PEG hybrid 
nanogels FAE−1 (A), FAE−2 (B), FAE−3 (C), and FAE−4 (D) at different temperatures. 
Curcumin has been pre-loaded into the nanogel at 22 °C. In the blank test (◊), 1 mL diluted 
solution of free curcumin (containing 5% ethanol) with an equivalent amount of drug trapped in 
FAE−1 was performed at 41°C. All releasing experiments were carried out in 50 mL PBS 







            Figure 5−8 shows the release kinetics of curcumin from the FAE−(1−4) hybrid nanogels 
at different temperatures. The in vitro release test was performed in a PBS (pH = 6.15) to avoid 
the evident degradation of curcumin from the long time exposure in water. A free curcumin 
solution (containing 5% ethanol) with an equivalent amount of drug trapped in the hybrid 
nanogel FAE−1 was set as a blank release experiment, which shows that the dialysis membrane 
(cutoff 12000 – 14000 Da) played a negligible role in the release of curcumin. In comparison 
with the rapid curcumin release rate in the blank test under the same conditions, the release of 
curcumin from the hybrid nanogels demonstrates much slower rates, indicating a sustained 
curcumin release from the hybrid nanogels FAE−(1−4). More importantly, the release kinetics of 
curcumin from the hybrid nanogels significantly depends on the temperature of releasing 
medium. The increase in temperature can speed up the release of curcumin from all the four 
hybrid nanogels of FAE−(1−4). For example, after the same time period of 48 h, the amount of 
curcumin released from the FAE−1 hybrid nanogels increases from only 7.5 % at 22 °C to 31.6 % 
(37 °C), 52.1 % (39 °C), and 69.0 % (41 °C), respectively (Figure 5−8 A). The observed 
temperature dependency of the curcumin releasing rate should be associated with the thermo-
sensitive outer shell of the nonlinear PEG-based gel. The increase in temperature induces a 
shrinking of the outer PEG gel shell. The shrunk and thinner outer PEG gel shell will not only 
compress the inner poly(4-allylanisole) gel network and thus squeeze out the curcumin 
molecules loaded in the interior of the gel network, but also reduce the restricted diffusion path 
length of the curcumin molecules from the inner gel layer to the medium outside the hybrid 
nanogel particles. Both effects can speed up the releasing rate of curcumin from the hybrid 
nanogels. Therefore, the higher the temperature is, the more the outer PEG gel network collapses, 




confirmed by the effect of the outer shell thickness of nonlinear PEG gel on the releasing kinetics 
of curcumin from the hybrid nanogels. Curcumin molecules could be released more quickly from 
the hybrid nanogels coated with thinner outer PEG-based gel shell. For example, after the 
cumulative release for 48 h at the same temperature of 41 °C, 75.4 % and 78.3 % of loaded 
curcumin could be respectively released from the FAE-2 and FAE-3 hybrid nanogels with thin 
outer PEG gel shell. In contrast, only 69.0 % of curcumin could be released from the FAE−1 
sample with the thickest outer PEG gel shell.  
 
5. 3. 6   In vitro cytotoxicity 
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Figure 5−9 Comparison of B16F10 cell viability following treatments with curcumin-loaded and 
drug free Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels of FAE−1 and FAE−4, respectively 






            Having demonstrated the curcumin delivery ability of the hybrid nanogels in buffer 
solution, we selected FAE−1 and FAE−4 hybrid nanogels to examine the in vitro cellular 
cytotoxicity of the drug free and curcumin-loaded hybrid nanogels. As shown in Figure 5−9, the 
drug free hybrid nanogels were non- or low-cytotoxic to B16F10 cells after incubation for 24 h 
even at high concentration of 706.0 and 659.2 µg/mL for FAE−1 and FAE−4, respectively, 
indicating an excellent in vitro biocompatibility benefited from the outer shell of nonlinear PEG 
gel. In contrast, the cell viability decreased to 36.4% and 27.5% for curcumin-loaded FAE−1 and 
FAE−4 hybrid nanogels, respectively, under the same conditions with the corresponding 
curcumin concentration of 249.2 µg/mL, indicating that the curcumin-loaded hybrid nanogels 
maintain the high anticancer activity of curcumin. These results should be attributed to the 
cellular uptake of these hybrid nanogels and the sustained release of curcumin from these hybrid 
nanogels. The cell viability of free curcumin solution in PBS (containing 5% ethonal) was 6.9% 
at the concentration of 249.2 µg/mL. The lower cytotoxicity of the curcumin-loaded hybrid 
nanogels than the free curcumin solutions with the equivalent curcumin concentration is 
understandable, because less than 30% of the loaded curcumin was released from the FAE−1 and 
FAE−4 hybrid nanogels in 24 h at 37 °C. 
 
5. 4     Conclusion 
            Well-defined magnetic hybrid nanogels with a core-shell-shell nanostructure composed 
of the magnetic Fe3O4 NPs in the core, hydrophobic poly(4-allylanisole) gel as inner shell, and 
the hydrophilic  thermo-responsive PEG gel as outer shell could be successfully synthesized via 
precipitation polymerization. The resultant Fe3O4@poly(4-allylanisole)-PEG hybrid nanogels 




ability. The hybrid nanogels with ferromagnetic property could also be potentially used for 
magnetic resonance imaging contrast. The hydrophobic aromatic groups of the rationally 
designed poly(4-allylanisole) inner shell gel can form strong hydrophobic complexation with the 
curcumin molecules, resulting in high drug loading capacity. The polymer gel could also protect 
the curcumin molecules from degradation as in free aqueous solution. The outer shell of the 
nonlinear PEG gel composed of the P(MEO2MA-co-MEO5MA) copolymer network with the 
comonomer ratio of MEO2MA:MEO5MA = 1:2 could not only increase the stability and 
biocompatibility of the hybrid nanogels in aqueous media, but also trigger the curcumin drug 
release by local temperature stimuli in the physiologically important temperature range, offering 
sustained drug release profiles. While the drug-free hybrid nanogels are nontoxic to B16F10 
tumor cells, the curcumin-loaded hybrid nanogels exhibit potent cytotoxicity against cell. This 
high therapeutic efficacy of the curcumin-loaded hybrid nanogels is likely to bring this natural 
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A Newly Developed Glucose Responsive Microgel for 
On-Site Tunable Self-Regulated Insulin Delivery 
 
6. 1      Introduction 
            Diabetes mellitus is a group of chronic diseases in which a person has high blood sugar, 
either because the pancreas does not produce enough insulin, or because cells do not respond to 
the insulin that is produced1. This high sugar level in blood strongly impinges on a person’s 
quality of life and may lead to complications, such as blindness, nerve damage, foot or leg 
amputation, and stroke2, 3. The advent of insulin revolutionized the treatment of diabetes mellitus 
and was one of the most outstanding achievements of twentieth century medicine. Exogenous 
insulin is administered subcutaneously to mimic the insulin secretion of the healthy pancreas. 
However, it is reported that only approximately 20% of insulin reaches the liver (primary site of 
action according to normal physiology) following the subcutaneous insulin injection4, resulting 
in hypoglycemia, insulin resistance, and other unwanted side effects of the excess insulin in the 
body5, 6. Therefore, intelligent insulin administration to match physiological need of patients 




approaches can be envisioned to achieve this objective, considerable research has focused on the 
development of self-regulated insulin delivery systems based on glucose-responsive polymers7−9. 
          Three kinds of typical glucose-responsive materials have been used to develop insulin 
delivery system. In early studies, glucose oxidase and concanavalin A were very popular due to 
their versatility and high specificity. However, the reliance on protein-based components 
presented severe limitations such as potential instability during use or sterilization10. Conversely, 
a synthetic ligand phenylboronic acids (PBA) and its derivatives were explored as substitutes for 
natural receptors because of their great stability, longtime storability, and low cytotoxicity11, 12. 
In aqueous solution, PBA is in equilibrium between undissociated neutral trigonal form (1) and a 
dissociated anionic tetrahedral form (2) (Scheme 6−1). Both forms undergo reaction reversibly 
with 1, 2-cis-diols such as glucose. While cyclic boronic esters between the neutral boronic acid 
and a diol are generally considered hydrolytically unstable, the anionic form (2) is able to 
reversibly bind with diols to form a 5- or 6-membered ring cyclic boronate ester (3), shifting the 
equilibrium to the anionic forms (2 and 3)13. The glucose-PBA complexation also changes the 
polymer−solvent affinity. PBA is hydrophobic in the neutral state, which becomes more 
hydrophilic upon complexation. The better polymer-solvent affinity and the increase in the 
Donnan potential14 can both induce the volume phase transition (swelling) of the PBA-
containing hydrogels. Accordingly, the glucose-triggered insulin release from these systems lies 
in one of the two different mechanisms: (1) altering the diffusion behavior of the preloaded 
insulin molecules by glucose-responsive volume phase transition, (2) exchanging of the 







Scheme 6−1 Complexation equilibrium between the PBA and glucose in aqueous solution.  
 
            However, because of the high pKa of the PBA groups15 the working pH (≥ 8.5) of these 
insulin delivery systems is much higher than the physiological pH of 7.4. Two methods have 
been proposed to enhance the glucose sensitivity of the PBA moiety at physiological pH: (a) 
designing boronate analogues with lower pKa values16, 17; (b) introducing intramolecular Bδ-∙∙∙Xδ+ 
bonds that confer a tetrahedral conformation at the boron centre through the neighboring effect 
of an orthogroup18−20. While sometimes the preparation protocols for the boronic acid derivatives 
with strongly electron-withdrawing substituents are rigorous and time-consuming, the 
intramolecular Bδ-∙∙∙Xδ+ attraction approach is more appealing. We recently synthesized a new 
class of hybrid nanogels made of Ag nanoparticle cores covered by a glucose-responsive 
copolymer gel shell of poly(4-vinylphenylboronic acid-co-2-(dimethylamino) ethyl acrylate) 
[poly(VPBA-DMAEA)]21. It was demonstrated that this Lewis base DMAEA with small degree 
of ionization can successfully enhance the binding affinity of PBA to glucose at physiological 
pH, thus the release of the encapsulated insulin can be realized at physiological pH. However, 
small amount of glucose can induce the swelling of the poly(VPBA-DMAEA) nanogels, 
resulting in the release of significant amount of insulin from the nanogels even at the low glucose 
concentrations below the normal blood glucose level (4−8 mM)22−23. The released insulin will 




insulin delivery carrier is supposed to initiate the release of insulin only after the glucose 
concentrations in blood are above the normal glucose level. 
            Herein, we design a novel class of biocompatible microgels copolymerized from VPBA, 
DMAEA, and oligo(ethylene glycol)methyl ether methacrylate(MEO5MA) (Scheme 6−2) for on-
site tunable glucose responsive insulin release. The resulted poly(VPBA-DMAEA-MEO5MA) 
microgels upon a rational design of the polymer chains can undergo a volume phase transition in 
response to the change in glucose concentration with high sensitivity and selectivity over a 
clinically relevant range (0−30 mM) at the physiological pH and temperature. Copolymerization 
of MEO5MA can not only increase the hydrophilicity and biocompatibility, but also shift the 
onset of the glucose-responsive volume phase transition of the microgels to desirable glucose 
level. The microgels contain both ethylene glycol and PBA moieties, thus the addition of glucose 
into the microgel solution can have two types of competitive interactions. One is the formation of 
hydrogen bonds between the ether oxygen of the ethylene glycol units and the hydroxyl groups 
of glucose molecules, which will not induce the microgels to swell. Another is the boronic acid-
cis-diol complexation between the PBA groups and glucose molecules, which will induce the 
microgels to swell due to the production of negative charges. Because the formation of hydrogen 
bonds between glucose and ethylene glycol is much faster than the PBA-glucose complexation, 
only after the ether oxygen atoms of the polyMEO5MA segments are saturated with glucose 
molecules, free glucose molecules will start to bind with PBA group to induce the swelling of 
microgels. Therefore, we can control the onset of glucose responsive volume phase transition of 
the microgels through the feeding ratios of comonomers of MEO5MA to VPBA in synthesis. 




the glucose concentration above desirable level may hasten the development of more efficacious 
systems toward a self-regulated insulin delivery for good diabetic control. 
            We also synthesized glucose-imprinted microgels by polymerization of comonomers in 
the presence of the molecular target (glucose). It is expected that the collective weak interactions 
between the VPBA monomers and the glucose target molecules can form populations of 
complementary binding sites favorable for glucose bindings in the resulted polymer chain 
networks24, 25, which should increase the sensitivity of glucose. Additionally, the embedding of 
Ag nanoparticles (NPs) to the glucose-imprinted microgels can successfully convert the 
biochemical signal (glucose level here) into optical signals, realizing a combination of optical 
detection of glucose and self-regulated insulin release. The insulin-loading capacity, sustained 
insulin release behavior, and cytotoxicity of the microgels were also evaluated. 
 
Scheme 6−2 Schematic illustration of poly(VPBA-DMAEA-MEO5MA) microgels that can tune 
the onset for glucose-induced volume phase transition only after the glucose concentration 




6. 2      Experimental 
6. 2. 1  Materials 
            D(+)-Glucose was purchased from ACROS, and all other chemicals were purchased from 
Aldrich. Oligo(ethyleneglycol)methyl ether methacrylate (Mn = 300 g/mol, MEO5MA) and 2-
(Dimethylamino)ethyl acrylate (DMAEA) was purified with neutral Al2O3. The lyophilized 
fluorescein isothiocyanate-labeled insulin (FITC-insulin) from bovine pancreas (~5800 Da), 4-
vinylphenylboronic acid (VPBA), N,N´-methylenebisacrylamide (MBAAm), 2,2′-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), sodium dodecyl sulfate (SDS), dulbecco's 
modified eagle medium (DMEM), and fetal bovine serum (FBS) were used as received without 
further purification. The water used in all experiments was of Millipore Milli-Q grade. 
 
6. 2. 2 Synthesis of glucose responsive poly(VPBA-DMAEA-MEO5MA)microgels 
            In a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, 
VPBA (1.63 mmol) and 100 mL deionized water were heated to 70 °C. After VPBA was totally 
dissolved, DMAEA(0.329 mmol), MBAAm (0.002g), SDS(0.351 mmol), and MEO5MA with 
designed concentrations were successively added to the solution under stirring. After the 
temperature was maintained at 70 °C and a continuous N2 purge for 30 min, the polymerization 
was initiated by adding 1 mL of 0.105 M AAPH. The polymerization reaction was allowed to 
proceed for 5h. The dispersion was centrifuged at 6000 rpm (30 min, Thermo Electron Co. 
SORVALL® RC-6 PLUS super-speed centrifuge) with the supernatant discarded and the 
precipitate was redispersed in 100 mL deionized water. The resultant microgels were further 
purified by 3 days of dialysis (Spectra/Por molecular porous membrane tubing, cutoff 




temperature (~22 °C). The resultant microgels made with feeding of MEO5MA = 0, 0.163, 0.326, 
0.489, and 0.652 mmol were coded as VDM−0, VDM−1, VDM−2, VDM−3, and VDM−4, 
respectively, and the recipes for the synthesis of the poly(VPBA-DMAEA-MEO5MA)microgels 
are listed in Table 6−1. 
 
Table 6−1 
Feeding compositions for synthesis of the poly(VPBA-DMAEA-MEO5MA) microgels. 
Sample (mmol) VPBA DMAEA MEO5MA  Glucose  SDS 
Non-imprinted 
 
     
VDM−0 1.63 0.329 − − 0.351 
VDM−1 1.63 0.329 0.163 − 0.351 
VDM−2 1.63 0.329 0.326 − 0.351 
VDM−3 1.63 0.329 0.489 − 0.351 
VDM−4 1.63 0.329 0.652 − 0.351 
Imprinted microgels      
IVD−1 1.63 0.329 0.489 0.82 0.351 
IVD−2 1.63 0.329 0.489 1.63 0.351 
 
 
6. 2. 3 Synthesis of imprinted glucose responsive poly(VPBA-DMAEA-MEO5MA)microgels 
            In a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, 
VPBA (1.63 mmol) and 100 mL glucose aqueous solution (pH = 8.8) with a designed 
concentration were heated to 70 °C. After VPBA was completely dissolved, DMAEA (0.329 
mmol), MBAAm (0.002g), SDS (0.0.351 mmol), and MEO5MA (0.489 mmol) were successively 
added to the solution under stirring. After a continuous N2 purge at 70 °C for 1 h, the 
polymerization was initiated by adding 1 mL of 0.105 M AAPH. The polymerization reaction 
was allowed to proceed for 5h. The dispersion was centrifuged at 6000 rpm (30 min, Thermo 




and the precipitate was redispersed in 100 mL deionized water. The resultant glucose-imprinted 
microgels were further purified by dialysis against very frequently changed water at room 
temperature (~22 °C) for at least two weeks. The resultant microgels with low and high glucose 
imprinting degrees were coded as IVD−1 and IVD−2, respectively (Table 6−1). 
 
6. 2. 4  Insulin loading and release 
            FITC-insulin was loaded into the microgels by complexation method. A stock solution of 
FITC-insulin (1 mg/mL) was prepared in 0.005 M phosphate buffer solution (PBS) of pH = 7.4, 
and stored in the refrigerator (4 °C). The pH value of the microgel dispersion (5 mL) was 
adjusted to 9.0 by using diluted NaOH solution. This dispersion was stirred in an ice water bath 
for 30 min and then 1 mL of FITC-insulin solution was added dropwise to the vial. The 
immediate clouding phenomenon revealed the hydrogen bonding complexation of the insulin 
molecules (protein) with the ethylene glycol units and boronic acid groups in the microgels. 
After stirring overnight, the suspension was centrifuged at 6000 rpm for 30 min at 22 °C. To 
remove the free drug molecules, the precipitate was redispersed in 5 mL of PBS of pH = 7.4 and 
further purified by repeated centrifugation and washing. Finally, the precipitate of insulin-loaded 
microgels was redispersed in 1 mL of PBS of pH = 7.4. All the upper clear solutions were 
collected, and the concentration of free insulin was determined by fluorescence spectrometry at 
518 nm upon excitation at 492 nm. The amount of loaded FITC-insulin in the microgels was 
calculated from the decrease in drug concentration. The loading content is expressed as the mass 
of loaded drug per unit weight of dried microgels. 
            The in vitro release test of FITC-insulin from the microgels was evaluated by the dialysis 




immersed in 50 mL of 0.005 M buffer solutions of pH = 7.4 at various glucose concentrations. 
The released FITC-insulin outside of the dialysis bag was sampled at defined time intervals and 
assayed by fluorescence spectrometry at 518 nm upon excitation at 492 nm. Cumulative release 
is expressed as the total percentage of insulin released through the dialysis membrane overtime. 
 
6. 2. 5 In vitro cytotoxicity 
            B16F10 cells (2000 cell/well) were cultured in DMEM containing 10% FBS and 1% 
penicillin-streptomycin in a 96-well plate, and exposed to microgels VDM−(1−4) respectively. 
To cover the high concentrations, the microgels were concentrated and adjusted to an appropriate 
concentration in DMEM right before feeding into the wells. The plate was incubated at 37 °C for 
24 h. The medium was then aspirated, and these wells were washed using fresh serum-free 
DMEM. After that, 25 µL of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide 
(MTT) solution (5 mg/mL in PBS) were added to the wells. After incubation for 2 h, the solution 
was aspirated and 100 µL of dimethyl sulfoxide was added to each well, and the plate was sealed 
and incubated for 30 min at 37 °C with gentle mixing. Three portions of the solution obtained 
from each well were transferred to three respective well of a 96-well plate. Cell viability was 
measured using a microplate reader at 570 nm. Positive controls contained no microgels, and 








6. 2. 6 Synthesis of hybrid microgels with Ag NP as core and the glucose-imprinted 
poly(VPBA-DMAEA-MEO5MA) gel as shell  
6. 2. 6. 1 Synthesis of Ag NPs 
            Citrate-stabilized Ag NPs were first prepared by dropwise addition of fresh NaBH4 
solution (10.6 mM, 2.5 mL) to an aqueous solution of AgNO3 (0.1 mM, 200 mL) in the presence 
of sodium citrate (0.1 mM) under vigorous stirring. The resultant solution was stirred for 1 h and 
aged for 7 days at ambient conditions before use. The long aging time is necessary for 
completely degrading the reducing agent of NaBH4. SDS stabilized Ag NPs were obtained by 
adding 0.053g SDS into 100 mL of aqueous disperson of citrate-stabilized Ag NPs in a 250 mL 
round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, and then aging the 
mixture overnight (∼ 10 h). 
 
6. 2. 6. 2 Synthesis of Ag@glucose-imprinted poly(VPBA-DMAEA-MEO5MA) hybrid 
microgels 
            In a 250 mL round-bottom flask equipped with a stirrer, a N2 gas inlet, and a condenser, 
100 mL of as-prepared aqueous solution (pH = 8.8) of SDS stabilized Ag NPs was heated to 30 
°C, followed by addition of VPBA(0.4075 mmol), DMAEA(0.0825 mmol), MBAAm (0.0005 g), 
SDS (0.0878 mmol), MEO5MA (0.1223 mmol), and glucose(0.4075 mmol) under stirring (one 
quarter recipe of IVD−2, Table 6−1). After a continuous N2 purge for 1 h, the temperature was 
raised to 70 °C and the polymerization was initiated by adding 1 mL of 0.105 M AAPH. The 
polymerization reaction was allowed to proceed for 5h. The dispersion was centrifuged at 6000 
rpm (30 min, Thermo Electron Co. SORVALL® RC-6 PLUS super-speed centrifuge) with the 




resultant hybrid microgels were further purified by dialysis against very frequently changed 
water at room temperature (~22 °C) for at least two weeks. The resultant hybrid microgels were 
coded as Ag@IVD−2. 
 
6. 2. 7 Characterization 
            The morphology of the microgels was characterized with transmission electron 
microscopy (TEM). The TEM images were taken on a FEI TECNAI transmission electron 
microscope at an accelerating voltage of 120 kV. Approximately 10 µL of diluted microgel 
suspension was dropped on a Formvar covered copper grid (300 meshes) and then air-dried at 
room temperature for the TEM measurements. The UV−vis absorption spectra were obtained on 
a Thermo Electron Co. Helios UV−vis spectrometer. The PL spectra were respectively obtained 
on a JOBIN YVON Co. FluoroMax®-3 Spectro fluorometer equipped with a Hamamatsu R928P 
photomultiplier tube, calibrated photodiode for excitation reference correction from 200 to 980 
nm, and an integration time of 1 s. The pH values were obtained on a METTLER TOLEDO 
SevenEasy pH meter. 
            Dynamic light scattering (DLS) was performed on a standard laser light scattering 
spectrometer (BI-200SM) equipped with a BI-9000 AT digital time correlator (Brookhaven 
Instruments, Inc.). A Nd:YAG laser (150 mW, 532 nm) was used as the light source. All 
microgel solutions were passed through Millipore Millex-HV filter with a pore size of 0.80 µm 
to remove dust before the DLS measurements. In DLS, the Laplace inversion of each measured 
intensity-intensity time correlated function can result in a characteristic line width distribution 
G(Γ). For a purely dissuasive relaxation, Γ is related to the translational diffusion coefficient D 




index, the wavelength of the incident light in vacuo, and the scattering angle, respectively. G(D) 
can be further converted to a hydrodynamic radius (Rh) distribution by using the Stokes-Einstein 
equation, Rh = (kBT/6πη)D−1, where kB, T, and η are the Boltzmann constant, the absolute 
temperature, and the solvent viscosity, respectively. 
 
6. 3 Results and Discussion 
6. 3. 1   Synthesis of glucose responsive poly(VPBA-DMAEA-MEO5MA) microgels 
            The glucose responsive poly(VPBA-DMAEA-MEO5MA) microgels were synthesized 
from the free radical precipitation copolymerization of VPBA, DMAEA, and MEO5MA using 
MBAAm as a crosslinker (Table 6−1). Figure 6−1 shows the typical TEM image of the 
poly(VPBA-DMAEA-MEO5MA) microgels VDM−3. The resultant particles have a spherical 
morphology. The DLS results indicate that the microgels synthesized with only VPBA and 
DMAEA but no MEO5MA (as a control), coded as VDM-0, have the smallest size with Rh= 83 
nm. After being copolymerized with MEO5MA, the microgel particles become larger. The 
microgels VDM−1, VDM−2,VDM−3,and VDM−4 with an increased MEO5MA feeding of 7.68 
mol%, 14.27 mol%, 19.98 mol%, and 24.97 mol% have an increased Rh of 106, 118, 142 and 
148 nm, respectively, indicating that the increase in the feeding amount of comonomer of 
MEO5MA can significantly increase the size of the microgels. The size increase of the microgels 
at higher feedings of MEO5MA should be attributed to the decrease of the feeding ratios of 
surfactant SDS to the total comonomers. While we fixed the same feeding amount of 
comonomers of VPBA and DMAEA and the dispersing agent of SDS, we gradually increased 
the feeding of comonomer of MEO5MA. Relatively, less SDS molecules are available for the 




process and larger microgel particle size. The controllable size of the microgels is very important 
to their fate in the bloodstream. Recognition by the reticuloendothelia system (RES) is known to 
be the principal reason for the removal of many colloidal drug carriers from the blood 




Figure 6−1 Typical TEM image of the poly(VPBA-DMAEA-MEO5MA) microgels (VDM−3). 
 
            The previous method to fabricate glucose-responsive polymeric microgels involves the 
subsequent functionalization of carboxylated microgels with aminophenylboronic acid (APBA) 
through the carbodiinide-catalyzed coupling reaction27−37. Our group have previously employed 
poly(VPBA-DMAEA) based polymers to fabricate polymeric micro/nanogel with high glucose 
sensitivity and selectivity at physiological pH and temperature because the small degree of 
ionization of the polyDMAEA segments with positive charge can enhance the binding affinity of 




6−2 shows the pH-induced volume phase transitions of the microgels in terms of the change of 
hydrodynamic radius (Rh) measured at 37 °C. The pH-dependent volume phase transition has 
been observed due to the presence of pH-sensitive functional groups from the DMAEA (pKb ≈ 
7.5) and VPBA (pKa ≈ 8.9) components. Both the protonation of the amino groups in the 
polyDMAEA segments and the donation of proton from the boronic acid groups in the 
polyVPBA segments can increase the ionization degree of the copolymer chains, thus induce the 
swelling of the microgels with larger Rh. The amino groups in the polyDMAEA segments are 
slightly ionized at the physiological pH. The further decrease in pH from the physiological pH 
can increase the ionization degree of polyDMAEA segments with positive charges, thus increase 
the size of microgels. The copolymer microgels demonstrated the smallest size at pH = 7.7, 
where both polyDMAEA (pKb ≈ 7.5) and polyVPBA (pKa ≈ 8.9) segments have a minimum 
degree of ionization. The continuous increase in pH from pH = 7.7 will increase the ionization 
degree of polyVPBA segments with negative charges, thus can also induce the swelling of 
microgels and increase their size.   













Figure 6−2 pH-dependent average Rh values of the microgels VDM-0 (■), VDM-1 (●), and 




6. 3. 2   Glucose-induced volume phase transition 
            It is known that the PBA group is in equilibrium between the undissociated (trigonal, 
uncharged) and the dissociated (tetrahedral, charged) forms in aqueous solution38. Both forms 
react reversibly with 1,2-cis-diols such as glucose, but the binding of glucose induces the 
thermodynamically more favorable charged form. The presence of glucose can move the 
dissociation equilibrium of PBA to the right and further decrease its pKa, so if a strong 
intramolecular Bδ−⋅⋅⋅Xδ+ bond can be generated, then such boronic acids would bind glucose at 
physiological pH. In our poly(VPBA-DMAEA-MEO5MA) microgels, the small degree of 
ionization of the polyDMAEA segments can also enhance the binding affinity of PBA to glucose 
at physiological pH range through the intramolecular Bδ−⋅⋅⋅Xδ+ bonding between the boronate 
ester and the adjacent slightly protonated dimethyl amino groups19, 39−41. Figure 6−3 shows the 
glucose induced swelling curves of the copolymer microgels, in terms of the 
Rh,[glucose]=c/Rh,[glucose]=0 measured in a 5.0 mM PBS of pH = 7.4 at 37 °C and different glucose 
concentrations. The binding of glucose with the microgels produces negatively charged 
boronates and builds up a Donnan potential for the microgels to swell37. The polyMEO5MA 
segments play two very important roles for the copolymer microgels. First, polyMEO5MA 
segments can improve the hydrophilicity and biocompatibility of the microgels. According to our 
previous work, the polyMEO5MA microgels should have a LCST above 50 °C42. Therefore, the 
local polyMEO5MA gel domains in the microgel particles are in a swollen state at our study 
temperature of 37 °C, which should lead the microgels more stable in aqueous buffer solution. 
Second, the microgels with different comonomer MEO5MA/VPBA feeding molar ratios 
exhibited different glucose responsive swelling behavior. As shown in Figure 6−3, both VDM−0 




monomer exhibited a similar sharp increase in particle size even at a very low glucose 
concentration. The glucose-induced maximum swelling ratio of VDM−1 was slightly lower than 
that of VDM−0. The continuous gradual increase in the feeding molar ratios of MEO5MA/VPBA 
comonomers in the synthesis of VDM−2, VDM−3, and VDM−4 can further decrease the 
glucose-induced maximum swelling ratio of microgels, which could be attributed to the 
relatively lower content of glucose-sensitive PBA components in the microgels because we fixed 
the same feeding of VPBA and DMAEA monomers, but increased the feeding of MEO5MA 
monomer. More importantly, one can clearly find that with the increase in the feeding ratio of 
MEO5MA/VPBA comonomers, the onset of the glucose responsive volume phase transitions of 
the resulted microgels gradually shifts to a higher glucose concentration. The higher the feeding 
ratio of MEO5MA/VPBA comonomers, the higher the glucose concentration required to initiate 
the glucose-responsive swelling of the microgels. For example, VDM−2, VDM−3, and VDM−4 
microgels synthesized with the gradually increased content of MEO5MA comonomers 
demonstrated an increased initial glucose concentration of 2, 4, and 5 mM, respectively, to 
induce the glucose-responsive volume phase transitions of the microgels.  These results should 
be attributed to the prior hydrogen bonding between the glucose and the polyMEO5MA segments 
in the microgels. Kinetic studies show that the formation and dissociation of intermolecular 
hydrogen bond in liquid solutions is ultrafast (e.g., on a picoseconds time scale)43. On the other 
hand, the kinetics of the glucose-induced swelling of the PBA-containing microgels is on a time 
scale from seconds to ~100 seconds, depending on the glucose concentrations, due to the slow 
complexation reaction between the PBA groups and glucose molecules44, 45. Thus, when the 
copolymer microgels containing both polypolyMEO5MA and polyVPBA segments were added 




hydrogen bonding. Only after the ether oxygens of the polyMEO5MA segments were saturated 
by glucose molecules, the boronic acid groups in the polyVPBA segments can access the 
remained glucose molecules to form negatively charged complexes and thus induce the swelling 
of microgels. Our results indicate that the content of the polyMEO5MA segments in the PBA-
containing glucose-responsive microgels can control the onset of glucose responsive volume 
phase transition, which is very important to initiate and regulate the insulin release when these 
microgels are used as insulin delivery carriers. 
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Figure 6−3 Swelling ratio of the microgels VDM−0 (■), VDM−1 (●), VDM−2 (▲), VDM−3 
(▼), and VDM−4 (♦) as a function of glucose concentration in PBS of pH = 7.4. All 
measurements were made at 37 °C and a scattering angle θ= 45°. 
 
6. 3. 3 Insulin loading and in vitro glucose-regulated insulin release from the microgels  
            Having demonstrated the glucose-responsive volume phase transitions of the copolymer 




and delivery of FITC-insulin. The porous network structure of the microgels, together with the 
hydrogen bonding interactions between the insulin molecules and microgel network chains 
(containing ethylene glycol and boronic acid units), is particularly well suited to trap insulin, 
resulting in a high drug loading capacity. The yields of FITC-insulin loaded into the microgels 
were determined to be 33.3, 35.9, and 37.0 wt% (expressed as the mass of loaded insulin per unit 
weight of dried microgels) for VDM−1, VDM−3, and VDM−4, respectively. Considering the 
approximate concentrations of the microgel dispersions, these insulin loading capabilities are 
equivalent to the free insulin concentrations of 159.6, 163.2, and 160.0 mg/L, respectively. It 
should be noted that the microgels can be concentrated and adjusted to an appropriate 
concentration to cover an even higher insulin dose. Figure 6−4 shows the in vitro insulin 
releasing profiles from the microgel measured by the dialysis method for 48 hours in pH = 7.4 
PBS at 37 °C. A blank release experiment of free FITC-insulin (~5800 Da) solution with an 
equivalent amount of drug to that trapped in VDM−1 was also performed, showing that the 
dialysis membrane (cutoff 12000 − 14000 Da) played a negligible role in the release kinetics. 
The much slower insulin release from the microgels compared to that from the free insulin 
solution indicates a sustained release process from the microgels. The release can be further 
regulated by varying the glucose concentration in the releasing medium because of the glucose 
responsive volume phase transitions of the PBA-containing microgels. The higher the glucose 
concentration in the medium, the more the insulin being released from the microgels, which is a 
basic requirement for self-regulated insulin delivery. For example, only 8.8% of insulin was 
released from VDM-1 after 48 h in PBS buffer solution without glucose. When the concentration 
of glucose was increased to 3, 6, 8 and 15 mM, the percentage of insulin released from VDM-1 




glucose dependent insulin release behavior should be attributed to the binding of glucose with 
the PBA groups in the copolymer microgels, producing negatively charged boronates and 
resulting in the microgel network to swell. The enlarged mesh size of the microgels is easier for 
the insulin molecules trapped in the interior of gel networks to diffuse out. Additionally, the 
copolymer microgels containing different amount of polyMEO5MA segments played different 
release profiles. The insulin can be significantly released from the microgels containing low 
polyMEO5MA segments even at low glucose concentrations of 3−6 mM, which is not desirable 
because the release of insulin at these low or normal glucose levels could cause hypoglycemia. In 
contrast, the increase in the content of polyMEO5MA segments in the copolymer microgels can 
solve this critical problem. For example, at a normal glucose level of 6 mM, 67.4, 29.8, and 19.9 % 
of insulin can be released after 48 h from the VDM−1, VDM−3, and VDM−4 microgels, 
respectively. At abnormally high glucose level (e.g., 15 mM), all the three microgels can release 
out about 85% of the loaded insulin after 48 h. The insulin release profiles from microgels of 
VDM−3 and VDM−4 containing high polyMEO5MA segments are more desirable for self-
regulated insulin delivery to match the diabetic patients’ need, because ideal insulin delivery 
carriers should keep the loaded insulin minimally released at normal glucose levels but release 
rapidly upon reaching hyperglycemia to control glucose levels. First, these microgels containing 
high polyMEO5MA segments only released minimum amount of insulin when the glucose 
concentration is below or in the normal level (4−8 mM)22, 23, which could significantly reduce 
the potential hypoglycemia problem. Second, these microgels could start to deliver the insulin in 
less than 30 min when the glucose level is above the normal range. The sustained release over 2 




studies, these insulin releasing characteristics from the microgels containing high polyMEO5MA 
segments clearly confers the advantages for the self-regulated insulin delivery systems.  
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Figure 6−4 Releasing profiles of FITC-insulin from VDM-1 (A), VDM-3 (B), and VDM-4 (C), 
in the presence of 0 (■), 3(●), 6(▲), 8(▼), and 15(♦) mM glucose in PBS of 7.4. In the blank 
release (◊), the release experiment of the FITC-insulin solution with an equivalent amount of 





























Figure 6−5 In vitro cytotoxicity of the microgels against B16F10 cells.  
 
            Although these microgels present immense opportunities on smart insulin release, it is 
known that the cytotoxicity of the drug carriers is extremely important for their future application. 
Cell viability was quantified by an MTT assay using B16F10 cells. MTT assay was first 
developed by Moamann in 198346. A mitochondrial dehydrogenation enzyme in viable cell can 
cleave the tetrazolim rings of the MTT, forming formazane crystals with a dark blue color. 
Therefore, the number of surviving cells is directly proportional to the level of the resulted 
formazane. Figure 6−5 shows the cell viability upon treatment with the microgel VDM−1, 
VDM−2, VDM−3, and VDM−4, respectively. It is clear that our poly(VPBA-DMAEA-
MEO5MA) copolymer microgels were non- or low-cytotoxic to B16F10 cells after incubation for 
24 h at concentration of up to 208 µg/mL. The high contents of polyMEO5MA segments in the 
VDM−3 and VDM−4 microgels also improved the cell viability due to the biocompatibility of 






6. 3. 5   Glucose-induced volume phase transition of imprinted microgels 
            The imprinted poly(VPBA-DMAEA-MEO5MA) microgels were prepared by one-pot 
method via free radical precipitation polymerization with the same recipe of VDM−3 (Table 6−1) 
but in presence of glucose, MBAAm, and SDS at 70 °C and pH = 8.8, as illustrated in Scheme 
6−3. Previously, Willner’s group successfully imprinted glucose recognition sites by electro 
polymerization of a bis-aniline-crosslinked Au nanoparticles composite containing 
mercaptophenyl boronic acid on an Au electrode47. Our group has exploited an alternative 
method by using glucose to complex the charged PBA groups of the comonomer VPBA at pH ≈ 
pKa (= 8.8) prior to polymerization47. It is expected that when the collective weak interactions 
between the VPBA monomers and the target glucose molecules can form populations of 
complementary binding sites in the resulted polymer chain network24, 25. 
 
Scheme 6−3 Schematic illustration of the approach to the molecularly imprinted poly(VPBA-
DMAEA-MEO5MA) microgels with specific glucose-binding sites for highly sensitive and 




            The swelling process of the glucose-imprinted poly(VPBA-DMAEA-MEO5MA) 
microgel can also occur at physiological pH. Figure 6−6 shows the glucose-induced swelling 
curves in terms of the Rh values as a function of glucose concentration of the non-imprinted 
microgel of VDM−3 and the corresponding imprinted microgels of IVD−1 and IVD−2, measured 
in a 5 mM PBS of pH = 7.4 at 37 °C. First, prepared from the same feeding ratio of all 
comonomers, the three copolymer microgels of VDM−3, IVD−1 and IVD−2 with the same high 
content of poly MEO5MA segments exhibited the same onset of the glucose-induced volume 
phase transitions. The microgels swell very little when the glucose concentration was below ∼3 
mM. Significant glucose-induced increases in the swelling ratios were only clearly observed 
after the glucose concentration was above ∼4 mM. As we discussed above, the glucose-ethylene 
glycol hydrogen bonding interaction and the glucose-PBA binding complexation are competitive 
processes.  Glucose molecules would start to bind with PBA moieties to induce the swelling of 
microgels only after the ether oxygens of the polyMEO5MA segments were saturated with 
glucose molecules. Second, the three microgels of VDM−3, IVD−1, and IVD−2 with a gradually 
increased glucose imprinting degree with [glucose]/[VPBA] ratio of 0, 1:2, and 1:1 in the 
synthesis exhibited an increased swelling ratio (Rh,20mM/ Rh,0mM) of 1.61, 1.66, and 1.69, 
respectively. This result can be explained that the microgels with a high glucose imprinting 
degree can create and rigidly retain more binding sites complementary to the shape of the target 
glucose molecule in the crosslinked polymer network, thus possessing a higher affinity to 





















Figure 6−6 Glucose-dependent average Rh values of the microgels of VDM-3 (■), IVD-1 (●), 
and IVD-2 (▲), in PBS of pH = 7.4. All measurements were made at 37 °C and a scattering 
angle θ = 45°. 
 
6. 3. 6   FITC-insulin loading and in vitro glucose regulated insulin release from the 
imprinted microgels 
            The glucose-imprinted poly(VPBA-DMAEA-MEO5MA) microgels could also serve as 
excellent drug carriers benefited from the stable porous network structure under typical 
administration conditions and the hydrogen bonding complexations of the insulin molecules with 
the copolymer network chains. A drug loading capacity of 36.5 wt% and 36.7 wt% (expressed as 
the mass of loaded drug per unit weight of dried microgels) was determined for IVD−1 and 
IVD−2, respectively. As expected, the glucose imprinting degree of the microgels will not affect 




synthesized with the same feeding of comonomers and corsslinkers, but in the presence of 
different amount of glucose. 
            The glucose-induced volume phase transitions of the imprinted microgels can also be 
used to regulate the release of the pre-loaded insulin. As shown in Figure 6−6, we have 
demonstrated that the increase in the glucose imprinting degree of microgels can slightly 
increase the glucose-induced swelling ratio of the microgels due to the improved glucose affinity 
of the imprinted PBA sites. To examine whether the small increase in the glucose-sensitive 
swelling ratio will affect the insulin releasing behavior from the microgels, the in vitro insulin 
release from the imprinted microgels of IVD−1 and IVD−2 was determined in buffer solutions of 
pH = 7.4 at 37 °C but  different glucose concentrations (Figure 6−7). Similar to the insulin 
releasing behavior from the non-imprinted microgels, the glucose imprinted microgels also 
demonstrated a sustained release of the loaded insulin, which can be regulated by varying the 
glucose concentration in the surrounding medium. Because of the same high content of 
polyMEO5MA segments in the microgels of VDM−3, IVD−1, and IVD−2, all these three 
microgels with different imprinting degree demonstrate a minimum release of insulin when 
glucose concentration was below 3 mM (Figure 6−4B for VDM−3, Figure 6−7 for IVD−1 and 
IVD−2). When glucose concentration was increased to 8 and 15 mM, the releasing percentage of 
insulin can reach to about 56 and 87%, respectively, after 48 h. These results demonstrate a great 
promise for the microgels to serve as a smart insulin delivery carrier. Similar to the effects on the 
glucose-induced volume phase transition, the gradual increase in the glucose imprinting degree 
of the microgels also leads to a slight increase in the insulin release capacity. For example, at 
glucose concentration of 15 mM, the releasing percentage of insulin of VDM−3, IVD−1, and 




increased glucose-induced swelling degree of the imprinted microgels. The higher the glucose 
imprinting degree, the higher the glucose affinity of the microgels, which leads to a larger 
swelling degree and correspondingly a higher insulin release rate. 












































Figure 6−7 Releasing profiles of FITC-insulin from IVD-1 (A) and IVD-2 (B), in the presence 
of 0 (■), 3(●), 6(▲), 8(▼), and 15(♦) mM glucose in PBS of 7.4. All experiments were carried 






6. 3. 7 Optical glucose detection of the core-shell hybrid microgels with Ag NP as core and 
glucose-imprinted poly(VPBA-DMAEA-MEO5MA) gel layer as shell 
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Figure 6−8 Typical UV−vis absorption spectra of the Ag@IVD-2 hybrid microgels. As a 
comparison, the absorption spectrum of the free Ag NPs is also presented. 
 
            Considering the glucose imprinting can create and rigidly retain more binding sites 
complementary to the shape of the target glucose molecule in the crosslinked polymer network, 
we expect that glucose imprinted microgels should demonstrate high sensitivity and selectivity 
for optical glucose detection if an optical code can be installed into the microgels. Here, we 
synthesized a core-shell hybrid microgel using the fluorescent Ag NPs as the core template and 
the imprinted microgel layer (same composition as the IVD-2) as shell in order to convert the 
glucose level change (biochemical signal) into the fluorescence change of Ag NPs (optical 
signals). After the coating of the gel layer, the absorption peak of the Ag NPs red-shifted by ∼13 
nm (Figure 6−8). This red-shift is related to a change in the local dielectric constant around the 




NPs. As shown in Figure 6−9, the resultant core-shell particles have a spherical morphology. The 
markedly high electron density of Ag enables direct visualization of the Ag NP core within the 
poly(VPBA-DMAEA-MEO5MA) microgels. 
 
Figure 6−9 TEM image of the core-shell hybrid microgels Ag@IVD-2 hybrid microgels with 
Ag NP as core and glucose-imprinted poly(VPBA-DMAEA-MEO5MA) gel layer as shell. 
 
            When the Ag@IVD-2 hybrid microgels were dispersed in PBS at pH = 7.4, robust 
photoluminescence (PL) can be detected, because the size of Ag NPs is far smaller than the 
electron mean free path length (∼ 50 nm)48, 49. The reversible glucose-responsive volume phase 
transitions (swelling-shrinking transitions) of the IVD−2 gel shell can modify the 
physicochemical environment and surface tension of the Ag core NPs, thus induce the 
photoluminescence (PL) change of Ag NPs. Figure 6−11 shows the PL spectra of the Ag@IVD-
2 hybrid microgels dispersed in PBS buffer of pH = 7.4 but with different glucose concentrations. 
The Ag@IVD-2 hybrid mcirogels demonstrate a strong peak at about 588 nm, which should be 




clear that the PL intensity of the hybrid microgels was gradually quenched when the microgels 
gradually swelled up at the elevated glucose concentration. One reason for the PL property 
change of Ag NP cores in the hybrid microgels is associated with the variation of the Rayleigh 
scattering through the local refractive index change of the medium surrounding the Ag NPs, 
deriving from the glucose-induced volume phase transition of the microgel50. The non-radiative 
energy loss paths, which are highly dependent on the nature of the environment around the metal 
particles, possibly provide a second scenario for the fluorescence change51. The crosslinked 
copolymer chains tend to expand as the glucose concentration increases. On the other hand, the 
Ag core NPs offer the restoring force to hinder the network expansion, introducing an elastic 
tension in the bond at the Ag-polymer interface that would induce strain at the relaxed Ag NP 
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Figure 6−10 PL spectra of the Ag NPs, Ag@IVD-2 hybrid microgels, and IVD−2 microgels, 
respectively. 

































Figure 6−11 Typical evolution of the PL spectra of the Ag@IVD-2 hybrid microgels in response 
to the increase in glucose concentration change. All measurements were made in PBS of pH = 





            Figure 6−12 summarizes the quenched PL intensity as a function of glucose 
concentration. Interestingly, this plot of the glucose responsive PL property change demonstrates 
a similar trend to the glucose responsive swelling curve (Figure 6−6). When the concentration of 
glucose was increased from 0 to 3 mM, the PL signal at 588 nm of the hybrid microgels only 
quenched by ∼5%. As the glucose concentration was above 4 mM, the increase in glucose 
concentration can induce a dramatic PL quenching until the glucose concentration reaches about 
16 mM where the PL quenching leveled off, corresponding to the same glucose level at which 
the microgel network chains stretched to nearly a maximum (Figure 6−6). Another important 
finding is that the glucose molecular imprinting can dramatically improve the sensitivity of the 
hybrid microgels for glucose detection. As shown in Figure 6-6, the imprinted hybrid microgels 
of Ag@IVD−2 demenstrated a slightly higher swelling ratio of Rh,20mM/Rh,0mM = 1.69 compared 
to the nonimprinted hybrid microgels of Ag@VDM−3 with Rh,20mM/Rh,0mM = 1.61. The PL 
response to the glucose concentration change in terms of a quenched PL intensity shows a 
significantly different value of (I0−I20mM)/I0 = 0.86 and 0.50, respectively for the Ag@IVD−2 
and Ag@VDM−3 hybrid microgels. This result indicates that the slightly larger volume response 
of the imprinted Ag@IVD−2 to the same glucose concentration (e.g. 20 mM) has been 
dramatically amplified to as large as ∼1.64 times in the PL response, demonstrating the 
enhancement effect of the molecular imprinting on the glucose-binding ability. Additional 
experiment of glucose-responsive PL decay of the imprinted imprinted Ag@IVD−3 (nVPBA : 
nglucose = 1:1.5 presented in polymerization) has also performed. The slightly different value of 
(I0−I20mM)/I0 = 0.97, comparing 0.86 of Ag@IVD−2, indicating glucose bonded most of PBA 
group during the polymerization. The glucose-binding ability of imprinted microgels would not 



















Figure 6−12 Glucose-responsive PL decay (I0−I)/I0 of the imprinted (Ag@IVD−2, ●) and non-
imprinted (Ag@VDM−3, ■) hybrid microgels, respectively. Glucose-responsive PL decay of the 
imprinted imprinted Ag@IVD−3 (▲, nVPBA : nglucose = 1:1.5 presented in polymerization) has 
also performed. I0 and I are the PL intensity at 588 nm in the absence and presence of glucose at 
different level. All measurements were made in PBS of pH = 7.4 and 37 °C. Excitation 
wavelength = 492 nm. 
 
6. 4     Conclusion 
            Well-defined glucose-sensitive poly(VPBA-DMAEA-MEO5MA) copolymer microgels 
could be successfully synthesized via a simple precipitation polymerization method. The 
presence of polyMEO5MA segments could retard the poly(VPBA-DMAEA-MEO5MA) 
copolymer microgel network from swelling in response to the addition of glucose. The reason is 
that the formation of hydrogen bonding between the glucose molecules and the ether oxygens of 
the polyMEO5MA segments, which causes no swelling of microgels, is much faster than the 




higher the content of the polyMEO5MA segments in the copolymer microgels, the higher the 
glucose concentration required to initiate the glucose sensitive volume phase transition. Thus, the 
onset point of glucose sensitivity of the copolymer microgels could be tuned through the 
adjustment of the feeding amount of MEO5MA comonomer in the preparation of microgels. 
These newly designed biocompatible glucose sensitive microgels are promising for smart insulin 
delivery carriers, which can release minimum amount of insulin when the glucose level is below 
or in the normal range, but start to release insulin rapidly when the glucose level is above the 
normal range. The higher the glucose level, the faster the insulin release from the microgels.  
Compared to the non-imprinted copolymer microgels, the glucose imprinting of the microgels 
can create and rigidly retain more binding sites complementary to the shape of the target glucose 
molecule in the crosslinked polymer network, thus improve the sensitivity and selectivity of the 
microgels in response to the glucose level change. Additionally, the introduction of fluorescent 
Ag NPs to the microgels can realize the integration of optical glucose detection and self-
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Chapter 7  
Summary  
 
 The overall goal of the work in this dissertation was to investigate the design, properties 
and applications of multi-responsive microgels, especially, their role act as cell scaffolds, 
particular carriers for controlled and targeted drug delivery system and response to different 
environmental stimuli.   
            A cell scaffold could be realized by colloidal supra-structures, which constructed by the 
thermo-driven gelation of the colloidal dispersion of poly(NIPAM-co-AAm) microgels.  
Different from the previous examples in which the VPTT of the temperature-responsive 
microgels are much below 37 oC, making them fully collapsed and possibly hard-sphere-like 
under the physiological conditions, the presented poly(NIPAM-co-AAm) microgels exhibit a 
reversible and continuous volume transition in water with VPTT ≈ 35 oC and remain partially 
swollen and soft under physiological conditions. The constructed colloidal supra-structure can be 
regarded as a model system for a new class of cell scaffolds. More importantly, the size of the 
microgel particles can affect the sol-to-gel phase transition of the microgel dispersions, alter the 
syneresis degree of the constructed colloidal supra-structures, and tailor the cytocompatibility 




            Microgel can also be applied as a drug delivery carrier. In Chapter 4, well-defined 
thermo-responsive PVAS@PEG core-shell microgels with the PVAS microgels as hydrophobic 
core and the nonlinear PEG gel as a hydrophilic shell could be successfully synthesized via 
precipitation polymerization. The rationally designed PVAS core chain networks can effectively 
store the hydrophobic curcumin drug molecules via hydrophobic interactions, thus provide high 
drug loading capacity. The nonlinear PEG gel shell composed of the copolymer P(MEO2MA-co-
MEO5MA) with the comonomer ratio of MEO2MA:MEO5MA = 1:2 could not only increase the 
stability of the core-shell microgels dispersion in aqueous media, but also prevent the PVAS 
hydrophobic core network from collapsing. This designed structure of hydrophobic core with a 
large mesh size in the core-shell microgels can load hydrophobic drug molecules much more 
effectively, which indicates that both the drug-core hydrophobic interactions and the mesh size 
of core networks are important to determine the drug loading capacity. The thermo-sensitive 
nonlinear PEG gel shell of the microgels could trigger the drug release by local temperature 
change, offering sustained drug release profiles.  
            A magnetic Fe3O4 NPs has been involved in microgel in Chapter 5. The magnetic hybrid 
nanogels appear to be quite suitable for being a drug targeted carrier, due to their capability of 
delivering pharmaceuticals to a specific site of the body by means of a gradient magnetic field. 
The core-shell structure nanogel composed of the magnetic Fe3O4 NPs core and poly(4-
allylanisole)-PEG double-layer gel shell could be successfully synthesized via precipitation 
polymerization. 4-allylanisole, a natural organic compound produced by many conifers and 
herbs, is general consider as a biocompatible polymer. It is usually used in the preparation of 
fragrances and a flavoring additive of bakery products and beverages. Similar like PVAS in 




gel can form strong hydrophobic associations with the aromatic phenols in curcumin molecules 
to form intermolecular complexes, resulting in relative high drug loading capacity. 
            In Chapter 6, a class of well-defined glucose-sensitive microgels polymerization from 
VPBA, DMAEA, and MEO5MA is synthesized as an insulin drug release carrier. The presence 
of MEO5MA monomer could retard the glucose-sensitive network from swelling because the 
rapid hydrogen bonding between the glucose molecules and the ether oxygens of the MEO5MA 
is prior to the glucose binding to the PBA groups.  The onset point of glucose sensitivity of the 
microgels could be controlled through the adjustment of the feeding amount of MEO5MA 
monomer. Glucose-imprinted microgels that polymerized in the presence of glucose can 
increases sensitivity of glucose. The introducing of Ag NPs to the microgel realized the 
integration of glucose detection and self-regulated insulin delivery into a single nano-object. 
These newly designed biocompatible glucose sensitive microgels are promising for insulin 
delivery carriers, which can detect the glucose level at the same time as well as regulate the 
insulin release from the microgel only after the glucose level is above critical zone in diabetes 
management.   
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